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Summary Polypeptide growth factor signaling, such as exerted by the Transforming Growth Factor type  (TGF) family system, is crucial to steer several processes within cells, including cell proliferation and differentiation, cell survival and cell death, and cell migration in embryogenesis, but also in adult tissue homeostasis and repair. The many extracellular ligands of this family provide these cues via binding to surface receptor complexes that initiate a number of biochemical cascades, with a major one being dependent on the intracellular Smad proteins. The resulting intracellular set of signals ultimately shape a regulatory network of transcription, characterized by tight, temporal and precise control of target gene expression in ligand-stimulated cells. This intricate transcriptional network is, like many other operating regulations on TGFβ family signaling within these cells (e.g. receptor complex assembly, endocytosis of liganded receptors, controlled stabilization versus degradation of the components), highly regulated at several co-operating layers to achieve the eventual activation or repression of the downstream target genes that will steer the cellular response of the stimulated cells.    Here we make use of several perturbation methods (knockouts, knockdowns) followed by omics based analysis in selected cells isolated from mouse models (and embryonic cells thereof) to focus on the effects on the transcriptome and connecting these to the DNA-methylome (in the embryonic stem cells (ESCs) used in part of these studies). In addition, we document how effects of bone morphogenetic proteins (BMPs) and Activin/Nodal, key members of the TGF family, together with their signal transduction and downstream components are themselves dynamically integrated in this network, particularly by using ESCs, which are well-suited for such experiments. Furthermore, we extend our research to two in vivo model systems to investigate more complex interactions within a developing embryo.   In Chapter 2 we present the development of a new strategy to deconstruct the transcriptional interactions between genes encoding components of prime interest of our signaling pathway and the transcriptional regulators and drivers of a cell differentiation system, 
i.e. mouse ESCs in neural inducing environment. We have first optimized many aspects of the experimental set-up and then documented and subsequently integrated a transcriptional regulatory network in three dimensions. We started by selecting and prioritizing, based on precise criteria, a small, manageable TGF family centric network for which we (i) analyzed the temporal kinetics of mRNA levels together with (ii) the systematic documentation of cell-stage specific gene-gene interactions based on esiRNA-mediated perturbations. We then added another layer of refinement (iii) by assessing the transcriptional heterogeneity at the single-cell level. This has provided an unprecedented and more systems level insights for TGFβ signaling thereby also moving beyond the – often binary and linear – understanding of its pathway(s) and target gene expression output. This potentially provides a new starting point to better understand complicated cellular responses and also improve differentiation protocols for various stem cells ex vivo in which this relevant signaling system operates.   Cellular systems, such as ESCs, and their use in studies of cell lineage determination, differentiation and/or maturation are indeed an invaluable tool to study more detailed mechanisms and processes that often require strict control of environmental cues and exclusion of confounding factors. In Chapters 3 and 4 we investigate the concept of pluripotency and 
   
some of its emerging phases in mouse ESCs and how it affects the downstream cell fate potential. In the first study we generated clones of Zeb2 knockout (KO) mouse ESCs and subjected them to both neural and general differentiation. Zeb2 is an important transcription factor in health and disease. Its functions include the response and control of TGF family signaling and Zeb2 is crucial for neuroectoderm versus mesendoderm formation in human ESCs. Here we carried out temporal RNA-sequencing (RNA-seq) and DNA-methylome (reduced representation bisulfite sequencing, RRBS) analysis to illustrate that Zeb2-deficient mouse ESCs subjected to differentiation protocols stall in an early epiblast-like state. These mutant ESCs remain competent to revert the initially acquired DNA-methylation marks which is also associated with reduced irreversible commitment in normal cells. In the second study we used a similar approach, i.e. a (double-)knockout of two of three major BMP-Smads (Smad1 and Smad5) and complemented this with a BMP-responsive reporter gene in mouse ESCs to examine the role of BMP signaling in naïve pluripotent cell states. With the help of RNA-seq and RRBS we concluded that although BMP-Smad signaling appeared dispensable for ESC self-renewal, it modulates lineage priming by transiently regulating the DNA-methylation machinery.   In Chapters 5 and 6 I carried out comparable omics studies in selected cells of knockout mouse models to study the effect of Zeb2 deficiency in specific cells of the developing mouse forebrain. Here, mainly RNA-seq was used to highlight potential affected pathways and identify underlying mechanisms of action and generate new hypotheses, which were then tested experimentally. This work brought to light novel biological effects and action modes of the multi-faceted transcription factor Zeb2.   In Chapter 7 I summarize how our embryology laboratory has explored a more systems-biology type of approach for the first time via this PhD research. This meant moving away from the one-gene-at-a-time strategy it had been and is using successfully for a long time to study 
TGFβ family signaling in vertebrate embryos. Furthermore, I discuss how it has opened several new research lines by combining higher-throughput experimental methods with combinations of genome-wide next-generation omics based experiments. I conclude by explaining how our recent work has provided a strong basis for exploring and leaping into single-cell biology and analysis, which re-addresses and fine-tunes many studies of analysis of cell state(s) and differentiation, including those that connect extrinsic signaling to intrinsic cellular responses in cells in health and disease.  
  
   
Samenvatting Signalering via polypeptide groeifactoren, zoals deze gebruikt door de Transformerende 
Groeifactor type β (TGF) familie, is cruciaal om verschillende processen te sturen in cellen, inbegrepen hun celdeling en differentiatie, hun overleving en gecontroleerde dood, hun migratie in het embryo, maar ook in adult weefsel homeostase en weefselherstel. De vele extracellulaire liganden van deze familie leveren instructies aan cellen door te binden aan receptorcomplexen aan het celoppervlak en daarna een aantal biochemische cascades initiëren, waarin een zeer belangrijke afhankelijk is van intracellulaire Smad eiwitten. De resulterende set van signalen geven ultiem vorm aan een regulatorisch netwerk dat gentranscriptie controleert en hierbij een strikte, temporele en precieze controle mogelijk van de transcriptie van doelwitgenen in gestimuleerde cellen. Dit ingewikkeld transcriptioneel netwerk wordt, zoals vele andere operationele regulaties in TGFβ familie signalering (zoals de samenstelling zelf, en de manier waarop, van de receptor complexen, de endocytose van ligand-receptor complexen, de gecontroleerde stabilisatie of degradatie van de componenten), ook sterk gereguleerd op meerdere niveaus om uiteindelijk de juiste doelwitgenen te activeren of inhiberen die het antwoord van de cel bepalen.    Hier gebruiken we verschillende perturbatie methoden (knockouts, knockdowns) gevolgd door op ‘omics’ gebaseerde analyse van geselecteerde cellen van de muis (of embryonale cellen ervan) en pasten dan bio-informatische analyses toe om ons vooral te richten op de effecten op het veranderend transcriptoom en dat soms (met name in dat deel van onze studies die gebruik maakt van embryonale stamcellen (ESCs) te verbinden met analyses van het DNA-methyloom. Bijkomend brengen we in kaart hoe de effecten van beenmorfogenetische proteïnes (BMPs) en Activin/Nodal, sleutelliganden van de TGF familie, samen met hun signaaltransductie en andere stroomafwaartse componenten zelf dynamisch geïntegreerd worden in dit netwerk, opnieuw door gebruik te maken van ESCs, die hiervoor zeer geschikt zijn. Vervolgens breiden we ons onderzoek nog uit naar twee in vivo modelsystemen om meer complexe interacties te bestuderen in een ontwikkelend embryo.   In hoofdstuk 2 presenteren we de ontwikkeling van een nieuwe strategie om transcriptionele interacties te deconstrueren tussen genen die coderen voor geprefereerde componenten van het door ons bestudeerde signaalpad en de transcriptieregulatorische eiwitten die ESCs sturen naar neurale differentiatie. Eerst hebben we de experimentele benaderingen op vele punten geoptimaliseerd en dan het geïnfereerde netwerk gedocumenteerd en geïntegreerd vanuit 3 dimensies. Wij zijn dus getart met de selectie en prioritering, op basis van precieze criteria, van een klein, beheersbaar moleculair TGF familie centrisch netwerk waarvoor we (i) de temporele kinetiek van de mRNA niveaus analyseerden, samen met (ii) het systematisch documenteren van celstadium specifieke gen-gen interacties gebaseerd op esiRNA-gemedieerde perturbaties. Vervolgens voegen we nog een extra laag van verfijning toe door te onderzoeken (iii) wat transcriptionele heterogeniteit op het niveau van enkelvoudige cellen bijdraagt. Dit leidt tot een volledig nieuw, meer systeemniveau inzicht in TGF signalering waarin we voor de eerste keer ook de vaak binaire en lineaire voorstelling van dit (deze) signaalpad(en) en doelwitgen modulatie verlaten. Dit laat ons mogelijk toe om voortaan de complexe cellulaire antwoorden processen beter te begrijpen, maar ook het differentiatieprocedures verschillende stamcellen (in celcultuur) waarin dit relevant  signaleringssysteem operatief is, te verbeteren. 
   
  Cellulaire systemen, zoals ESCs, en hun gebruik in studies van celdeterminatie, -differentiatie en -maturatie zijn inderdaad een onmisbaar werktuig om in detail de mechanismen en processen te bestuderen waarin meestal strikte controle van omgevingsfactoren en mogelijkheid storende factoren te elimineren. In zowel hoofdstuk 3 als 4 exploreren we het concept ‘pluripotentie’ (en enkele van de fasen ervan die momenteel worden gedocumenteerd) in muis ESCs en gaan we na hoe dit gepaard gaat met veranderingen in het ontwikkelingspotentieel van deze cellen. In een eerste studie werden Zeb2 knockout muis ESCs gegenereerd en als ‘embryoid bodies’ gestuurd in neurale en algemene differentiatierichting. Zeb2 is een belangrijke transcriptiefactor, inbegrepen in het antwoord op TGF familie signalering, in gezonde en zieke cellen. Zeb2 vervult bovendien ook een cruciale positie in de vorming van neuroectoderm versus mesendoderm in humane ESCs. Hier gebruiken we temporele RNA-sequencing (RNA-seq) en DNA-methyloom (reduced representation bisulfite sequencing, RRBS) analyse om te illustreren dat Zeb2-deficiënte muis ESCs onder differentiatiecondities voornamelijk reeds stoppen in een vroege epiblast-achtige staat. Bovendien behouden zij de competentie om reeds gemethyleerde DNA sequenties te reverteren naar hun originele staat. Dit staat in scherp contrast met de veronderstelling dat in normale cellen, inbegrepen ESCs, DNA-methylering geassocieerd is met onomkeerbare differentiatie. In een tweede studie, opnieuw in muis ESCs, volgden we een gelijkaardige strategie: in dubbel-knockout muis ESCS voor Smad1 en Smad5, de twee voornaamste (van drie) BMP-Smads gebruikten we o.m. ook een BMP-gevoelig reportergen om de rol van BMP signalering in de ESC naïeve pluripotentie status te onderzoeken. Deze analyses werden weer uitgevoerd gebruik makend van RNA-seq en RRBS. Wij konden besluiten dat BMP signalering, ondanks dat het niet cruciaal lijkt voor het in stand houden van de pluripotente status, zorgt voor priming van celdifferentiatie door transiënt een  impact te hebben op de DNA-methylatie machinerie. In de 
hoofdstukken 5 en 6 voerde ik gelijkaardige ‘omics’ studies uit in geselecteerde cellen van knockout muis modellen om het effect van Zeb2 genetische inactivatie te bestuderen in specifieke cel types van de ontwikkelende voorhersenen van een muis. Voornamelijk RNA-seq werd hiervoor gebruikt om potentieel misgestuurde signaaltransductiewegen en de onderliggende mechanismen op te sporen en aldus ook nieuwe hypothesen te formuleren, waarvan een paar experimenteel konden worden getest. Dit bracht nieuwe biologische effecten en actiemechanismen van de veelzijdige transcriptiefactor Zeb2 aan het licht.    In hoofdstuk 7 geef ik een kort overzicht hoe ons embryologie laboratorium voor het eerst via dit doctoraatsonderzoek een meer systeem-biologisch type van aanpak heeft geëxploreerd en hiermee het pad verliet van de één-gen-per-keer-studie dat het lab lange tijd succesvol heeft toegepast en nog toepast in studies van TGFβ familie signalering in embryos van gewervelde dieren. Verder bespreek ik hoe mijn onderzoek de wegen heeft geöpend naar verschillende nieuwe onderzoekslijnen door het te combineren met ‘higher-throughput’ experimentele  methoden met combinaties van genoomwijde ‘omics’-gebaseerde  experimenten. Ik besluit dan met een uiteenzetting hoe dit recente onderzoek een sterke basis heeft gelegd voor de exploratie van, en er een stap in voorwaarts te zetten, in de analyse van individuele cellen, inbegrepen in studies van analyse van celstatus en –differentiatie, inbegrepen deze die extrinsieke signalering verbinden met intrinsieke cellulaire antwoorden in gezonde en zieke cellen.  
 
   
 
  
   
Scope of this thesis My PhD research represents many years of team work. It describes investments in cellular systems (by others and myself) and mouse model systems (by others) on the one hand and building an extensive bio-informatics expertise (with myself and therefore also for the laboratory) on the other hand. In doing so, it provided a crucial contribution to a strategical transition in our embryology team that was decided many years ago. Moving to a non-reductionist, more global approach has provided a clear advantage over the previous use of reductionist approaches, wherein a combination of biochemistry and functional genomics in vivo was repeatedly and successfully used for studying one protein/gene at a time in one biological context/process and/or experimental setup at a time.    The latter approach, fully illustrated by the content of the different selected Chapters of this PhD thesis text, aimed at: 
- increasingly using ‘omics’, here in particular transcriptomics and DNA-methylome analysis, in selected cell types to find indications for possible action mechanism(s) in an unbiased instead of educated-guess way, with the aim to explain cellular (including stem cells) or tissue/organ defects in (mainly) cell-type specific knockout embryonic and early post-natal mouse models (see Chapters 3-6); 
- mapping and understanding how upon such perturbations (e.g. loss-of-function, knockdown) of one component of a signaling system may generate compensatory mechanisms via modified and dynamic intra-family transcriptional cross-talk and how this also affects other key regulators of cell state (i.e. transcription factors as part of gene regulatory networks). This was a novel approach in the field of TGFβ family signaling at the start of this PhD research (see Chapter 2); 
- establishing bio-informatics expertise, needed for this type of studies, in our team (all 
experimental Chapters).   After a broad, concise introduction addressing the major aspects of this PhD research (Chapter 1), I present a format that untes both Erasmus MC and KU Leuven recommended PhD thesis styles and describe the results and my role in the following projects: (i) Establishment of a new perturbation method in cultured mouse ESCs to address transcriptional cross-talk by selected players within a cell state and fate determining (TGFβ family) signaling system, which is the true core of my own work (Chapter 2). (ii) Molecular phenotyping of Smad1/5-deficient mouse ESCs via trancriptomics and DNA-methylation analysis (Chapter 3). (iii) Similar to Chapter 3, the molecular phenotyping of Zeb2-deficient mouse ESCs (Chapter 4). (iv) Molecular phenotyping, including by RNA-sequencing, of Zeb2-deficient embryonic and early postnatal cells of a neurogenic niche in the mouse forebrain (Chapter 5). (v) Molecular phenotyping, including by RNA-sequencing, of Zeb2-deficient GABAergic interneurons of embryonic mouse ventral forebrain (Chapter 6). I round off the work reported in this PhD thesis with a General Discussion, including also selected future perspectives (Chapter 7). 
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1.1 Mammalian development and early cell-fate decisions   Fertilization, i.e. the fusion of the haploid male sperm cell and female mature oocyte, establishes the diploid zygote, which is the single-cell origin of an entirely new animal. This zygote contains all necessary information and instructions to develop into a multi-cellular, increasingly complex embryo capable of performing both basic self-organizing and sustaining processes (e.g. mesoderm formation and establishing the primitive body plan) as well as highly specialized tasks throughout embryogenesis, certainly in the case of mammals where the embryo implants in the uterine wall (Rossant and Tam, 2009). In order to complete this series of complex transitions and stepwise cell fate decisions successfully, a cascade of tightly controlled spatio-temporal cellular and molecular processes emerges shortly after fertilization. Due to its relative fast development (despite the slow first cleavages of the zygote to create early multi-cellularity) and high breeding intensity Mus musculus (i.e. lab variants thereof) serves as a well-suited species to interrogate the consecutive steps of mammalian embryogenesis, although it also has some unique characteristics (i.e. embryonic turning, cylinder-shaped pre-gastrulation embryo etc) (Takaoka and Hamada, 2012).   In the first three days the mouse zygote undergoes a series of asynchronous, slow cleavages (of the rotational cleavage type in mammals), which results in modest and slow increase of cell number without significant gain in total size of the embryo, which will only become possible immediately after implantation. Around embryonic (E) day E3.0 a first subtle variance between individual cells can be observed, when one or few cells get completely surrounded by other embryonic cells and as such acquire differences in polarity and cell-cell contact. This co-triggers the formation of two distinct cell populations and initiates the first cell-fate choice leading to the formation of trophectoderm (TE) and inner cell mass (ICM) cells from predominantly outer and inner cells, respectively (Figure 1.1). One of the best studied molecular pathways involved in this first lineage bifurcation is the HIPPO signaling pathway, which is influenced by cell polarity and is repressed in the outer cells (Anani et al., 2014). This leads to the induction of TE-specific genes, such as Gata3 and Cdx2 (Ralston et al., 2010; Home et al., 2012). In the next step Cdx2 reinforces this early bifurcation by inducing the expression of other TE-related genes (e.g. 
Eomes) and (in)directly inhibiting the expression of the gene-triad Pou5f1, Nanog and Sox2 (Strumpf et al., 2005) that form the regulatory core of ICM fate commitment. Furthermore, this triad has been shown to be – at least partially – responsible for the repression of TE-specific genes in the ICM cells (Nichols et al., 1998; Chen et al., 2009) .   Next this meanwhile – in mammals – compacted ball of cells develops further into a structure named the blastocyst, which contains a fluid-filled cavity, the blastocoel. The TE cells line up around the outer side and will later serve implantation and contribute to placental structures. At the same time the asymmetrically located ICM cells (at the embryonal pole of the blastocyst) make a second cell-fate decision and reposition themselves according to their new fate, thereby segregating into two discrete layers that will become either epiblast (EPI) or hypoblast (i.e. primitive endoderm, PE) cells at E4.5 (Figure 1.1) (Rossant and Tam, 2009). PE cells contribute to definitive endoderm (DE) (Kwon et al., 2008) and engage in the formation of the parietal and the visceral endoderm, the latter becoming later part of the extraembryonic yolk sac, but also providing an important signaling center as anterior visceral endoderm (AVE) in the future head region of the embryo, where different from the posterior side of the embryo 
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primitive streak (PS) formation has to be inhibited (Hiramatsu et al., 2013). EPI cells will form all embryonic (and resulting adult) tissues and also contribute to extraembryonic structures; these cells are pluripotent. The molecular process underlying this second cell-fate decision encompasses the gene-triad Pou5f1, Sox2 and Nanog together with Gata6, which are each expressed in early ICM cells (Guo et al., 2010). However due to differential responsiveness of some cells to Fgf4 – whose effects are mediated via Fgfr2/MAPK signaling – they can either adopt an EPI or PE specific fate, respectively with high Nanog / low Gata6 or low Nanog / low Gata6 mRNA and protein levels (Yamanaka et al., 2010; Boroviak et al., 2015). Interestingly, these players create an intricate transcriptional network to stabilize and enforce the aforementioned second decision. First Sox2, Nanog and Pou5f1 can induce the expression of 
Fgf4 in EPI-cells resulting in an increase of this paracrine-acting ligand, which also causes upregulation of Gata6 in the PE-cells (Frum et al., 2013). Secondly, Nanog and Gata6 seem to be part of a double-negative feedback loop in both cell types, thereby restricting each other’s expression (Bessonnard et al., 2014). Finally, Pou5f1 (Oct4) is also involved in the cell autonomous induction of both EPI and PE genes (Frum et al., 2013). This dual role of Pou5f1 in two different cell types is currently best explained through its binding with cell-type specific TFs, i.e. Sox2 in EPI and Sox17 in PE (Aksoy et al., 2013). Subsequently these distinct Pou5f1-centered protein complexes can recruit the transcription initiation complex to different target genes in the respective cell-types, e.g. Gata4, Pdgfra, Sox7 and in PE cells Sox17 itself.                 
Figure 1.1 (next page) Overview of early embryonic development and cell fates. Shortly after fertilization of the female ovum with the male sperm cell a zygote is formed (E0.5), close to the ovary, in the ampulla. Through a series of asynchronous, slow cleavages the number of cells increases, forming a non-compacted morula (E3.0). This morula-stage embryo has inner and outer cells giving rise after compaction of the embryo to two different cell types, i.e. the inner cell mass (ICM) cells and throphectoderm (TE) cells, the latter forming the trophoblast later in the embryo. The ICM and TE cells rapidly create the blastocyst (E4.5) wherein the ICM cells subsequently segregate into Epiblast (EPI) and Primitive Endoderm (PE) cells. As peri- and post-implantation the blastocyst undergoes a series of dynamic morphogenetic changes generating (in the mouse) an egg cylinder (containing a proamniotic cavity) that implants in the hormone-prepared uterine wall. Importantly, pluripotent stem cell populations representing different developmental phases (i.e. named as naïve, intermediate and primed, see Chapter 1.2.1) can be derived in vitro from a continuing spectrum of in vivo embryonic stages. Figure taken from Takaoka and Hamada (2012). 
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    The subsequent time window of development is perhaps the most intriguing process in embryogenesis. Probably due to its 3-dimensional and increased complexity, this has not received the same degree of attention and research in recent years as the early stages of pluripotency and cell fate decisions described above. It starts shortly after implantation of the late blastocyst in the uterine wall (E4.5-5.0 in the mouse) and comprises a congruent interplay of symmetry breaking, axial formation, cellular movements and germ layer specification. Ultimately this leads to a primitive body plan comprising of embryonic definitive endoderm, mesoderm and ectoderm, whose cells will enter further differentiation and maturation and establish functional tissues and organs through a process called organogenesis (Brink et al., 2014). In short, embryonic endoderm gives rise to lungs, liver, pancreas and the digestive system; mesoderm is responsible for the formation of skeletal, muscular/tendon, circulatory and reproductive systems, and ectoderm to forming skin and the nervous system (see Chapter 1.2.2). In addition a temporary group of cells, the neural crest cells, originate from the ectodermal lineage and further differentiate according to their anterior-posterior location at the dorsal midline of the embryo and delamination and extensive migration, leading ultimately to a diverse ensemble of ectomesenchymal cells, including cells of the peripheral nervous system (PNS) (Patthey and Gunhaga, 2014).   
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1.2 Modeling and steering of early embryogenesis 
 
1.2.1 Pluripotency and priming  Mouse embryonic development is still a fairly short phase ending with birth after approximately 3 weeks of gestation. To overcome this limitation of a long time span researchers put great effort to capture specific cell states using in vitro cell growth conditions that mimic the in vivo spatio-temporally defined cell populations, especially for those of the pre-implantation and the early post-implantation stage embryo (Figure 1.2).   
Conventional mouse embryonic stem cells (mESCs) Undoubtedly, one of the most influential discoveries was made by both the Evans/Kaufman and Martin teams, when they were able to isolate ICM cells of early-blastocyst stage mouse embryos and cultivate them in undifferentiated status on mitotically inactivated, LIF-producing (see 
below) feeder cells in the presence of serum and establishing the first mouse embryonic stem cell (mESC) lines (Evans and Kaufman, 1981; Martin, 1981). In addition to their pluripotent potential – like ICM cells – these mESCs are able to self-renew in the appropriate conditions and in theory provide an unlimited source of cells. This allowed the studies of pluripotency maintenance and exit, differentiation potential ex vivo and genetic and epigenetic mechanisms driving these processes. In subsequent work, the extrinsic signals able to maintain mESCs were LIF and BMP4 (Ying et al., 2003a). In fact, LIF – together with appropriate extracellular matrix - could substitute for feeder cells by activating the JAK-STAT3 pathway resulting in the establishment of the pluripotency network (Smith et al., 1988; Williams et al., 1988). BMP4 binds to a receptor complex containing its cognate receptor BMPR1a (also named ALK3) that can phosphorylate and activate SMAD1/5. Some of the best documented downstream targets of BMP-mediated Smad signaling in mESCs are members of the Id gene family that can inhibit the expression of many genes related to mESC differentiation (Ying et al., 2003a) and Cdh1 (E-
Cadherin). Co-operatively they maintain stem cell fate (Malaguti et al., 2013). Non-Smad signaling  exerted by BMP4 occurs and relies on inhibition of MAPK pathways (Qi et al., 2004). This extrinsic control eventually converges on a number of TFs, with Pou5f1 and Sox2 as true core regulators that can inhibit differentiation and maintain the ‘naive’ state resembling the early epiblast cells of the ICM of the early blastocyst.   In the last years it has emerged that the use of these conventional culture conditions results in a naïve ‘metastable’ state in which mESCs present themselves in at least 2 interchangeable and transcriptionally different subpopulations that show morphological differences and variable degrees of permissiveness to differentiation cues. Best known examples of genes displaying heterogeneous mRNA expression are Nanog (Chambers et al., 2007), Dppa3 (Hayashi et al., 2008) and Zfp42 (Rex1) (Toyooka et al., 2008). Although there are claims that these observations might also be due to artifacts associated with the use of fluorescent-based reporter protein in such studies (Faddah et al., 2013), it is generally accepted that these fluctuations reflect a tenable dynamic equilibrium capable of balancing self-renewing and differentiation-poised states (Kolodziejczyk et al., 2015).   
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Ground-state mESCs To identify a true ‘blank’ state of stem cell identity and deal with the aforementioned heterogeneity in the transcriptomes of mESCs, the team of Austin Smith was able to establish a more homogeneous state, accompanied with increased self-renewal capacity and reduced spontaneous differentiation. This “ground” state (Ying et al., 2008) is believed to represent the earliest EPI-cells, shortly after segregation of PE-cells from the other ICM cells. They showed that exposure to an autocrine fibroblast growth factor (Fgf), i.e. Fgf4, is the first driver of differentiation acting through ERK signaling. Chemical inhibition of this pathway prevented differentiation into any lineage (Kunath et al., 2007). In addition, they discovered that inhibition of glycogen synthase kinase 3 (GSK3) could alleviate the Tcf3-mediated block on downstream genes of the Wnt signaling pathway and hence promote self-renewal of the cells. The prime target here was Esrrb, since its forced overexpression could substitute for GSK3 inhibition (Martello et al., 2012). The best cocktail to maintain mESCs in the ground state is therefore the combination of the 2 respective inhibitors (2i) in the medium, supplemented with LIF (referred to as 2i/LIF). This characteristic ground state cell population displays uniform and high expression of Pou5f1, Sox2 and Nanog and their encoded proteins act cooperatively by recruiting a variety of co-activators and TFs (e.g. Stat3, Ctnnb1 and Smad1). This results in their binding to overlapping regions within target genes, including their own promoters, thereby creating robust positive auto-regulatory feedback loops that maintain the pluripotent state. This induced network consists of many other TFs, such as Klf2, Klf4 and Tbx3, which can safeguard the network against stochastic or less impacting differentiation cues.  
Epiblast and epiblast-like stem cells Pluripotency is for most workers in the field merely a functional term and hence not associated with strict molecular signatures. In fact, it would be favorable to associate the term pluripotency with a continuous spectrum of states, captured in vitro, which ideally share an in vivo equivalent developmental stage(s), starting from the newly formed blastocyst to certain epiblast-derived cell populations of the late-gastrula embryo.    It is possible to culture pluripotent cells that better resemble the post-implantation pre-gastrula or late-gastrula epiblast cells. These are often commonly referred to as ‘intermediate’ or ‘primed’ cells, indicating that they are poised for further lineage commitment and are in a developmentally more advanced state. Although the core of their transcriptional regulatory network (TRN) still consists of Pou5f1 and Sox2, they display fundamental molecular, morphological and functional differences. To maintain their TRN they seem to primarily depend on FGF2 and Activin A induced signaling pathways (Brons et al., 2007), resulting in a partially different set of active TFs. Moreover these cells have undergone substantial epigenetic changes, including X-chromosome inactivation and a significant gain of DNA-methylation, and they are less efficient in contributing to chimeric blastocysts. Interestingly, small changes in culture conditions or timing in this later developmental window give rise to states displaying different molecular and functional properties. For example, epiblast stem cells (EpiSCs) resemble more the anterior primitive streak (Kojima et al., 2014) and cannot be efficiently induced to primordial germ cell (PGC) fate, while the more recently described epiblast-like cells (EpiLCs) share more homology with the earlier post-implantation epiblast (E5.5-E6.5) and seem ideal for PGC induction experiments (Hayashi et al., 2011). However, it is unclear whether these EpiLCs can be maintained as long-term cultures using current growth conditions.  
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Primordial Germ Cells (PGCs) and Embryonic Germ Cells (EGCs) During mouse development, germ cell fate is induced at around E6.0 by a gradient of BMP4 that originates in the extraembryonic ectoderm and spreads towards the future posterior end of the egg cylinder where the PGCs will form around E7.25 (Lawson et al., 1999). Furthermore, embryonic germ cells (EGCs) can be derived from these PGCs at even later stages and they exhibit almost identical properties as ICM-derived ESCs when cultured in 2i/LIF or serum/LIF (Leitch et al., 2013). This is for example apparent from their global DNA-demethylation state and by the important role for Prdm14 as critical transcriptional regulator.  
  
Figure 1.2 Spectrum of pluripotent states in developmental progression. Pluripotent stem cells can be derived from a continuing spectrum of developmental cell stages of the mouse embryo. The cella that are most naïve and less restricted in their developmental potential are derived from the ICM, between E3.5-E4.5, and are referred to as ground-state or conventional mESCs, depending on the growth conditions (for details, see text) and their associated molecular and morphological differences. Conventional mESCs are grown in serum-supplemented media and display heterogeneous and interconvertible mRNA expression levels for several pluripotency genes, such as Rex1 (Zfp42). More primed cell populations can be derived from the peri- and post-implantation epiblast at around E5.5-E8.0. Embryonic germ cells (EGCs) can be derived from primordial germ cells (PGCs) and share almost indistinguishable characteristics with ICM-derived mESCs. Figure taken from Hackett and Surani (2014). 
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1.2.2 Lineage specification and neural commitment  The first lineage determination of cells of the mouse epiblast starts around E6.0 when cells at the future posterior side of the embryo proper ingress through the PS (Figure 1.3A) (Norris et al., 2002; Nowotschin and Hadjantonakis, 2010; Ramkumar and Anderson, 2011). To achieve their drastic relocation and completing their migration path, these cells need to undergo epithelial-to-mesenchymal transition (EMT) (Thiery et al., 2009). This occurs sometimes together with EMT of the later neural crest cells elsewhere in the embryo referred to as primary EMT. The resulting cells, located and expanding in the embryonic part of the entire embryo between EPI and visceral endoderm (VE), are referred to as mesendodermal progenitor cells that give rise to the embryonic mesoderm and definitive endoderm, plus extraembryonic mesoderm like the allantois and cells that contribute to the formation of the bi-layered (with embryonic ectoderm) amnion and the chorion (with extraembryonic ectoderm) and the yolk sac (with visceral endoderm) (Figure 1.3B). The exact fate of cells of the PS is established in an anterior to posterior sequence and depends on the timing of ingression and position of the PS whose tip, led by the rather few cells of the node, moves to the distal tip of the embryo (Lawson, 1999). The first emerging lineage is the extra-embryonic mesoderm and is controlled by the aforementioned BMP4, produced in the extra-embryonic ectoderm (EEct) (Winnier et al., 1995). Subsequent cells from more middle and anterior PS regions will form cardiac, lateral plate and paraxial mesoderm. At the most anterior PS position (when the node reaches the distal tip) a number of cells will extend their migration and give rise to the axial mesendoderm (notochord and prechordal plate) and (as shown more in detail recently, the majority but not all of) definitive endoderm (DE) (Zernicka-Goetz, 2002). Cells of this latter DE population have been proposed to intercalate also with existing VE to form all endoderm-derived tissues of the embryo (Kwon et al., 2008; Burtscher and Lickert, 2009).   The remaining EPI cells adapt to a more committed ectodermal fate, whereby the cells that are located at the future anterior side of the embryo develop into neuro-ectodermal cell types in a process called neural induction, which leads to the formation of the neural plate. The posterior end of the neural plate was recently shown to indirectly derive from the EPI; it passes through an intermediate state of axial stem cells (Kondoh and Takemoto, 2012; Takemoto et al., 2011; Tzouanacou et al., 2009). Remarkably, this population has been proposed to provide also precursors for the paraxial mesoderm (Figure 1.3B).    The neural plate will undergo neurulation and ultimately form a closed tube at the dorsal side of the elongated embryo with an anterior-posterior pattern reflecting the future brain and downstream spinal cord locations. The ectoderm that is situated in more ventral regions of the developing embryo will ultimately form epidermal cell-types, including the future keratinocytes in the epidermis via preceding periderm formation. At the boundary of this ventral region and the future neural plate the neural crest cells originate. These are a transient group of embryonic cells with high ectomesenchymal potential that are able to extensively migrate and according to their anterior-posterior level of origin contribute to a variety of tissues/organs. This includes 
e.g. the specific craniofacial bones, melanocytes, and cells of the peripheral nervous system (Figure 1.3B) (Ozair et al., 2013) which originate from the interaction between neural crest and sensory placodes in the anterior part of the embryo, and cells of the enteric nervous system, 
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predominantly originating from the vagal neural crest, which partially overlaps with the cardiac neural crest.   
Role of TGFβ family signaling in anterior-posterior axis formation Prior to gastrulation the EEct and VE in the cup-shaped mouse embryo have to discriminate the future anterior and posterior end, hence establish the AP axis (Rossant and Tam, 2009). Via embryonic expression of Nodal in the epiblast, followed by the expression of Bmp4 in the EEct, and a complex interplay of BMP (which is high in the posterior part of the embryo and lower in the distal tip), Nodal (which is high in the distal tip and lower towards the posterior part) and Wnt, the PS will be patterned during gastrulation (Nowotschin and Hadjantonakis, 2010). In addition, the most distal VE cells thickens (Kimura-Yoshida et al., 2005) which are sometimes referred to as distal visceral endoderm, DVE) start to express Cerberus-like (Cerl)-1 and Lhx-1 around E5.5, soon followed by Foxa2, Otx2, Lefty-1 and Dkk-1 around E6.0, concomitant with the progressive location of these DVE cells at the future anterior side, hence its name anterior visceral endoderm (AVE) (Srinivas et al., 2004). The aforementioned secreted antagonists Cerl, Lefty-1 and Dkk-1 protect the anterior EPI from any PS-inductive signals, while on the opposite posterior side the PS is induced (see above) by signals and their cascade that are subject to regulatory feedback (Ben-Haim et al., 2006). Altogether, these expression domains and regulatory events present the first clear signs of an AP axis establishment after which, in the mouse, both gastrulation (see paragraph above) and ectodermal patterning can initiate (Figure 1.3).  
 
Figure 1.3 Germ layer specification and lineage segregation in the mouse post-implantation 
embryo. Lineage specification during early mouse development (E6.5 – E7.5).  A. The developing embryo gradually acquires an egg-cylinder shape at start of implantation. Herein the respective embryonic-abembryonic axis becomes the proximal-distal axis. A molecular cascade of BMP (in light blue) produced in extra-embryonic ectoderm or EEct (in grey), Fgf, Nodal and Wnt signaling and subsequent migration drives the formation of an anterior visceral endoderm (AVE) population (dashed line). This population demarcates the future anterior side and protects the underlying epiblast (EPI) in purple from primitive streak (PS) inducing signals. The PS (in red) will develop at the future posterior side and completes the first anterior-posterior (A↔P) axis. B. Cell lineage diagram with approximate matching colors to panel A. Dashed boxes represent extra-embryonic committed fates. 
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Ectodermal patterning Conceivably one of the best - if not the best - experiments illustrating patterning and the later identified inductive signals was done by Mangold and Spemann in amphibian embryos. Grafting the dorsal blastopore lip, the region where gastrulation initiates in the ball-shaped embryo, from this dorsal side of the early gastrula stage embryo to the opposite, ventral side of an acceptor early gastrula resulted in ectopic (and hence second axis forming) gastrulation. This results in the formation of a twinned embryo, with an extra (second) dorsal axis including an entire second notochord, paraxial mesoderm (somites) and nervous system whose cells (in particular in its paraxial mesoderm and nervous system) were recruited from the acceptor region and acquire a fate they normally never would (Spemann and Mangold, 2001, a revised version of old work). This elegantly illustrated that signals from this unique and dominant grafted tissue (later called the Spemann Organizer) is responsible for the conversion of the acceptor region of the embryo in tissues that normally only are formed at the dorsal side of the embryo, including - as the result of neural induction - the conversion of presumptive ectodermal cells to neural fate. Similar experiments were later performed in zebrafish and the mouse with a similar outcome, except for the mouse where in the second axis a head was never observed (Oppenheimer, 1953; Beddington, 1994).    From the late 80s, the hunt was on for endodermal-derived signals that would induce mesoderm from presumptive ectoderm, and also induce the dorsal mesoderm of the Spemann Organizer and the subsequent signals that pattern the mesoderm (identifying ultimately also a ventral signaling center in the blastula-stage amphibian embryo) or induce the neural ectoderm in part of the ectoderm. The use of the Xenopus animal cap assay facilitated the identification of candidate endogenous and/or added inductive signals, in particular those of mesoderm induction and to a lesser extent those for neural induction. For the latter the experimental results in animal caps were sometimes over-interpreted. The first proteins found capable of inducing mesoderm were FGF and XTC-MIF, identified as Activin A, a member of the  emerging 
TGFβ family (Asashima et al., 1990; van den Eijnden-Van Raaij et al., 1990; Smith et al., 1990). BMPs, identified later as TGFβ family ligands, were found to counteract Activin-induced dorsal mesoderm formation vigorously (Wilson and Hemmati-Brivanlou, 1995), promote epidermis differentiation and strongly inhibit neural tissue formation. Furthermore, different Activin doses were found to yield different mesodermal cell types in the Xenopus animal cap assay (Ariizumi et al., 1991; Armes and Smith, 1997).    While the successful use of animal caps of Xenopus blastula-stage embryos has been crucial for the identification of candidate endogenous mesoderm-inducing signals, the over-interpretation of the results emanating from the use of these same animal caps in studies on neural induction (see above) and the fact that these resulted in different conclusions (in part) from separate observations in chick embryos, caused quite some confusion, such as to whether neural induction by the mesoderm occurs in combination with factors within the neural tissue itself. For example, this assay led to the identification of candidate neural inducers, including Noggin (Smith and Harland, 1992), Chordin (Sasai et al., 1994) and Follistatin (Hemmati-Brivanlou et al., 1994). Each of these is secreted and ligand-binding and therefore called 
antagonists of TGFβ family ligands, in particular the BMPs, hence leading to the default model of neural induction. In any case, this and subsequent work have also led to a working model wherein BMP activity can be dosed to pattern the ventral and lateral mesoderm in the marginal 
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zone of the amphibian embryo and protect the organizer at te dorsal side from BMP activity by the production of secreted, diffusible antagonists for BMP by the organizer itself (Figure 1.4A). This same interplay is re-exploited in the formation of presumptive epidermis (which needs BMP) versus neuro-ectoderm (where BMP activity has to be avoided) (Figure 1.4B) (see, for example, Piccolo et al., 1996 for a system analysis). An interesting observation at that time was that both inductive and antagonistic players show a significant amount of redundancy at this early stage, indicating that single-perturbation or overexpression studies not always succeeded in characterizing the properties of individual players. Later, the antagonist Cerberus joined this list in Xenopus, and meanwhile many more antagonists have been identified and, together with structural studies, their action mechanism documented in detail (see, for example, Chang et al., 2001, 2001; Piccolo et al., 1996).   
 
Figure 1.4 Dorsalizing activity and neural fate specification in Xenopus.  
A. Dorsal view of the early gastrula of Xenopus. The Spemann organizer (O, blue) produces diffusible BMP antagonists such as Chordin, Noggin and Follistatin. This creates an increasing gradient of BMP activity in the overlying ectoderm which leads to positional corresponding fates, respectivily neural plate (NP), neural crest (NC), cement gland (CG) and epidermis (EP). A ventral signaling center is not shown here. B. Illustration of the different ectodermal fates at neurula stages. Figure 1.4A and 4B taken and adapted from Zeeshan Ozair et al. (2013). 
 
Neural induction in mESCs Many approaches have been used for inducing neural or neural-like fates in mESCs. They include the formation of embryoid bodies (EBs), the use of neural-inducing cell lines or the addition of polypeptide factors and/or small molecules. Perhaps the most elegant protocol involved using a defined medium that contains minimal amounts of inductive cues and where the cells were seeded at low density in adherent monoculture, i.e. without feeder cells (Ying et al., 2003b). This latter approach is both the least protrusive and also best in line with the earlier discussed frog-based data, where animal cap cells (grown at low-density and devoid of any inducing activity) can acquire neural fate. Despite these analogies several groups described that neural fate, in line with the aforementioned experiments in chick embryos, could be enhanced by activating the Fgf-Erk signaling pathway (Kunath et al., 2007; Stavridis et al., 2007). Currently it seems more likely that FGF is actually only needed in a narrow time window to exit the naïve pluripotency network and have the cells change their fate to epiblast. This is also in agreement with later discoveries of FGF capable of even inhibiting neural differentiation when added to EpiSCs in differentiating conditions (Greber et al., 2010; Sterneckert et al., 2010).   
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 Based on current knowledge it seems that the conversion from ground-state mESCs to neuro-ectodermal progenitors, which will be exploited in experimental approaches further in this PhD research (see Chapters 2 and 4), covers at least two early transitions and two consecutive lineage commitments. The first transition drives the exit from the  naïve ground-state network into an intermediate naïve cell state that can be maintained by BMP4/LIF (Figure 1.5, red dashed circle) and the second one is the acquisition of a primed epiblast-like state that can be maintained using Activin and Fgf2 (Figure 1.5, blue dashed circle). Thereafter the first cell-fate choice is between ectodermal and mesendodermal fate, where cells of the latter lineage can be induced by adding Activin; hence, this choice resembles in vivo PS induction. Ultimately, all remaining ectodermal cells will develop an epidermal, neural crest, placode or neuro-ectodermal fate (Figure 1.5) which is correlated to some extent to dosed (here: decreasing) levels of BMP signaling activity (Aihara et al., 2010; Qiao et al., 2012). This suggests that the ‘default’ model operates here, whereby mESCs will develop a neuro-ectodermal fate when devoid of any cues (like in the aforementioned Xenopus animal cap explants), further supported by the fact that active inhibition of Nodal (Activin-type) and BMP signaling can ameliorate this conversion in both mouse and human ESCs (Chambers et al., 2009; Najm et al., 2011). This also highlights the necessity for developing cells that allow tight control of their the auto/paracrine 
properties, in particular of the TGFβ family, and their intracellular signal transduction. In addition to expression control of the genes encoding the components involved, it is not yet clear what the relative contribution of other mechanisms is at these consecutive stages, e.g. (post-)transcriptional including (post-)translational regulatory mechanisms (see Chapter 1.3). In a major part of this PhD research I will focus on the transcriptional regulation in the context of intra-TGFβ family cross-talk and incorporation of these mechanisms in the core networks driving ESC pluripotency status and neuro-ectodermal differentiation.    
 
Figure 1.5 Cell-stages in neural conversion of mouse ESCs. Timeline comparison to induce neural fates in In vivo and in vitro conditions (top). In the adherent monoculture protocol, ground-state mESC transition first to metastable (red dashed circle) and then primed (blue dashed circle) stem cells appear, prior to decisions and commitment to differentiation into a specific embryonic lineage (bottom).     
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Cell intrinsic regulation Although the default model of neural tissue formation provides a plausible explanation for the need to inhibit extrinsic pathways, it does not sufficiently explain the downstream and causal mechanisms of neural fate acquisition. Hence it cannot as yet be interpreted as a complete absence of such signaling. Key questions are then as to how the intrinsic components of the signaling pathways are cell-autonomously regulated not only at the transcriptional level, but also post-transcriptionally at each of the possible levels. In particular, which transcriptional and epigenetic co-operative factors are responsible for the induction of neural specific genes and how are these factors (and/or markers) entangled in hierarchical and/or parallel networks?    At the onset of ESC differentiation, either in neural differentiation or in general differentiation protocols, Nanog is immediately downregulated, but Pou5f1 and Sox2 maintain or increase their expression in the mesodermal and neuro-ectodermal cells, respectively (Thomson et al., 2011). This is in agreement with in vivo studies that show that Sox2, during gastrulation, becomes restricted to anterior neuro-ectoderm. In addition its steady-state levels remain high later in development in the neural tube and future brain (Avilion et al., 2003). A mechanistic role for Sox2 at the first stage of lineage commitment in e.g. hESCs might be to compete with Pou5f1 and block the key regulators favoring mesendoderm formation (Wang et al., 2012).   Several other genes that display high expression levels in either mESCs or EpiSCs are important in the induction of neural fate, such as Pou3f1, Zic3 and Otx2 (Kondoh et al., 2016; 
Marchal et al., 2009). An interesting factor is Pou3f1, for which both genome-wide ChIP-seq and RNA-seq combined with overexpression versus knockdown (KD) studies suggest that it is a prime candidate positive regulator of neural-specific genes, such as Sox1, Sox2, Zic1, Zic2, Pax6 and Zfp521 and also is a negative regulator of BMP and Wnt signaling (Song et al., 2015; Zhu et al., 2014).   Other genes only have low or undetectable expression in mESCs or epiLC populations, but have a very strong induction upon neural differentiation and commitment. The zinc-finger transcription factor encoding gene Zfp521 is almost exclusively expressed in the anterior neuro-ectoderm and is crucial and sufficient to induce neural commitment. Furthermore, overproduction of Zfp521 overcomes the BMP4-induced barrier for neural differentiation (Kamiya et al., 2011). Zfp521 likely exerts its strong neural-inducing activity by teaming-up with co-activator p300, thereby upregulating neurogenic genes such as Sox1 and Pax6, TF-encoding genes that are often used as markers of early neuro-ectoderm specification (Shen et al., 2011). Their KD or knockout (KO) studies have shown that interfering with their normal activity during early neural lineage specification in the mouse has little impact, although they sometimes yield later developmental defects (e.g. eye lens).   Zeb2 (Sip1, Zfhx1b) downregulates E-cadherin (Cdh1) and thereby steers EMT, which is relevant to stem cell fate and tumorigenesis (Maruhashi et al., 2005; Wakamatsu et al., 2001). Mutations in ZEB2 cause Mowat-Wilson syndrome (MOWS; OMIM#235730), including defects in the central and peripheral nervous system (CNS, PNS) (Cacheux et al., 2001; Mowat et al., 1998; Wakamatsu et al., 2001). Many in vivo studies confirm the critical roles of Zeb2 in embryogenesis and neurodevelopment in particular. Zeb2 KO mice die shortly after E8.5 and have multiple defects, including defects in somitogenesis (Maruhashi et al., 2005), the neural plate and neural 
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crest cells (Van de Putte et al., 2003). Cell-type specific Zeb2 KO mice develop defects in e.g. the CNS (van den Berghe et al., 2013; McKinsey et al., 2013; Seuntjens et al., 2009) and PNS (Jeub et al., 2011; Van de Putte et al., 2007; Weng et al., 2012). Such studies in embryonic brain revealed cell autonomous, but also non-autonomous Zeb2 actions. In human (h) ESCs, ZEB2 regulates cell fate: upon ZEB2 knockdown (KD) they commit towards mesendoderm, while ZEB2 overproduction enhances neurogenesis (Chng et al., 2010). ZEB2 is controlled by NANOG, OCT4 and SOX2 in hESCs, but key genes downstream of ZEB2 in human and Zeb2 in mouse ESCs, and during early neural development, remain to be determined, and ZEB2 KO hESCs have not been reported.   
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1.3 The canonical TGFβ signaling pathway  
 
1.3.1 TGFβ layers and players 
 Embryonic development is an intricate process that starts from a totipotent zygote that needs to create multi-cellularity by cleavage, and subsequently the embryo must grow and also specialize its cells to form all distinct lineages, in a relatively short time window. For this, the early embryo relies on ligand-driven signaling pathways that converge on cell-specific TFs and epigenetic modifiers to steer the spatial-temporal expression of downstream target genes. These genes will eventually reflect the developmental potential, final fate and function (including maturation state) of a particular cell in development.    One of the most conserved signaling pathways tha is relevant to embryogenesis throughout the animal kingdom (including more primitive invertebrates) is TGFβ family signaling, with the Nodal/Activin and BMP branches as the evolutionarily most ancient family members and the main topic of this Chapter (Huminiecki et al., 2009). Their signaling directionality and downstream route of information processing is quite straightforward. It starts with the presence of extracellular ligands of the family (encoded by 33 genes in total in humans) that can bind to their cognate receptor complexes. These are biochemically well-studied but still continue to reveal interesting new functional and structural aspects in normal development and disease. Briefly, the complexes are composed of two types of transmembrane receptors with Ser/Thr-kinase activity (but co-receptors exist). This activates an internal machinery within the cells. The effector proteins (the receptor-regulated, activated – by C-terminal phosphorylation - Smad proteins), activated by the type I signaling receptor, ultimately accumulate in the nucleus as a complex. They do this mainly with Smad4, which is not activated by the liganded receptor complex, and lead or co-establish target gene transcription in a dynamic chromatin context. The canonical Nodal/Activin and BMP pathways, respectively, are no exception to this linear mode of operation (Figure 1.6). At each of the different layers in the cascade there are specific regulatory mechanisms to fine-tune and direct the informational flow, but also – in particular in the BMP system – involving synexpression, autoregulation and feedforward and feedback mechanisms. This comprises a long list of extracellular growth factors (some of which are controlled by secreted antagonists, see above), a shorter list of receptors and Smads, and many TFs and Smad-TF complexes operating in chromatin context, including those involved in long-range interactions (Conidi et al., 2011).          
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Ligands and receptors The TGFβ family of ligands are synthesized as precursor proteins, the C-terminal domain of which (after cleavage by furin-type protein convertases) represent the mature ligand, which operate as dimers (with the exception of 3 members, i.e. Lefty-1, Lefty-2 and GDF-3, while also BMP-9 has been purified as a mix of dimer and monomer ligand). In a number of cases, the mature ligands remain associated with the pro-domains after secretion, e.g. to provide latency of other types of regulation, which necessitates additional activation mechanisms of such latent ligand complexes other than removing the secreted antagonists by proteolytic activity in order to achieve bio-activity of the ligands (Constam, 2014). More importantly, to create dosed and even gradient-type ligand activities, specific and more broadly secreted antagonists have been described. These include the aforementioned Chordin, Noggin, Follistatin, but also Lefty-1 and Lefty-2, which operate in the embryo, but also in cultured embryonic as well as adult stem cells. Some ligands need non-signaling, membrane-bound co-receptors, such as CDC-EGF (or Cripto, Cryptic) in the case of Nodal.   In general two different types of Ser/Thr kinase receptor, type I and type II, are required and each is essential to elicit a ligand-induced response. There are respectively seven and five type I and II receptors, with varying modes of assembly and biochemical characteristics, based on structure cetermination studies. They form a ligand-bound heterotetrameric complex resulting in the phosphorylation, and hence activation, of the type I receptor by the type II receptor upon ligand binding. Subsequently the type I receptors phosphorylate at two specific Ser residues at and close to the C-terminus of the receptor-specific Smads, thereby activating the Smads (see paragraph above and below). Evidence has accumulated over the years illustrating that many receptor-receptor or receptor-ligand combinations are possible and that multiple additional factors, such has co-receptor presence, density, concentration and also internalization machinery (endocytic routes versus plasma membrane signaling), play important roles in modulating the ligand elicited response (Conidi et al., 2011; Schmierer and Hill, 2007).  Another observation is that heterodimeric BMP ligands can elicit a stronger differentiation response in human ESCs compared to the respective homodimeric ligands (Valera et al., 2010).   
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Figure 1.6 The canonical TGFβ family signaling pathway. Simplified and hence incomplete overview of many important players of the canonical TGFβ signaling pathway. Antagonists can bind and neutralize ligands in the extracellular space. The free ligands  signal via heterotetrameric receptor complexes which leads to phosphorylation and activation of downstream receptor Smads through receptor-associated kinase activity. Activated Smads form a trimeric complex with the co-Smad Smad4 and these complex accumulate in a time and amplitude specific manner in the nucleus. Here they can team up with co-factors and TFs to stimulate or repress transcriptional activity. Smad induced mechanisms can be terminated by their dephosphorylation, but also by cytoplasmic degradation of their complexes, via nuclear export and via upregulation of inhibitory Smads (Smad6 and 7). Denoted components, except these in blue, are part of our study described in chapter 2. 
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Smads Although ligand-dependent signaling receptor complex assembly might occur via more than one mechanism (see for example Schmierer and Hill, 2007) and complex and numerous ligand-receptor interaction patterns have been defined biochemically and functionally, the signaling converges on very few intracellular Smads. There are 3 groups of Smads, comprising the receptor-regulated Smads (R-Smads) Smad1, Smad2, Smad3, Smad5 and Smad9, the inhibitory-Smads (I-Smads) Smad6 and Smad7, and the co-Smad Smad4, respectively.    The R-Smads consist of two conserved domains, the N-terminal (MH1) domain that provides specific DNA- binding and nuclear import and the C-terminal (MH2) domain required for receptor-mediated activation and binding as a R-Smad:Smad4 complex in a mutually exclusive manner. Both domains also bind numerous partner proteins. A less conserved, Pro-rich linker region is situated in between these R-Smad domains, which is also the target of post-translational modifications and hence co-regulate Smad activities through a variety of biochemical mechanisms, including proteasomal degradation of e.g. Smad1/5 via Smurf1-enhanced ubiquitination and downregulation of Smad effects by co-operating GSK3-MAPK phosphorylation of the linker domain (Massagué, 2003).   Activation of R-Smads occurs via phosphorylation at their C-terminal end by the type I receptor which in turn got phosphorylated by the type II receptor in the ligand-bound receptor complex. In general, Smad2/3 is activated by Activin/Nodal and TGFβs, while Smad1/5/8 are activated by BMPs and the related GDFs. Both signaling branches form trimeric complexes by recruiting Smad4 (Figure 1.6). However, recently exceptions have been observed (ranging from unconventional Smad complexes, i.e. of Smad2/3 with Smad1/5, with or without Smad4 (Daly et al., 2008; Furtado et al., 2008; Grönroos et al., 2012; Pereira et al., 2012) that warn for an oversimplification of Smad signaling.    Eventually these Smad complexes act in the nucleus – together with many co-factors and DNA-binding TFs – and exert their transcriptional regulatory role (see next Chapter). An important concept to consider is that this does not encompass a binary on/off response, but rather a dynamic interchange of R-Smad proteins shuttling between cytoplasm and nucleus, after their C-terminal phosphorylation by the receptors and dephosphorylation in the nucleus (Lee et al., 2011), enabling them to (re-)probe the receptor complex with regard to its liganded status.   
Transcriptional regulation Once accumulated as a complex in the nucleus, Smad4 and the R-Smads (except for a Smad2 isoform emanating from alternative splicing) bind directly to DNA via their MH1 domain . They do so with low affinity on Smad-binding elements (SBEs), which are short 5’-GTCT-3’ motifs that can be found in many regulatory regions, including the promoter, of TGFβ-responsive target genes. However, Smad proteins are extremely versatile and rely for their full scala of effects on the interaction with or binding of additional DNA-binding factors (Gaarenstroom and Hill, 2014). Several studies investigating the role of these individual factors on a genome-wide level or within specific loci (including distal elements) have revealed that the mechanism of Smad-
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mediated action is context specific and occurs at all levels of transcriptional regulation. For example, repressive co-factors can be induced by a cell-type specific regulatory network and switch in a next phase into an activating modus (Fei et al., 2010; Koinuma et al., 2009; Lee et al., 2011; Mullen et al., 2011). Smads also interact with chromatin-modifying proteins and hence can modulate changes in expression also via epigenetic regulation (Dahle et al., 2010; Estarás et al., 2012; Kim et al., 2011). They can also directly interfere with or aid in the assembly of the 
transcription initiation complex. Perhaps even more important to consider is that the TGFβ signaling pathway does not act in a contained and limited environment, in terms of both cellular and chromatin context, but performs signaling crosstalk with other signaling pathways (Feng et al., 1998; Hussein et al., 2003; Varelas et al., 2008).    One important question in these various regulatory mechanisms concerns the timing and hierarchy of the recruitment of the co-acting proteins. For now, most evidence point towards an auxiliary role for Smad signaling that depends on the expression and binding of cell-specific master TFs. However, this may very well be an oversimplification as it does not perfectly 
reconcile with the inductive properties of the TGFβ ligands, suggesting that Smads themselves might perform an initial priming function. In that perspective it might be interesting to look in differentiating systems – rather than steady-state – systems how the TGFβ Smad family pathway changes its mode of action or even its overall logic and how it is itself differentially regulated, not only as a single gene, but also as a larger list/network of genes, in consecutive stages.  
 
 
Figure 1.7 Smad binding and chromatin regulation. Smad-mediated transcriptional activity is exerted via numerous mechanisms that are directly associated with the transcriptional machinery. It can help in chromatin looping by recruiting essential co-factors for enhancer-promoter interactions. Smads are known to be in the same complex as master transcription factors and might aid in the nucleosome remodeling and chromatin arrangement phases. Figure taken from Gaarenstroom and Hill, 2014.   
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1.3.2 TGFβ family in pluripotency and differentiation  A perfect example to illustrate the complexity of TGFβ family coordinated transcription, including via non-Smad pathways (involving intracellular kinases), is its role in maintaining pluripotency, and commitment and differentiation to various lineages (Figure 1.8).  
 
Naïve pluripotency For long time the central dogma for maintaining naïve pluripotency in minimal conventional media conditions, i.e. without the use of chemical inhibitors, was the interplay between LIF-activated Stat3 signaling and BMP-Smad1/5 instructed control (upregulation) of Id family genes. However recently the group of Susana de Sousa Lopes (Leiden) and Kohei Miyazono (Tokyo) have, each independently, shown (using double-KO mutant ESCs) that the BMP-Smads Smad1/5 are dispensable for naïve pluripotency. At the same time their work reveals additional cell-specific roles of Smad1/5 via interaction with different Krüppel-like TFs (the Klfs) and priming cells for lineage differentiation through influencing methylation dynamics (see Chapters 4 and 7).   Another ongoing debate is the role of Nodal/Activin in naïve mESC conditions. Genetic studies in the mouse suggest no apparent function in pre-implantation embryos. However, Smad2 co-localizes with the master TFs (abbreviated as OSN) in naïve mESC (Mullen et al., 2011). Furthermore, activation or chemical inhibition of activin-specific receptors Acvr1b/c (also named Alk4/7) triggers the cells to differentiate towards mesendoderm or trophectodermal fate, respectively (Lee et al., 2011). In contrast, another research team observed very subtle roles in dynamic heterogeneity and interplay between BMP and Activin/Nodal, which was dependent on the heterogeneous state of the mESCs as measured by a Nanog-GFP fusion (Galvin-Burgess et al., 2013). The most plausible model is the one wherein developmental genes in mESCs are simultaneously bound by Smad2/3 and specific transcriptional repressor complexes, such as PRC2/HEB (Lee et al., 2015), and hence poised for immediate differentiation.  
Primed pluripotency Activin/Nodal signaling via Smad2/3 is crucial for maintaining EpiSC state (described in Chapter 1.2). It achieves this function together with Fgf, which seems only necessary for boosting the response to Activin. Human ESCs require almost identical culture conditions, although there are differences in the expression of pre-implantation markers and X-inactivation. These discrepancies may a least partially be explained by species-specific differences. However another interesting observation was made in a very recent study involving perturbation approaches, where the expression profiles of EpiSCs derived at different embryonic stages were compared. Albeit with some transcriptional variation. they most closely resembled late-gastrulation stage epiblast and most effectively integrate into the anterior PS (Kojima et al., 2014). This further illustrates that Activin and Fgf signaling lead to a divergence of the normal differentiation path and are certainly not perfect systems to study early-lineage transitions and bifurcations. An elegant solution to this problem might be to use EpiLCs, which form around 48 h after withdrawal of 2i/LIF. These are transient cell populations that on the basis of 
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transcriptome profiling most closely resemble early-postimplantation epiblast stage cells (Hayashi et al., 2011).   The exact role of BMP signaling in primed pluripotency populations was fairly unrecognized until recently. In EpiSCs, stimulation with BMP ameliorates the LIF-induced conversion and de-differentiation to more naïve stem cells. It exerts this role in a Smad1-dependent way by recruiting the transcriptional activator p300 to LIF-responsive genes (Onishi et al., 2014). However, this has not been investigated in EpiLCs where stimulation with BMP leads to an induction of the DNA-binding transcription factor T (Brachyury, a pan-mesodermal marker) in the presence of active Wnt signaling. T can subsequently induce the mRNA expression of either mesendodermal (together with Wnt) or PGC genes. The induction of mesendodermal genes will be inhibited favoring PGC fate in the presence of BMPs only (Aramaki et al., 2013). This simple, but elegant interplay of signaling pathways shows strong analogy with the one causing fate of and within the most proximal PS.   
Lineage commitment One of the unresolved issues in lineage commitment is how a new transcriptional network is established, in particular when many of the main players are shared or have overlapping function(s) between two consecutive, driving transcriptional programs. A prime example of this dual function or even multi-functionality is Pou5f1, which is crucial for both maintenance and exit of pluripotency. This switch is possible through the rapid induction of Otx2 after withdrawal of pluripotency-inducing cues. The TF Otx2 enables the relocation of Pou5f1 to enhancer regions that are occupied by complexes of TF crucial for differentiation (Buecker et al., 2014; Yang et al., 2014). Hence, Pou5f1 acts as a mercenary to execute its transcription induction function. The role of signaling pathways in general is to convey the extracellular message to the intracellular chromatin-level transcriptional control. But also they have very spatial-temporal effects, as was recently shown by the group of Arias and co-workers (Turner et al., 2014). These studies confirmed the global idea of the default model for neural specification and showed that the balance between Activin/Nodal and BMP signaling leads to a more endodermal or mesodermal cell-fate. However they also illustrated that the role of Wnt-signaling was not Iimited to the mesendodermal lineages; instead it co-depends on the level of Activin. Hence Wnt could even support the production of neural precursor cells in the absence of Activin, thereby validating previous controversial claims.  
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Figure 1.8 Role of Nodal/Activin and BMP signaling in early development. Current summary view on the required levels of BMP and Nodal/Activin for the establishment or differentiation of cell fates in cellular in vitro systems, that mimic early embryonic developmental stages.  
1.4 Complex nature of transcriptional control  During its development the embryo harbors and continues to generate diverse sets of cell types that each contain a unique transcriptome (active and repressed genes) within their epigenomic landscape. These cell-type specific expression profiles come about via TRNs, a co-operational ensemble of TFs that exert its collective power by binding to proximal and distal enhancers to 
e.g. activate expression from selective promoters in a genomic 3-dimensional context. In general the following typical experiment can capture the output of this TRN, i.e. its steady-state (m)RNA, by whole-transcriptome analysis. However this is only a small part of its underlying epigenomic build-up, which also includes chromatin conformation and its dynamics (TADs, looping), DNA and histone modifications, and trans or cis-acting molecules such as TFs and non-coding RNAs. This more informative layer of information resulting in a defined transcriptional output is referred to hereafter as the gene regulatory network (GRN). Within the different compartments 
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of the GRN, I will focus most often on DNA-methylation, and its interplay with histone modifications and trans-acting regulators (Figure 1.9A).  
 
Figure 1.9 Interacting facets of transcriptional regulation. 
A. Diagram illustrating the cycle of transcriptional regulation. B. Visualization of three established genomic regions (enhancers, promoters and CpG islands) that play important roles in Pol II complex assembly and transcriptional initiation. C. Different levels of chromatin condensation, histone and DNA modifications, that can directly influence transcription.   
Essential components of transcription The steps towards effective gene transcription are best described as a relationship between gene regulatory elements (GREs) encoded in the genome and their cis and trans-acting regulatory factors, with the ultimate goal of recruiting for most genes of prime interest the DNA-dependent RNA polymerase II (Pol II) at the transcription start site (TSS) of every relevant gene. The best characterized distally located GREs are enhancers and insulators, which stimulate or inhibit recruitment of the Pol II complex, respectively. Active enhancers have distinct epigenetic signatures (see below), and bind cell-specific sets of TF(s) and co-activator(s), which if located at far linear distance can subsequently loop to the promoter region of a gene and initiate the assembly of the pre-initiation complex (PIC) (reviewed in Jonkers and Lis, 2015). Furthermore, recent SMC1-based ChIA-PET data in several cell-lines highlighted and finetuned the role of CTCF and the Cohesin complex in establishing both stable and specific insulating neighbourhoods, wherein most regulatory enhancer-promoter contacts are established (Dowen et al., 2014; Ji et al., 2016).   The PIC consist of several multi-subunits, i.e. general transcription factors, the aforementioned co-activator Mediator, and the Pol II complex itself. Additional binding of activating TFs together with phosphorylation activity of specific cyclin-dependent kinases 
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(CDKs) can induce a series of events that can generally be divided in three phases, based on the position of the Pol II complex and the proteins involved in each phase. The first phase involves the recognition, binding and recruitment of the Pol II complex to the promoter sequence. Hereafter, transcription can start and lead to RNA synthesis, however in eukaryotes the primary elongation is usually stalled rather quickly at promoter-proximal regions, and this Pol II pausing phase needs to be overcome before active and productive elongation can occur. The final step is the termination step which includes the removal of the Pol II complex and transcribed RNA, associated with efficient 3’-end maturation (exerted by CPSF complexes) and poly-adenylation of the transcript (Jonkers and Lis, 2015). Gene steady-state expression levels are mainly defined by the frequency and rate of these consecutive steps in which epigenetic features appear to play a key role (Veloso et al., 2014).    An important role in the fine-tuning of transcription is reserved for proximal GREs, such as CpG islands within the promotor region or regions associated with expression of antisense long non-coding RNAs (Villegas and Zaphiropoulos, 2015) (Figure 1.9B).  
Is the epigenome sculptured like a Matryoshka doll? Our body contains on average 38x1012 cells (Sender et al., 2016) and the genomic DNA of each diploid cell in its unfolded state is about 2 meter long (2 x 3x109 basepairs (bp) and 0.34nm/bp) (Annunziato, 2008). It results in a striking statement  that we have in theory enough DNA (38x1012 x 2 m) to reach out to the sun and back (2 x 150x109 m) (http://neo.jpl.nasa.gov/glossary/au.html) at least 250 times. This would require to stretch it out, but exactly the opposite happens in all our cells in order to contain its DNA within the nucleus. This architectural DNA condensation serves both storage and regulatory roles. The way to achieve this level of compaction is by systematically coiling the DNA in higher order and nested structures. At the basic level DNA presents itself as a double-stranded helix which is subsequently packed around a group of histones and together they form a nucleosome which is the functional unit of chromatin (Figure 1.9C).    Each nucleosome consists of 8 positively charged (hence basic) histones (two copies of each of H2A, H2B, H3 and H4, respectively) that allow the dense wrapping of 146 bp in a 1.65-turn. In addition to the aforementioned histone octamer, another histone (H1) teams up with the nucleosome to create the chromatosome (Venkatesh and Workman, 2015). Next, through a combination of folding and loops, the nucleosomes can be packed further and compressed in fibers, which display their most compacted form during the metaphase in the formation of classic chromosomes. We will not focus further on the role of the higher order chromatin structures or layers, although they are important in many other cellular processes such as mitosis (Woodcock and Ghosh, 2010), but rather restrict ourselves to the higher resolution window of nucleosomes and DNA (Figure 1.9C).      
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1.4.1 Histone modifications and nucleosome remodeling 
 The compaction status of genomic DNA must be very dynamic and can at least in part be ascribed to the change of properties of its different nucleosomes. In addition, the seemingly straightforward histone turnover introduces very discernible effects on defined genome regions. An increase or decrease in the rate of this turnover might make certain regions more or less accessible for i.e. the Pol II transcriptional complex  (Venkatesh and Workman, 2015; Voong et al., 2016). Furthermore, the core histones can be replaced by more specialized variants that alter the physical properties of the nucleosome and hence its binding partners, or they might be completely evicted, repositioned or replaced with the help of ATP-dependent remodeling enzymes. Moreover, the genetic DNA code is joined by another more fluid and complex histone code that is created by covalent modifications (and resulting genomic signatures) of these histones. More than 100 distinct modifications have now been identified, based on e.g. lysine (K) methylation (me) and acetylation (ac). Although these 2 modifications are only a fraction of the histone code they have nevertheless given us already tremendous insight in the role of these post-translational modifications (PTMs) and how they (co-)support the establishment of a TRN.    High levels of H3K4me3 presence are strongly associated with promoter regions, while putative active enhancers can be identified by the presence of H3K4me1 and/or H3K27ac (Hon et al., 2009). The latter PTM was already discovered in 1961 and its action mechanism elegantly illustrates how these modifications might directly alter the chromatin properties. First, acetylation leads to the neutralization of the otherwise positively charged lysine residues, which in turn weakens the charge-dependent interactions between a histone and its negatively charged DNA or other neighboring histones. The consequence is the delineation of a sharp or broad local increase in DNA accessibility and the potentiation of the recruitment of the transcriptional complex (Calo and Wysocka, 2013).    H3K27me3 is associated with an inactive or poised enhancer and plays important roles during development (Hagarman et al., 2013). Although many other histone marks have been discovered and mapped using high-throughput technologies, such as ChIP-chip and ChIP-seq, their impact and outreach is not always completely understood. Impairments of these complexes which are often associated with specific transcriptional states do not necessarily result in strong transcription defects. It may be that they provide a starting layer and that more specific context is needed, or that more of these PTMs should simultaneously be analyzed in an interacting and interrelating network.   
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Figure 1.10 Chromatin modifications and functional regulatory regions during development. Histone modifications and protein occupancy denote functional elements and transcriptional activity of chromatin. A. Repressed chromatin is characterized by methylation of H3K9, linked to HP1 and Polycomb binding respectivily, absence of acetylation, CpG promoter methylation and overall nucleosome compaction. B. Poised enhancers and promoters in SC represent a bivalent modification state, with methylation of H3K4 and H3K27, presence of (paused) RNA Pol II, p300, possible pioneer factor binding and PCG proteins, as well as being in an accessible state. C. Active enhancers are marked by H3K4me1, H3K4ac, presence of TFs and p300. D. Active promoters are characterized by overall high acetylation, H3K4me3 and Pol2 released from stalling via phosphorylation of both S5 (initiation) and S2 (elongation, gene body). Figure and legend (modified) taken from Gaarenstroom and Hill, 2014.   
1.4.2 Exploring the fifth base 
 Already since 1975 it was known that the pyrimidine ring of Cytosines could be modified to carry epigenetic information. Methylation of position 5 in cytosine (5-methylcytosine or 5mC) has been observed in plants, animals and fungal models and, due to its high abundance, also known as the fifth base of the genetic code. This highly conserved modification has significant impact on development, gene expression and genome stability. Methylation is most prevalent to palindromic CpG dinucleotides with symmetric methylation patterns on both strands (mC:mC). Nevertheless non-CpG methylation has been observed; it is relatively enriched in specific cell types, such as oocyte, ESC and neuron (Wu and Zhang, 2014).  
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Gain of methylation In mammalian cells there are two major players, Dnmt3a and Dnmt3b, that establish de novo DNA-methylation through their DNA methyltransferase activity (Okano et al., 1999). The preferential localization of the Dnmts was recently elucidated by using biotin-tagged proteins in combination with ChIP-seq in mESCs (Baubec et al., 2015). CpG-rich regions were highly enriched for Dnmts, however not when these CpG-regions were part of CpG-islands that were positive for H3K4me3, a marker for promoter regions in active genes (discussed in 1.4.1). In addition, also active distal enhancers bound by TFs displayed lower levels of DNA- methylation and Dnmt-binding.   Dnmt3l is enzymatically inactive, but has modulatory roles towards Dnmt3a/3b (Goll and Bestor, 2005). Another DNA methyltransferase, Dnmt1, is crucial for maintaining established methylation patterns including those that are inherited during cell division. Dnmt1 has the ability to detect hemimethylated CpG (C:mC) together with its complex partner Uhrf1 and to restore the full and symmetrical methylation pattern (mC:mC) (Liu et al., 2013). This is indeed of key importance during mitosis when the newly synthesized DNA strand loses its methylation marks, which is a process known as replication-dependent passive loss of 5mC (Wu and Zhang, 2014).  
Loss of methylation Passive loss cannot fully explain global genome-wide loss of 5mC during specific developmental events, i.e. development of the early ICM in the blastocyst, and formation of PGCs. In agreement with the resemblance of ground-state mESC to the early ICM stage they also display a global low level of DNA-methylation.    To induce or maintain a low DNA-methylation level cells rely on the activity of the ten-eleven translocation (TET) family of DNA dioxygenases that are able to stepwise oxidize 5mC to (first) 5-hydroxymethylcytosine (5hmC) and further to 5-formylcystone (5fC) and 5-carboxycytosine (5caC) (Ito et al., 2011; Pfaffeneder et al., 2014).  There are 3 members in this family, Tet1-3, whose enzymatic function each leads to an accumulation of 5hmC/5fC/5caC. Dnmt1 (see above) displays only minor activity on these oxidized Cytosines and hence replication-dependent passive dilution of methylation will increase. In addition, several active replication-independent demethylation mechanisms have been described or proposed in recent years.  
Tet regulation and localization In the mouse oocytes and zygote only Tet3 is expressed, whereas in most adult tissues both Tet2 and Tet3 are. Expression of Tet1 is limited to specific populations in the embryo, i.e. in cells of the ICM in the blastocyst (as such also in mESCs) and in developing PGCs (Wu and Zhang, 2014). In mESCs Tet1 is under direct control of pluripotency-associated TFs (Neri et al., 2015).   TET-mediated oxidization also shows strong preference for CpG dinucleotides and hence 5hmC is almost exclusively observed in this context. However in most cell types CpGs are methylated by default. An interesting paradox is unveiled at CpG-rich or high-CpG promoters 
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(HCPs) which often overlap with known CpG-islands where very low methylation and high levels of Tet1 are a hallmark with  almost no detectable 5hmC (Shen et al., 2013). This suggest that Tet1 plays another role at the promoter regions that is not dependent on its catalytic function. In contrast, intermediate or low-CpG promoters (ICPs or LCPs) display an enrichment of Tet-generated 5hmC. In stem cells many of the ICP or LCP associated genes belong to lineage-specific genes, which often also show bivalency and are in a transcriptionally poised state (Xu et al., 2011).   5hmC can be detected at both active enhancers and poised tissue-specific enhancers, although binding of TFs requires a very local depletion of 5mC and 5hmC. At present the exact recruitment of the demethylation machinery to these enhancers has not been mapped in detail, although transcriptional co-activators like p300 and DNA-looping might play an important role.  
Methylation dynamics during development As explained before, DNA-methylation is a dynamic and active mechanism executed by agonistic and antagonistic players; these play key roles in the spatiotemporal control of the methylome. In early development there are two major reprogramming events concerning DNA-methylation. In the first one the paternal and maternal genome in the zygote becomes hypomethylated by a fast (active demethylation) and slow (passive demethylation) mechanism, respectively (Smith and Meissner, 2013). Subsequently, the hypomethylated ICM of the blastocyst gradually acquires DNA-methylation during epiblast formation (Auclair et al., 2014). A similar pattern and extent of methylaion can be observed for the in vitro cultured counterpart cells. Indeed, ground-state mESCs are globally hypomethylated, with a function for Prdm14 that is able to inhibit the expression of Dnmt3a, Dnmt3b and Dnmt3l. Conventially grown mESCs show already high levels of methylation, even close to differentiated cells, which might indicate that the methylation machinery performs faster in these conditions. A second event concerns the global erasure of DNA-methylation occurring during PGC development which happens in two phases. Early-PGCs separate from the (methylated) epiblast and undergo replication-dependent passive dilution of 5mC, with again a possible role for Prdm14 to block expression of the de novo methyltransferases (Leitch et al., 2013). Here, functional Tet1/2 does not seem to be required. However, in the next phase, Tet1 demethylates very specific loci such as parental imprints or promoters of PGC-specific genes.   The role of Tet enzymes in more mature tissues is currently being pursued actively by many teams. Most evidence on their role has been gathered in the developing brain where all three 
Tet genes are expressed and where some specific cells types display exceptionally high levels of 5hmC (Rudenko et al., 2013). Altogether this indicates a possible important role for 5mC oxidation; this is further supported by both knockdown and overproduction of Tet proteins during neural differentiation; here it results in neuronal differentiation deficits and induction of corticogenesis, respectively (Santiago et al., 2014). 
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1.5 Connecting the dots  Biological systems are inherently complex because they have to comprise a broad range of functions and intrinsic potential. Stem cells are a prime example as they must be able to self-renew, divide, differentiate, migrate, but also interact with their environment and be part of higher-level systems such as adult tissues/organs. For this, they rely on a rather limited number of genes and - through environmental cues and challenges - they can activate as well as repress specific regions resulting in the construction, assembly, operation and regulation of thousands of system components. To describe and understand these interacting and dynamic multi-component structures, biologists had to abandon their reductionist “one-gene(-only)-at-a-time” experiments and advance to more systems-biology approaches. Moreover systems biology will yield more than just knowledge for the specific cells/systems studied, for it established tools and technologies enabling to enter interdisciplinary work and even beyond, such as computer science, biology, bioinformatics, physics and more. The role and structure of biological networks have been extensively reviewed in (Alon, 2007; Parikshak et al., 2015; Zhu et al., 2007). In the following first part of section 1.5.1 I will merely summarize the most important aspects that are necessary to understand the concepts that are used in Chapter 2.  
1.5.1 Networks 
 
World of networks The best way to describe and study multiple interacting components, including those in a biological system, is through the formation of networks, and even nested networks. Tissues themselves and certainly organs contain different cell types that can directly interact and/or signal to each other, our brain being a prime example. Within these cells and cell types a number of different networks, such as protein-protein interaction, protein phosphorylation and metabolic interaction networks are operating. Here, I will mainly discuss the combination of transcriptional regulatory networks established by e.g. TF-target combinations (biochemical interactions) and genetic interactions.    TF-target networks have largely been elucidated via two methods, identification of genome-wide TF binding sites with ChIP-seq (or ChIP-chip) or via perturbation approaches (see next paragraph). Perturbations can also be used to infer more general interaction or association networks not limited to TFs, in particular in cases where the focus is on the phenotypic output and biological implications. Similarly co-expression networks, which utilize the term ‘guilt-by-association’ to link components, usually show a varying degree of overlap with the aforementioned causality-driven networks. These networks also play important roles in the fast-growing field of epigenomics because they are a direct result of the underlying multi-layered DNA gene-regulatory network. Despite the fact that the players and interactions within all aforementioned biological networks are obviously different by nature they nevertheless show remarkably similar characteristics and properties.     
 Chapter 1  31
Network build-up The global topology of a network is defined by its components (nodes or vertices) and connections (edges) between these nodes. Depending on the nature of these edges we define a network as undirectional or directional. Protein-protein interaction networks are usually considered to be undirected, while protein phosphorylation networks are always directed since the kinase always targets its substrates and not the other way around. TF-target networks add another layer of refinement to directed networks by providing a positive or negative sign to the operating interactions because most TFs can exhibit both activating and inhibiting roles on their target genes. In addition it is possible to provide discrete and quantitative information about node and edge properties and visualize them by changing graphical parameters such as shape, color and width. For example, in a ‘weighted’ network the width of the lines that represent the edges is proportional to the measured strength of the connection.    A deeper insight in network topology will provide a better understanding of the network layout and competencies. Some of the most commonly used topological features comprise degree, distance, diameter, clustering coefficient and betweenness (see Figure 1.11). Degree represents the number of edges that connect a node in the network. In a directional network we can make an additional distinction between ‘outgoing’ and ‘incoming’ edges, i.e. out-degree and in-degree. Nodes with high out-degree are well-connected and hence influential players, often referred to as ‘hubs’. Distance then measures the shortest path between two nodes in the network, while diameter is the maximum distance between any two nodes in the whole network. Both diameter and average distance reveal the closeness of nodes within a network. Networks with a small diameter are often referred to as ‘small world’, whereby any two nodes can be linked together in only few steps.    Another indicator to determine network compactness is through determining the clustering coefficient of the nodes. Here, we calculate a ratio for the interactions between its neighboring nodes and the maximal theoretical number of interactions that are possible. Clustering coefficients provide a tool to identify highly interconnected subnetworks within a network. Betweenness calculates the fraction of the shortest paths between any two nodes that go through one specific node. Nodes that display high betweenness can be seen as critical regulators for a specific path. However, this assumes that most information flows via the shortest path and hence it does not take longer, alternative routes into account.   
 
 
 
 Chapter 1  32
Figure 1.11 (previous page) Understanding network properties. 
A. Representation of network components. Nodes or vertices (grey dots) are connected by undirectional or directional  edges. In specific cases the latter edges can be subdivided in activating (+) and inhibiting (-) edges. B. Network properties in an undirectional network: degree represent number of outgoing edges (6 for red node) or incoming edges (3 for green node), since this is an undirectional network out-and in-degree are the same. The shortest path between 2 nodes is termed distance and the longest path between 2 nodes (red) of the same network is the network diameter (2 red nodes). Clustering 
coefficient is the ratio of the edges between neighboring nodes (red edge) and all theoretical edges between these nodes (dashed edges) for a given node (red). Betweenness indicates how many times the shortest path between 2 nodes (red) goes through the node of interest (green).   An interesting observation for the majority – if not all - biological networks (Figure 1.12) is that they are scale-free, indicating that they have few nodes/hubs with many edges and many nodes with only few edges. This can easily be visualized by showing the relationship between the degrees, and by the probability of observing that degree in any node, which displays a power-law distribution. There are at least two interpretations to explain the omnipresence of similar scale-free networks. The first and perhaps most intuitive one is based on the well-known evolution theory. Hereby evolution ‘designs’ networks through favorable adaptations, i.e. connections with hub genes, such as crucial master TFs during development, might lead to an advantage while loss of non-hub genes has little effect. The higher probability of disease causing mutations in non-coding regulatory regions (Khurana et al., 2016), such as in enhancers and TAD/insulator boundaries, provides strong evidence for this theory. Nevertheless it might have to be compared with the second theory which is based on Dobzhansky’s statement “nothing in biology makes sense, except in the light of evolution”. Herein, the rewiring of regulatory networks is explained by high-probability events – e.g. likelihood of mutations examined and confirmed by biophysical and biochemical experiments - in an evolution time-scale that inevitably converges to the formation of scale-free networks. As always, the truth probably is situated somewhere in between these two views since they are not mutually exlusive and can even be complementary (Sorrells and Johnson, 2015).  
 
 
Figure 1.12 Biological network structure. Scale-free network topology (left) consists of hubs (red nodes) that have a high out-degree and are typical for most biological systems. Random networks (right) do not show any topological characteristic features.  
Network comprehension Despite the fact that we can describe the properties of a network, the end result is still rather descriptive and often culminates in the formation of big hairball-like structures that do not lead 
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to immediate, tangible conclusions or useful interpretations. Therefore, researchers have focused on extracting network modules or overrepresented network motifs. Network modules comprise a limited number of nodes that are highly interconnected and thus more likely to perform cooperative or smaller, better discernable functions. Interesting network motifs are those that occur at a much higher frequency than observed in randomized networks. In addition these network motifs have intrinsic properties that can be propagated to the entire network and as such likely also to the system itself. Many motifs can be identified with increasing number and complexity depending on the kind of network (e,g, undirectional vs signed directional) and number of nodes of the motif one is examining.     Two interesting 3-element motifs are feedback and feedforward loops (FBLs and FFLs, respectively). As an example I selected the different FFLs - meanwhile known to be overrepresented in transcriptional networks - in the context of a TF-target signed directional network. The basic design of such FFL consists of 3 nodes: a regulator A, which regulates B and C; an intermediate player B, which also interacts with C; and C, which receives input form A and B. In our experimental context of the major part of this PhD research A and B are TFs, but C can in fact be any kind of protein/gene. Since all 3 interactions can be positive (activating) or negative (inhibiting) there can be a total of eight possible conformations. Four of them are termed coherent, indicating that both TFs A and B have the same interaction on C, while in the other cases they will be incoherent (see Figure 1.13). Similarly, in FBLs A would only target B, B would target C, and C would target back to A. In this situation, depending on the signs of the interactions, there are four positive and four negative feedback loops, specifying that any node either reinforces or inhibits itself.   It is important to note that network motifs are never stand-alone structures, instead they are always part of an integrated and more complex harmony of motifs.  
 
Figure 1.13 Network motifs: feed-forward and feed-back loops. Three element network motifs with positive and negative edges are shown. A. A and B are TF components and C is any target gene of the system. On the left are four types of coherent feed-forward loop (FFLs): in these the sign of the direct path from A to C is the same as the indirect path via B. On the right are 4 incoherent FFLs: the sign of the direct and indirect path are not the same. B. A, B and C are all TF components of the system. There are four positive and four negative feed-back loops (FBLs).  
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Causality and multiple associations through perturbations The first type of genetic perturbation, including in mESCs, was based on chemical mutagenesis or (near-)random vector or transposon integration and termed ‘forward’ genetics (Novick et al., 1980). Large-scale screens using this approach were able to generate large panels of mutant phenotypes, after which the mutant gene was mapped back and identified, which was markedly facilitated with the emerging improved molecular methods. Shortly after the discovery of RNA interference (RNAi) (Guo and Kemphues, 1995), which allows to target with high specificity (despite off-target effects), the field of reverse genetics grew substantially with large screens performed in different cell types and species, including stem cells (Ding et al., 2009; Fazzio et al., 2008; Gingold et al., 2014). Several medium and large-scale perturbation approaches are available and they each show specific advantages and disadvantages.    The most recently emerged, most promising and already validated technique is CRISPR/CAS9 mediated gene KO (Cong et al., 2013). It acts at the DNA level and is capable of creating null or mutant alleles in a high-throughput manner (Wang et al., 2016). It is not yet clear enough to what extent it produces absolutely no off-target effects, which may depend on cell type and the KO gRNA itself.. It usually generates definitive changes, which might cause the cells to develop adaptive mechanisms (e.g. strengthening a different parallel path in their transcriptional network) and does not allow yet to perturb cells effectively at selective and consecutive stages during development, although this will be tried by many teams. A more simple technique is perhaps the use of siRNA and shRNA that can be readily applied to larger numbers of cells with limited specific needs. However since these RNAi methods will often lead to incomplete degradation of their target and they do not always guarantee a significant or sufficient loss at the protein(-activity) level. On the other hand they can be used at several time-points during a differentiation protocol and it is less likely they considerably change the structure/architecture of the TRN.    A recognized problem arises from off-target effects, for example due to partial complementation with other RNA transcripts. To overcome the latter problem the group of Frank Buchholz (Dresden) developed the endoribonuclease prepared siRNA (esiRNA) approach. esiRNA is produced by cleaving doubled-stranded RNA by E. coli endoribonuclease III and has been shown effective in various screens in mammalian cells (Kittler and Buchholz, 2005; Kittler et al., 2004). The main advantage originates from the fact that one creates a pool of siRNAs which all target the same RNA transcript, but differ in their off-target effects and thereby dilute the overall off-target effect. In addition, the same team has developed an algorithm to identify the optimal target region of the gene-of-interest and implemented it as the freely available tool DEQOR (Henschel et al., 2004).   Despite the elegance of these tools and the majority of scientists in biology working with a limited set of model organisms it was the life-long work of Eric H. Davidson in purple sea urchins (such as Strongylocentrotus purpuratus) that contributed significantly to the understanding, role and logic of GRNs in a developing embryo (de-Leon and Davidson, 2007; Li and Davidson, 2009). They systematically mapped lineage-specific genes in developing sea urchin embryos, ideal embryos to retrieve the spatiotemporal expression context, and combined this with antisense morpholino-mediated KD of TFs. Altogether this generated a  
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causal GRN (Su et al., 2009; Li et al., 2012; Ben-Tabou de-Leon et al., 2013) or - in their own words - “a network that could explicitly show why all aspects of a developmental process occur the 
way they do” that was further molded into an in silico network able to successfully predict the outcome of potential perturbations (Peter et al., 2012). On a side note, Davidson also advocated the use of hypothesis-driven experiments which he believed were being pushed aside by the very big, diverse and often non-coherent sets of genome-wide data.   In the last decade the generation of developmental regulatory networks has strongly increased, using both small-scale experiments and genome-wide set-ups. The latter provide an important additional advantage since it does not only reduce the size of the unknown “black box”, but provides the data to derive important cis-regulatory logic, which is likely as important as the actual network players themselves (Potier et al., 2014). Perhaps the most complete network is provided by the Caenorhabditis elegans field (see wormweb.org). This microscopic roundworm is eutelic (not counting the egg and sperm cells) and consists as an adult of 959 lineage-traced cells and is studied by a remarkably open community of scientists to build the first virtual organism (openworm.org and https://www.dnalc.org/view/15281-A-good-organism-to-use-for-genetic-research-Sydney-Brenner.html). Research in mammals is however nowhere near this goal. Most network based research is still focused on one specific cell-type and steady-state process, such as pluripotent stem cells (Nishiyama et al., 2013). Hence these networks cannot be easily transferred to a different set-up. However, important steps have been set, and it is clear that networks are dynamic. For example, the group of Aviv Regev (The Broad Institute, Boston, USA)  studied the role of naïve T-cells and how they differentiate to T-helper cells upon exposure to inductive cytokines or pathogens (Amit et al., 2009). This process takes several days and therefore they combined both multiple perturbations of regulatory factors with temporal profiling of mRNA abundances to computationally model a dynamic regulatory network (Yosef et al., 2013). In another study conducted in zebrafish (Danio rerio) they incorporated both spatial and transcriptional heterogeneity information. Their approach consisted of combining in situ expression studies of the animal cap with single-cell RNA-seq profiling which resulted in a complex dataset that was analyzed by computational inference. Interestingly, the methods, logic and dataset showed very similar characteristics with the pioneering work of Eric Davidson performed several years earlier in sea urchins (see also Cameron, 2015).   
1.5.2 Single-cell heterogeneity 
 If we think of the epigenetic landscape as already proposed in 1957 by Waddington where cells are represented as marbles rolling down a hill, they encounter ridges and valleys and may not take the same path. In the most simplistic scenario they will ultimately lead to different differentiated cells. However for many years researchers have simplified these marbles to a population of cells, i.e. bulk cell populations. In many situations this was justified by demonstrating that these bulk cell populations showed an “acceptable” degree of homogeneity. However, what then defines homogeneity or ultimately the existence of different cell types? It 
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can, for example, be based on features such as gross morphology, established markers, cellular activity or gene expression.  
 
 
Pitfalls at the bulk-cell level in addition to inevitably increasing the general confusion amongst scientists with time (see below), the recent rise of single-cell transcriptome profiling has of course clearly indicated that that bulk cell measurements can lead to misinterpretation of data, mainly due to averaging of the signals from single cells (Trapnell, 2015). Hence it can lead to an underestimation of sometimes subtle subpopulations of cells. An easy to understand example is the correlation of 2 genes in an otherwise morphologically homogeneous cell population. While bulk cell data might suggest a negative correlation, proper grouping of single cells, based on the expression of another gene or marker, might completely oppose the earlier claim (Figure 1.14A). With regard to semantics we might also question or be careful with the use of terms such as cell “state” and “fate”. These are terms that biologists tend to present in a black-and-white context, however they probably no longer hold when observed in the framework of temporal, single-cell data. It might be interesting to unravel how specific processes behave over time, i.e. do they follow a continuum of states or rather discrete steps of variable size?   Understanding homogeneity as a concept is difficult - especially when realizing that mammalian cells have at least around 20,000 dimensions, i.e. the number of possible expressed genes alone – and it makes us realize that single-cell measurements are also valuable in following situations: (i) perturbation of a heterogeneous cell population can induce the expression of a specific transcript. However at the bulk cell level this increase can be due to an increase of this transcript in just one subpopulation or it might lead to a change in composition of subpopulations (Figure 1.14B). Both outcomes cannot be discriminated form each other, but the functional implications and conclusions are substantially different; (ii) a similar situation occurs when cells are instructed to differentiate. The high increase of a cell-type specific marker cannot rule out the presence of another side-population, hence potentially valuable information will be lost (Figure 1.14C).    These situations are definitely not a rare or improbable event, since distribution profiles of transcripts are very skewed with a long tail towards very high expression (Ståhlberg and Kubista, 2014). This means that the majority of transcripts are often produced by a minority of the cells.   
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Figure 1.14 Bulk cell vs single-cell experiments.  
A. Failure to identify heterogeneity in bulk cell samples leads to incorrect conclusions. An apparent negative correlation between gene A and B can be observed in non-grouped cells, however with proper clustering this correlation is positive in both subpopulations. B. Perturbation and read-out at the bulk cell level does not allow  a discrimination between a shift in population composition or an increase of expression for a particular gene transcript (red). In both situations the increase of the number of transcripts is the same. C. Analogous logic as for panel B. Illustrates the possible misinterpretation of a transcript increase during differentiation.  
Transition to single-cell analysis and early findings Several ingenious genomic assays have been developed in the last years and few have been shown to work even at the single-cell level such as Hi-C and ATAC-seq (Nagano et al., 2013; Pott and Lieb, 2015). However single-cell transcriptome analysis is still the most widely used, irrespective of the criticism that ultimately one will have to document the protein levels and/or activities. Many technological breakthroughs have helped to distribute these transcriptomic methods. Microfluidic devices such as these provided by Fluidigm facilitate the creation of single-cell RNA-seq libraries or allow performing single-cell RT-qPCR on an almost daily basis with limited efforts. Another very promising technique developed in the lab of Steve McCarroll (Harvard Medical School, Boston, USA) is Drop-seq, which allows the profiling of thousands of individual cells in a single-experiment using a droplet based system (Macosko et al., 2015).   Already several labs have applied these methods to multiple cell types identifying – sometimes rare – cell populations or changes in gene expression variance (Wills et al., 2013). 
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Particularly the pluripotent states of ESCs have been thoroughly investigated. This resulted in the identification of two states in mESCs cultured in conventional serum/LIF conditions, a differentiation primed and a more pluripotent state. However at the same time mESCs in the ground-state that do not display these subpopulations show an equal amount of transcriptional variance. This is due to increased variability for cell-cycle related genes in these cells, while lineage specific and bivalent genes are more variable in conventional cultures of mESCs (Kolodziejczyk et al., 2015). Shortly after, the group of Guo-Cheng Yuan (The Dana-Farber Institute, Boston, USA) revealed that these highly variable gene clusters were inherently linked to different chromatin states and that this could be directly attributed to the extracellular culture environment (Guo et al., 2016). Another interesting perturbation study combined with single-cell profiling illuminated the role of micro-RNAs as potential inducers of transcriptional heterogeneity in these cells (Kumar et al., 2014).    
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Chapter 3 or The role of BMP-SMAD signaling in pluripotency 
3.1 Summary 
 Naïve mouse embryonic stem cells (mESCs) are in a metastable state and fluctuate between inner cell mass- and epiblast-like phenotypes. Here, we show transient activation of the BMP-SMAD signaling pathway in mESCs containing a BMP-SMAD responsive reporter transgene. Activation of the BMP-SMAD reporter transgene in naïve mESCs correlated with lower levels of genomic DNA-methylation, high expression of 5-methylcytosine hydroxylases Tet1/2 and low levels of DNA methyltransferases Dnmt3a/b. Moreover, naïve mESCs, in which the BMP-SMAD reporter transgene was activated, showed higher resistance to differentiation. Using double 
Smad1;Smad5 knockout mESCs, we showed that BMP-SMAD signaling is dispensable for self-renewal in both naïve and ground state. These mutant mESCs were still pluripotent, but they exhibited higher levels of DNA-methylation than their wildtype counterparts and had a higher propensity to differentiate. We showed that BMP-SMAD signaling modulates lineage priming in mESCs, by transiently regulating the enzymatic machinery responsible for DNA-methylation.   
3.2 Introduction 
 Culture conditions affect features of mouse embryonic stem cells (mESCs), such as their proliferation, gene expression, epigenetic status, self-renewal and capacity for multi-lineage differentiation (Marks et al., 2012; Tesar et al., 2007). In culture medium with fetal calf serum, naïve mESCs grown on mouse embryonic fibroblast feeder cells (MEFs) (here abbreviated as “serum”) transit between inner cell mass (ICM)-like and epiblast-like pluripotency states (Sasai et al., 2013; Trott and Martinez Arias, 2013). However, when cultured in serum-free conditions with inhibitors of mitogen-activated protein kinase (MAPK) and glycogen synthase kinase 3 (GSK3) signaling, also called “2i” medium, mESCs become more homogeneous and adopt the more ICM-like or “ground” state (Marks et al., 2012; Nichols et al., 2009; Ying et al., 2003). The observation that naïve mESCs interconvert between pluripotent states while remaining uncommitted has raised the suggestion that such heterogeneity may allow the cells to respond differently to environmental cues. In agreement, subpopulations of naïve mESCs show different potentials to differentiate (Graf and Stadtfeld, 2008; Hanna et al., 2009; Hayashi et al., 2008). How the metastable transcriptional and epigenetic diversity of cultured mESCs is regulated and maintained has remained elusive.    The two notable characteristics of mESCs are their capacity to self-renew and differentiate into all embryonic lineages (Niwa et al., 1998). In mESCs, pluripotency is maintained by a core network of regulatory transcription factors, including Pou5f1, Sox2 and Nanog (Kashyap et al., 2009; Kim et al., 2008; Marson et al., 2008; Navarro et al., 2012); the balance between self-renewal and differentiation is regulated by protein-encoding genes that include Id1 and Dusp9, 
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both downstream targets of the Bone Morphogenetic Protein (BMP) signaling pathway (Li and Chen, 2013). Moreover, it has been shown that both the BMP and TGFβ (via NODAL) SMAD-mediated signaling pathways are involved in maintaining heterogeneity of NANOG in naïve mESCs (Galvin-Burgess et al., 2013). Conversely, NANOG may attenuate BMP signaling via a feedback loop that involves titration of phosphorylated (P)SMAD1 by direct NANOG-SMAD1 interaction (Suzuki et al., 2006). However, the functional role of BMP-SMAD signaling in the metastable state of naïve pluripotency has not been investigated.   Here, we report the derivation and characterization of transgenic mESCs that allow a real-time read out of SMAD-mediated BMP signaling activity. This transgenic BRE:gfp reporter mESC line expresses a well-characterized BMP Responsive Element (BRE) containing several PSMAD1/5 DNA-binding sites isolated from the Id1 promoter to drive GFP expression (Korchynskyi and ten Dijke, 2002; Monteiro et al., 2008). Activation of the BMP-SMAD reporter transgene was heterogeneous in “serum” mESCs (± 50% GFP+ cells) and “2i” mESCs (± 4% GFP+ cells). By genetic abrogation of the core BMP pathway components SMAD1 and SMAD5, we demonstrated here that BMP-SMAD signaling is dispensable for the maintenance and self-renewal of mESCs both in “serum” and “2i” states, but that it regulates the levels of DNA-methylation (via Dnmt3a/b and Tet1/2) and hence lineage priming in pluripotent mESCs.  
3.3 Results 
3.3.1 BMP-SMAD signaling is activated during the acquisition of pluripotency 
 BMP signaling plays key roles in patterning of post-implantation mouse embryos (Kishigami and Mishina, 2005; Tam and Loebel, 2007). However, a role during pre-implantation development has been less evident because genetic ablation of single members of the BMP-SMAD pathway showed no evidence of a phenotype during the pre-implantation period (Goumans and Mummery, 2000; Graham et al., 2014; Reyes de Mochel et al., 2015; Zhao, 2003). We investigated whether the BMP-SMAD signaling pathway was active in pre-implantation embryos by examining BRE:gfp blastocysts at E3.5. We were unable to detect GFP at this stage (data not shown). As the BMP-SMAD pathway has been shown to play dual roles in self-renewal and differentiation of mESCs (Li and Chen, 2013), we monitored GFP during the derivation of mESCs from BRE:gfp blastocysts into the naïve state (“serum”) and the ground state (“2i”). One day after plating (D1), GFP was still undetectable in blastocysts in either culture condition (Figure 3.1A); however, by D4, GFP+ cells were evident within the ICM-like cells of BRE:gfp blastocyst outgrowths in both “serum” and “2i” (Figure 3.1A). This suggested that the BMP-SMAD pathway was activated during the acquisition of pluripotency in vitro.  
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Figure 3.1 BMP-SMAD signaling activation in “serum” and “2i” culture conditions.  
A. Derivation of BRE:gfp mESCs in “serum” and “2i” conditions. D1, one day after blastocyst collection; D4, D1 plus three days after blastocyst plating, P3 mESCs, passage 3 of the derived mESCs. Scale bars are 100 µm. B. Established “serum” and “2i” BRE:gfp mESCs and their respective GFP expression profile by FACS analysis. Scale bars are 100µm. C. Immunofluorescence of “serum” and “2i” BRE:gfp mESCs for ID1, POU5F1 and NANOG. Scale bars are 20 µm. D. Percentage (%) of NANOG positive cells in the GFP+ and GFP- cells per colony BRE:gfp mESCs E. Western blotting for PSMAD1/5/8, SMAD1/5/8, GFP and Tubulin in “serum” and “2i” BRE:gfp and E14 mESCs as well as “2i” E14 stimulated 1 hour with 25 ng/ml of BMP4. 
F. Percentage (%) of GFP+ and GFP- cells in “2i” BRE:gfp mESCs after 1 hour treatment with Activin A or BMP4. Bars represent mean±standard deviation (N=3). (G) Percentage (%) of GFP+ and GFP- cells in “2i” 
BRE:gfp mESCs switched to “serum” and “serum” BRE:gfp mESCs switched to “2i” and cultured for four consecutive passages (P1-P4). See also Figure S1 in online version of Gomes Fernandes et al. (2016).         
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3.3.2 BMP-SMAD signaling activation in “serum” and “2i” mESCs 
 Once BRE:gfp mESCs lines had been established (Figures 3.1A, 3.1B) and karyotyped (Figure S3.1A), a striking difference was observed between the two conditions: “serum” BRE:gfp mESCs exhibited an heterogeneous pattern of GFP expression with about 50% of the cells being GFP+, whereas in “2i” BRE:gfp mESCs less than 4% of cells were GFP+ (Figure 3.1B). In “serum” 
BRE:gfp mESCs, the GFP+ cells produced ID1 (Figure 3.1C), confirming that GFP expression corresponded to the activation of BMP-SMADs. The promoter of Id1 contains the PSMAD1/5 DNA binding sites that were used to generate the BRE:gfp transgene (Figure S3.1B). Most “2i” 
BRE:gfp mESCs showed no GFP and consequently no/low ID1 (Figure 3.1C). POU5F1 and NANOG were detected in both “serum” and “2i” BRE:gfp mESCs. Quantification of NANOG suggested that NANOG was more homogeneously expressed in GFP- cells per colony (Figure 3.1D) and this difference was statistically significant (n=16; p<0.05).   To measure BMP-SMAD signaling activation, we investigated the levels of PSMAD1/5/8, which were low in “2i”, medium in “serum” mESCs and high in “2i” after 1 hour of stimulation with 25 ng/ml of BMP4; in agreement, faint GFP was observed in “2i” compared to “serum” 
BRE:gfp mESCs (Figure 3.1E). In addition, we examined the number of GFP+ cells present in “2i” and showed that this increased in response to BMP4, but not to Activin A (which activates the NODAL pathway) (Figure 3.1F) and that BRE:gfp mESCs could be interconverted to adopt the GFP pattern associated with each culture medium within four cell passages (Figure 3.1G). 
 
 
 
Figure S3.1 The BRE:gfp construct, related to Figure 3.1.  
(A) Representative karyogram of a XY BRE:gfp mESC line. The arrow identifies the subtelomeric region of mouse chromosome 15, where the BRE:gfp construct was mapped by DNA-FISH. (B) Schematic representation of the BRE:gfp construct. Multiple binding elements (red and light blue boxes) are arranged in tandem, both in forward and reverse orientations and placed downstream of the cytomegalovirus (CMV) enhancer (CMVe) and upstream of a minimal promoter (MLPA) in order to drive the expression of eGFP.  
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3.3.3 In “serum”, GFP+ BRE:gfp mESCs correlated with low levels of Dnmt3b and 
lower DNA-methylation 
 To further understand the role of BMP-SMAD signaling activation in pluripotency, Fluorescence activated cell sorting (FACS) sorted subpopulations of “serum” (GFP++, GFP+, GFP-) and “2i” (GFP+, GFP-) BRE:gfp mESCs (Figures 3.2A, S3.2A) were analyzed by qPCR (Figures 3.2B, S3.2B). In “serum”, the sorted GFP++ mESCs (N=3) exhibited lower levels of Dnmt3a/b, in particular 
Dnmt3b, and higher levels of Tet1/2, but similar high transcriptional levels of pluripotency genes (Figure 3.2B). A direct comparison between “2i” and “serum” is provided in Figure S3.2B. Comparing whole transcriptome RNA-seq data of three independent “serum” GFP++ and GFP- mESC samples, we confirmed that Dnmt3b as well as Tet1/2 were among the few statistically significant differentially regulated genes observed (n=315; p<0.05), mostly protein coding-genes (Figures 3.2C, S3.2C, S3.2D; Table S1). Next, using available single-cell RNA-seq data (Sasagawa et al., 2013), we performed an hierarchical clustering of 38 individual cells from naïve mESCs based on the expression of 30 selected genes. Interestingly, the cluster with the lowest transcriptional levels of Dnmt3b and high levels of Tet1 (Group 1) did not correlate with the cell clusters showing high transcriptional levels of Id1/BMP4 (Group 2/3) (Figure S3.2E). This is in agreement with our qPCR (Figure 3.2B) and RNA-seq results (Id1 is not differentially expressed) (Figures 3.2C; Table S1) and suggests a clear   
 
Figure 3.2 (previous page) Transcriptome and methylome in subsets of “serum” BRE:gfp mESCs.  
A. Gatings used to FACS sort three subpopulations (GFP-, GFP+, GFP++) of “serum” BRE:gfp mESCs and the profile of the individual cell groups. B. Relative expression of several genes in the three subpopulations (GFP-, GFP+, GFP++) of “serum” BRE:gfp mESCs compared to the GFP- cells. Each bar 
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represents mean±standard deviation of technical triplicates and the three bars of the same color represent independent experiments (n=9, N=3). C. Volcano plot showing –log10 P values versus log2 fold transcriptional changes between GFP++ and GFP- fractions of “serum” BRE:gfp mESCs. Differentially expressed genes (DEGs) with P < 0.05 are blue, and genes with P >0.05 are red; some highlighted DEGs are black. D. Scatterplot depicting a comparison of percentage of DNA-methylation in each 600bp tile (dot) between GFP++ and GFP- fractions of “serum” BRE:gfp mESCs. Each tile was classified into a biotype category according to the nearest TSS. The red line represents no difference; the inner and outer blue lines represent respectively borders for 10% and 20% change in methylation levels. E. Distribution of DNA-methylation at specific genomic regions in GFP++ (in blue) and GFP- fractions of “serum” BRE:gfp (in red) mESCs. P values were calculated with two-sample Kolmogorov-Smirnov test. Abbreviations: HCP, high CpG-content promoters; LCP, low CpG-content promoters; Enh, enhancers; NA, no annotation. F. Number of (600bp tile) counts showing loss of methylation (LOM) or gain of methylation (GOM) in GFP++ compared to GFP- “serum” BRE:gfp mESC. See also Figure S2; and Table S1 and S2.  discrepancy between the cells expressing ID1 protein (and GFP protein) and Id1 transcript. This discrepancy in the co-expression of proteins and transcripts is a well-known confounding, but intrinsic property of cells, including mESCs (Torres-Padilla and Chambers, 2014).    We performed reduced-representation bisulfite sequencing (RRBS) of GFP++ and GFP- 
BRE:gfp mESCs and observed that DNA-methylation levels were in general lower in mESCs with activation of the BMP-SMAD reporter transgene than in mESCs without reporter activity, as illustrated by the significant shifts towards lower DNA-methylation at all genomic regions in GFP++ cells (Figures 3.2D, 3.2E, 3.2F; Table S2). This is in agreement with the reduced levels of 
Dnmt3b expression in GFP++ cells.  
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Figure S3.2 Characterization and comparison of “serum” and “2i” mESCs, related to Figure 3.2. 
A. Gatings used to FACS sort two subpopulations (GFP- and GFP+) of “2i” BRE:gfp mESCs and the profile of the individual cell groups. B. Relative expression of several genes in the subpopulations (GFP-, GFP+, GFP++) “serum” and (GFP- and GFP+) “2i” BRE:gfp mESCs compared to the GFP- “serum” cells. Each bar represents mean±standard deviation of technical triplicates. C. Hierarchical clustering of independent “2i” S1fl/flS5fl/fl mESCs (FL), “2i” S1-/-S5-/- mESCs (KO), “serum” GFP++ (pos) and GFP- (neg) fraction of 
BRE:gfp mESCs. D. Barplot depicting the number of the significantly differentially expressed genes (DEGs) between “serum” GFP- and GFP++ fraction of BRE:gfp mESCs per biotype. In orange DEGs with P <0.05.  E. Heatmap of the log2 fragments per kilobase of transcript per million reads (FPKM) values of 30 genes of interest in 38 individual naïve mESCs.    
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3.3.4 BMP-SMAD signaling is dispensable for self-renewal of mESCs 
 To clarify the role of BMP-SMAD signaling in the maintenance of the naïve and ground state, we derived Smad1 and Smad5 double-knockout (S1-/-S5-/-) mESC lines in “2i” from double homozygous floxed Smad1;Smad5 mESC lines (S1fl/flS5fl/fl) (Tremblay et al., 2001; Umans et al., 2003) that were hemizygous for the R26R Cre-reporter transgene (Soriano, 1999) using Cre (Figures S3.3A, S3.3B). We derived the S1-/-S5-/- mESC in “2i”, because BMP-SMAD signaling activation was less prominent in “2i” and therefore the chance of deriving pluripotent S1-/-S5-/- mESCs was higher. The pluripotency of the S1-/-S5-/- mESCs was confirmed by showing contribution to the three germ layers in S1-/-S5-/- <> wild type chimeric embryos (Figure S3.3C) as well as in teratoma formation assays (Figure S3.3D), in independent lines with a normal karyotype (Figure S3.4A). Moreover, we showed that Smad8/9 was not upregulated in response to the deletion of Smad1 and Smad5 and that Id1 and Id2 were upregulated after stimulation with BMP4 only in the S1fl/flS5fl/fl parental line, as expected (Figure S3.4B). The “2i” S1-/-S5-/- mESCs self-renewed at the same rate as the parental S1fl/flS5fl/fl mESCs (Figure 3.3A) and showed comparable alkaline phosphatase activity (Figure 3.3B). Unexpectedly, when S1-/-S5-/- mESCs were switched from “2i” to “serum”, after an initial period of adaptation, the cells continued to self-renew at similar rates as the parental S1fl/flS5fl/fl mESCs (Figure S3.4C) instead of differentiating. In general, the expression level of pluripotency genes remained high in the parental S1fl/flS5fl/fl and S1-/-S5-/- mESCs in “2i” (Figure 3.3C) and “serum” (Figure S3.4D). Our results demonstrated that BMP-SMAD signaling is dispensable for self-renewal of mESCs.  
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Figure S3.3 (previous page) Derivation and pluripotency state of “2i” S1-/-S5-/- mESCs, related to 
Figure 3.3.  
A,B. Scheme representing the location of the primers and the size of the respective genotyping PCR bands before and after excision of the exon 2 of Smad1 and respective representative PCR gel (A) and of the exon 2 of Smad5 and representative PCR gel (B). Lane numbers: 1, S1fl/flS5fl/fl mESCs; 2, 3 and 4, S1-/-S5-/- mESCs; L, DNA ladder 100 Kbp+. C. β-Galactosidase staining of chimeric embryos isolated at E8.5 generated using 3 different S1-/-S5-/- mESC lines (1.2A28, 1.7A28 and 1.7A1). Whole mount embryos are shown in the left side, and selected paraffin sections show contribution of S1-/-S5-/- mESCs to ectoderm, endoderm and mesoderm (black arrows). A, anterior; P, posterior. Scale bars are 50 µm. D. Hematoxylin and eosin-stained paraffin sections of teratomas formed after subcutaneous injection of S1-/-S5-/- mESCs (1.2A6 and 1.7A1). The teratomas obtained contained tissues from three embryonic germ layers: mesoderm (osteoid tissue, cartilage); ectoderm (keratinized epithelium, neural rosettes); endoderm (ciliated epithelium, mucosa epithelium). Scale bars are 50 µm.  
3.3.5 S1-/-S5-/- mESCs have high levels of Dnmt3b and high levels of DNA-
methylation 
 Next, we investigated the SMAD1/5-responsive genes using RNA-seq (Figure 3.3D) and found that most differentially expressed genes between S1-/-S5-/- and S1fl/flS5fl/fl mESCs were protein-coding genes (Figure S3.4E). Interestingly, about half of the differentially expressed genes (DEGs, including protein-coding, pseudogenes and long non-coding RNAs) were upregulated (n=781; p<0.01) and half of the genes were downregulated (n=854; p<0.01) in S1-/-S5-/- mESCs (Figure 3.3E; Table S1).  
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Figure 3.3  Transcriptome and methylome in S1-/-S5-/- versus S1fl/flS5fl/fl mESCs.  
A. Growth of S1fl/flS5fl/fl mESCs and three independent S1-/-S5-/- mESCs lines in “2i” during 26 days. Mean±standard deviation are depicted. B. Alkaline phosphatase activity in “2i” S1fl/flS5fl/fl and S1-/-S5-/- mESC. Scale bars are 100 µm. C. Expression of Sox2, Zfp42, Nanog and Pou5f1 in transcripts per million (TPM) in “2i” S1fl/flS5fl/fl (FL) and S1-/-S5-/- (KO) mESC. D. Volcano plot showing –log10 P values versus log2 fold transcriptional changes between S1fl/flS5fl/fl and S1-/-S5-/- mESC in “2i”. Differentially expressed genes (DEGs) with P < 0.05 are blue, and genes with P >0.05 are red; some highlighted DEGs are black. E. Percentage of DEGs (P<0.01) (n=781 upregulated in “2i” S1-/-S5-/-; n=854 downregulated in “2i” S1-/-S5-/-) showing putative SMAD1/5 binding-sites (GGCGCC/GCCG) in the promoter region. F. Top-10 gene ontology (GO) terms associated with biological processes (P<0.05) in DEGs in “2i” S1-/-S5-/- mESC. G. Distribution of DNA-methylation levels at specific genomic regions in “2i” S1fl/flS5fl/fl (in red) and S1-/-S5-/- mESC (in blue). P values were calculated with two-sample Kolmogorov-Smirnov test. Abbreviations: HCP, high CpG-content promoters; LCP, low CpG-content promoters; Enh, enhancers; NA, no annotation. H. Number of (600bp tile) counts showing loss of methylation (LOM) or gain of methylation (GOM) in “2i” 
S1fl/flS5fl/fl compared to S1-/-S5-/- mESCs. I. Scatterplot depicting a comparison of percentage of DNA-methylation in each 600bp tile (dot) between “2i” S1fl/flS5fl/fl and S1-/-S5-/- mESCs. Each tile was classified into a biotype category according to the nearest TSS. The red line represents no difference, the inner and outer blue lines represent respectively borders for 10% and 20% change in methylation levels. See also Figure S3.3 and S3.4; and Table S1, S2 and S3. 
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 To interrogate whether the observed expression changes were consistent with direct transcriptional regulation, we integrated our RNA-seq data set with a list of direct SMAD1/5 targets (n=562) identified by ChIP (Fei et al., 2010). Using gene set enrichment analysis, we found a significant enrichment of SMAD1/5 targets in genes that were downregulated in S1-/-S5-
/- mESCs (p<1e-4) (Figure S3.4F).   Moreover, the great majority of the DEGs contained the sequence motifs GCCG and/or GGCGCC, well-characterized SMAD1/5 binding sites (Korchynskyi and ten Dijke, 2002), in their promoters, defined as ±2 Kb from the transcriptional start site (TSS) (Figure 3.3E; Table S3). By contrast, genome-wide occurrence of GGCGCC and GCCG motifs at such promoters (including protein-coding, pseudogenes and long non-coding RNAs) was not, or much less, enriched (Figure S4G) and significantly different from the enrichment observed at DEGs (p<2.2e-16). As an example, Dnmt3b was significantly upregulated in S1-/-S5-/- mESCs and contained 21x GCCG and 5x GGCGCC in the promoter region, suggesting direct (co-)regulation by DNA-binding BMP-SMADs. The DEGs were significantly enriched for gene ontology (GO) categories such as “regulation of developmental process”, “regulation of cell development” and “regulation of cell differentiation” (Figure 3.3F), compatible with BMP-SMAD signaling not being involved in self-renewal of mESC, but rather predisposing mESCs to differentiate. The downregulation of 
Dnmt3b and enrichment in “developmental” genes in S1-/-S5-/- mESCs, led us to investigate the levels of DNA-methylation by RRBS on several independent S1fl/flS5fl/fl and S1-/-S5-/- mESC lines (Table S2). S1-/-S5-/- mESCs displayed a significant shift towards higher levels of DNA-methylation at all genomic regions analyzed when compared to S1fl/flS5fl/fl mESCs (Figures 3.3G, 3.3H, 3.3I), suggesting that the enrichment in “developmental” genes is caused by the higher levels of DNA-methylation.   
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Figure S3.4 Characterization of S1-/-S5-/- mESCs, related to Figure 3.3.  
A. Representative karyogram for independent S1-/-S5-/- mESC lines showing a normal karyotype (40, XX). 
B. Relative expression of several Smad and Id genes in “2i” S1-/-S5-/- mESCs compared to S1fl/flS5fl/fl mESCs, before and after 1 hour stimulation with 25 ng/ml of BMP4 (+B4) Bars represent mean±standard deviation of relative expression of technical triplicates. C. Proliferation rate of S1fl/flS5fl/fl mESCs and three independent S1-/-S5-/- mESCs lines in “serum” during 26 days. Mean±standard deviation is depicted. D. Relative expression of pluripotency genes in “serum” S1-/-S5-/- mESCs (1.11, 1.27, 1.35) compared to 
S1fl/flS5fl/fl mESCs. E. Number of significantly differentially expressed genes (DEGs) between the “2i” 
S1fl/flS5fl/fl and S1-/-S5-/- mESCs per biotype. In blue DEGs with P <0.01 and in orange DEGs with P <0.05. F. Enrichment score for SMAD1/5 targets (n=562) identified in mESCs (Fei et al., 2010) calculated using standard gene enrichment analysis (Subramanian et al., 2005) (top panel). Mid panel depicts the position of the SMAD1/5 target hits in the ranked gene list. Genes were ranked by log2 fold-change of expression between S1-/-S5-/- (KO) and S1fl/flS5fl/fl  (FL) mESCs (bottom panel). A gene with a low rank is more highly expressed in the KO. G. Presence of the putative binding motifs of SMAD1/5 (GGCGCC and GCCG) in the promoter region, defined as ± 2Kb from the transcription start site (TSS) of DEGs (P<0.01) between S1-/-
S5-/- and S1fl/flS5fl/fl mESCs; and, as comparison, presence of the same binding motifs in the promoter region of all genes genome-wide.       
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3.3.6 mESCs differentiated more efficiently to mesendoderm or neuro-ectoderm 
in the absence of BMP-SMAD signaling 
 Finally, we examined the differentiation capacity of S1-/-S5-/- mESCs in both “serum” and “2i” and found that they formed endoderm (Sox17), mesoderm (T) and ectoderm (Pax6 and Sox1) more efficiently than the parental line (Figures 3.4A, 3.4B, 3.4C) in monolayer using differentiation protocols for either the mesendoderm (ME) or neuroectoderm (NE) lineages (Thomson et al., 2011). In addition, we investigated the capacity of the FACS-sorted subpopulations of “serum” 
BRE:gfp mESCs to differentiate to ME and NE and showed that GFP++ mESCs had lower levels of ME and NE early differentiation markers than GFP- mESCs (Figure 3.4D), demonstrating that GFP++ mESCs were less prone to differentiate. In agreement, GFP++ mESCs retained higher levels of pluripotency markers, at least after 4 days of differentiation to ME (Figure 3.4E). Our data showed that transient BMP-SMAD signaling activation tilted mESCs to a less differentiation-prone state, whereas in the absence of BMP-SMAD signaling the balance was shifted towards an increased predisposition to differentiate.   
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Figure 3.4 (previous page) BMP-SMAD signaling during mESC differentiation to mesendoderm and 
neurectoderm.  
A. Schematic representation of the protocol to differentiate mESCs to mesendoderm (3 µM CHIR) or neurectoderm (500 nM retinoic acid). B. Relative expression of early lineage markers in differentiated “serum” and “2i” S1-/-S5-/- and S1fl/flS5fl/fl mESCs. C. Immunofluorescence of differentiated “serum” 
S1fl/flS5fl/fl and S1-/-S5-/- mESCs for NANOG, SOX17, T and SOX1. Scale bars are 100 µm. D. Relative expression of early lineage markers in differentiated subpopulations (GFP-, GFP+, GFP++) of “serum” 
BRE:gfp mESCs compared to GFP- cells. E. Relative expression of pluripotency genes in differentiated subpopulations (GFP-, GFP+, GFP++) of “serum” BRE:gfp mESCs compared to GFP- cells. Each bar represents mean±standard deviation of technical triplicates and bars of the same color represent independent experiments (n=9, N=3) in B and independent experiments (n=6, N=2) in D and E. Statistical analysis was performed on technical triplicates of independent experiments (n=9, N=3), * P≤0.05, **P≤0.01. 
 
3.4 Discussion A recent study reported the absence of BMP4 and Id1 in (embryonic day) E3.5 ICMs and a high transient upregulation in E4.5 epiblasts followed by the downregulation of BMP4 and Id3 expression during the next 6 days of the derivation of mESCs and their further maintenance in “2i” (Boroviak et al., 2014). We now show this in real-time using BRE:gfp blastocysts to derive mESCs. Moreover, we demonstrated that BMP-SMAD signaling is functionally not implicated in self-renewal, in agreement with studies that have mapped genome-wide the genes that are directly regulated by SMAD1/5 (Chen et al., 2008; Fei et al., 2010). They showed that the genes regulated by SMAD1/5 were involved in fate determination, rather than self-renewal. Here, we provide functional evidence that SMAD1/5 are not necessary for mESC self-renewal in either naïve (“serum”) or ground (“2i”) state.    Specific levels of DNA-methylation and associated enzymes have been associated with the different pluripotency states (ground, naïve, primed) (Habibi et al., 2013; Hackett et al., 2013; Smallwood et al., 2014) as well as with different levels of GFP in Nanog:gfp naïve mESCs (Ficz et al., 2013). This reflects faithfully the rapid loss of genomic DNA-methylation that the embryo undergoes in vivo during pre-implantation development and the gain of DNA-methylation during the transition between ICM and epiblast (Smith et al., 2012). Therefore, it is perhaps not surprising that the machinery to regulate rapid switches in genomic DNA-methylation is present in pluripotent stem cells derived from ICM and epiblast. A role for BMP-SMAD signaling in LIF-dependent conversion between EpiSCs and ESCs has been reported (Onishi et al., 2014), but the association with changes in DNA-methylation between EpiSCs and ESCs remains to be investigated.     Finally, it has been suggested that the epigenetic variation observed in pluripotent cells is stochastic and results in a diversity of predispositions to acquire specific cell fates when the cells are triggered to differentiate (Lee et al., 2014). Our data provides evidence that the cellular diversity of both “serum” and “2i” mESCs regarding DNA-methylation and associated enzymes is not a stochastic process, as previously thought, but is in fact regulated by cell-cell signaling interactions involving the BMP-SMAD signaling pathway.  
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3.5 Experimental Procedures 
mESCs derivation and culture  Derivation of BRE:gfp mESCs  in “2i” and “serum” and the conditional knockout mESCs for Smad1 and 
Smad5 (S1fl/flS5fl/fl) in “2i”, as well as the Cre-recombination of S1fl/flS5fl/fl mESCs are described in the Supplemental experimental procedures. Genotyping of the BRE:gfp mESCs was performed as described (Monteiro et al., 2008). E14 mESCs were cultured in either “2i” or “serum”. Stimulation (1 hour) with BMP4 (R&D Systems) or Activin A (R&D Systems) was followed by FACS analysis or Western blotting (see Supplemental experimental procedures). Details about generation of chimeric embryos, teratoma formation assay, RNA-seq and RRBS are provided in the Supplemental experimental procedures.  
mESCs differentiation and proliferation mESCs were differentiated to mesendoderm (ME) or neurectoderm (NE) as described (Thomson et al., 2011). Briefly, mESCs (10000 cells/cm2) were grown in N2B27 medium without supplements for 48 hours, after which either 3 µM of CHIR99021 or 500 nM of all-trans retinoic acid (RA) (Sigma-Aldrich) was added to the N2B27 medium for an additional 48 hours. Cells were then collected for immunofluorescence or qPCR (see Supplemental experimental procedures). For the proliferation assay, the total number of “serum” and “2i” mESCs was monitored during each passage for 26 days of culture. “serum” mESCs were pre-plated prior to counting.  
Statistics 
Quantification of NANOG-positive cells: Whole BRE:gfp mESC colonies (total of n=16) from 3 independent experiments (N=3, 5-6 colonies per experiment) were manually counted 3 times and averaged. “N” refers to the number of independent experiments; “n” refers to total number or colonies counted. Statistical analysis was performed using a Student’s t-test (two-tailed, unequal variance), *P≤0.05. 
qPCR: each bar represents average of technical triplicates. “N” refers to the number of independent experiments; “n” refers to total replicates. Statistical analysis was performed using a Student’s t-test (two-tailed, unequal variance), *P≤0.05; **P≤0.01. 
RNA-seq expression data: To determine significan tly DEGs between GFP++ and GFP- or S1-/-S5-/- and S1fl/flS5fl/fl mESCs, we applied a cut-off of 0.01 and/or 0.05 on the p-values (P) adjusted for multiple testing hypothesis. “N” refers of independent experiments; “n” refers to number of genes. 
RNA-seq gene ontology: Enrichment analysis for gene ontology (GO) terms was made with the R package topGO based on DEGs (P < 0.05) and utilizing Fisher’s exact test. 
RNA-seq motif sequence analysis: One-sided Fisher’s Exact was used to determine significant overrepresentation of the analysed motifs in promoter regions of DEGs relative to the genome wide promoter regions. “n” refers to number of genes. 
SMAD1/5 ChIP-on-chip data: To calculate the enrichment of SMAD1/5 targets identified p-values were calculated by permuting genes. “n” refers to number of genes. 
RRBS global methylation profile: To quantitatively assess global DNA-methylation changes, we created histograms for tiles (methylation change > 20%) and performed a one-sided two-sample Kolmogorov-Smirnov test to determine significant distribution differences between populations.  
Accession numbers The GEO accession number for both the transcriptomics and methylomics data reported in this paper is GSE71556. (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71556) 
 
Blastocyst collection All animal procedures here described were approved by the local animal ethical committee. Blastocysts from CBA/Bl6 females crossed with BRE:gfp heterozygous CBA/Bl6 males were isolated on embryonic day (E)3.5 using M2 with HEPES (Sigma-Aldrich) containing 75 μg/ml of bovine serum albumin (BSA, Life Technologies). E0.5 was considered the noon of the day of the plug. The blastocysts were cultured for 24 
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hours in a drop (30 µl) of EmbryoMax KSOM+AA with phenol red (Chemicon) under mineral oil (Sigma-Aldrich) at 37ºC in humidified air. Next day, the blastocysts were washed in Dulbecco’s phosphate buffered saline (DPBS, Life Technologies) without calcium and magnesium, treated with acid Tyrode’s solution for 3 minutes at room temperature (RT) to remove the zona pellucida and placed individually in separate organ culture dishes (Fisher Scientific) for mESC derivation.   
Derivation of BRE:gfp mESCs, S1fl/flS5fl/fl mESCs and Cre-recombination to obtain S1-/-S5-/- 
mESCs Conditional knockout mESCs for Smad1 and Smad5 (S1fl/flS5fl/fl) mESCs were derived by crossing homozygous mice carrying both the Smad1 conditional allele (Smad1RobPC) (Tremblay et al., 2001) and the 
Smad5 conditional allele (Smad5tm1Huy2) (Umans et al., 2003) and were hemizygous for the R26R Cre-reporter transgene (Soriano, 1999). During derivation of BRE:gfp mESCs and S1fl/flS5fl/fl mESCs, blastocysts were cultured for 3 days in either “2i” medium [N2B27 medium (1:1 mixture of Dulbecco’s Modified Eagle Medium DMEM/F12 1:1 nutrient mix (Life Technologies) and Neurobasal (Life Technologies), with 1x non-essential aminoacids (NEAA) (Life Technologies), 50 μg/ml BSA, 0.1 mM 2-mercaptoethanol (Life Technologies), 50 U/ml penicillin and 50 μg/ml streptomycin (Life Technologies), 1x N2 (Life Technologies) and 1x B27 (Life Technologies)) and 2000 U/ml mouse leukemia inhibitory factor (LIF) (Millipore), 1 µM PD0325901 (Axon) and 3 µM CHIR99021 (Axon)] on 0.1% gelatin-coated organ dishes; or in “serum” medium [DMEM+glutamax (Life Technologies) with 15% fetal calf serum (FCS) (Life Technologies), 1x NEAA, 0.1 mM 2-mercaptoethanol, 50 U/ml penicillin and 50 μg/ml streptomycin and 1000 U/ml LIF] in organ dishes coated with FCS. Thereafter, individual ICM outgrowths were isolated mechanically, washed 3x in DPBS, placed in a drop of 0.25% trypsin/EDTA (Life Technologies) for 5 minutes at RT and disrupted mechanically by pipetting. The cell clumps were placed directly in either “2i” on gelatin or “serum” on MEFs and cultured for an additional 3-5 days. Emerging mESCs colonies (passage 1, P1) were passed using 0.05% trypsin/EDTA.  The excision of the Smad1 and Smad5 floxed alleles was achieved by homologous recombination using a Cre recombinase-expression vector (pEFBOS-CreIRESpuro) as described (Davis, 2008). Briefly, 8x106 cells were suspended in 750 µl phosphate buffered saline (PBS) and 10 µg of the vector added directly to the cell suspension. Electroporation was performed as described (Barnett and Köntgen, 2001). The electroporated cells were plated in “2i” medium. Selection with 2 µg/ml puromycin was started 48 hours after plating and maintained for 48 hours. From the resulting colonies, 96 clones were manually isolated, grown in “2i” conditions and genotyped as described (Tremblay et al., 2001; Umans et al., 2003). Karyotyping of the mESC lines and DNA-FISH for GFP in BRE:gfp mESCs was performed as described (Szuhai and Tanke, 2006).  
Generation and analysis of chimeric embryos Blastocysts where obtained by superovulation of CD1(HsD) females. Mouse chimeric embryos were produced by injection of  “2i” S1-/-S5-/- mESCs into the blastocoel cavity of blastocysts. Per line, around 20 to 30 injected blastocysts were obtained. Those were transferred into uteri of E3.5 pseudo-pregnant females and 4 days later the embryos were recovered, fixed 2 hours at RT in 25% gluteraldehyde/2% formaldehyde in PBS, washed in PBS and incubated overnight (o/n) at 30°C in an humidified chamber in freshly made staining solution (1 mg/ml of X-gal, 2 mM of MgCl2, 5 mM of K3Fe(CN)6 and 5 mM of K4Fe(CN)6x3H20 in PBS) previously heated to 50°C to avoid precipitation. Thereafter, the embryos were postfixed o/n with 4% paraformaldehyde (PFA) at 4°C, individually embedded in 2% low melting point agarose (Life Technologies), followed by inclusion in paraffin, sectioned (7 µm) and eosin stained following standard procedures.  
Teratoma formation assay For teratoma formation assays, “2i” S1-/-S5-/- mESC were trypsinized and 1x106 cells (per injection) were resuspended in 300 µl ice cold 1:1 culture medium and Matrigel growth factors reduced (Corning) and drawn into 1 ml syringe immediately before the injection. NOD.CB17-Prkdcscid/NcrCr mice were injected in the right dorso-lateral area. Per mESCs line, 3 mice were injected. Animals were monitored for weight 
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and health, and sacrificed once the tumor reached 1 cm3. Teratomas were surgically removed, fixed o/n in 4% PFA, paraffin embedded, sectioned (5 µm) and stained for hematoxiline and eosin by standard procedures.  
 
Immunofluorescence and alkaline phosphatase activity Cells were fixed with 4% PFA for 15 minutes at RT, permeabilized with 0.1% Triton-X (Sigma-Aldrich) in 
PBS for 8 minutes at RT, blocked with 100 μg/ml BSA in 0.05% Tween 20 (Millipore) in PBS (blocking solution) for 1 hour at RT and incubated o/n at 4ºC with the primary antibodies. Primary antibodies used were rabbit NANOG (1:200, ab80892, Abcam), goat POU5F1 (1;100, sc8628, Santa Cruz), rabbit ID1 (1:100, sc488, SantaCruz), goat Brachyury T (1:100, sc17743, SantaCruz), goat SOX17 (1:100, AF1924, R&D Systems) and goat SOX1 (1:100, AF3369, R&D Systems). Next day, cells were incubated with the secondary antibodies diluted in blocking solution for 1 hour at RT. Secondary antibodies were Alexa Fluor 488 donkey goat (1:500, A-11055, Life Technologies), Alexa Fluor 594 donkey goat (1:500, A-11058, Life Technologies), Alexa Fluor 594 donkey mouse (1:500, A-21203, Life Technologies) and Alexa Fluor 555 donkey rabbit (1:500, A-31572, Life Technologies). Thereafter, cells were treated with DAPI (Life Technologies) 1:1000 in PBS, washed and mounted using ProLong Gold (Life Technologies). The assay for phosphatase activity was performed as described (Lawson et al., 1999).   
Imaging and quantification Bright field images were made with a Nikon eclipse Ti-S inverted microscope coupled to a Nikon Digital Sight DS-2 MBW (Nikon) operating under the NIS-elements BR version 3.0 software (Nikon). Confocal images were made on a Leica TCS SP8 confocal microscope (Leica, Mannheim) operating under the Leica Application Suite Advanced Fluorescence software (Leica, Mannheim).  Quantification of NANOG heterogeneity in “serum” BRE:gfp mESC was determined in the maximum intensity projection of z-stack imaging covering the entire volume of each colony using the SP8 confocal. NANOG-positive cells in each colony (total of n=16 colonies from N=3 independent experiments) were manually counted 3 times and averaged. Statistical analysis was performed using a Student’s t-test (two-tailed, unequal variance), *P≤0.05.  
Quantitative reverse-transcription polymerase chain reaction (qPCR) 
RNA isolation was performed using RNeasy Micro Kit (Qiagen) for a maximum of 45 μg of RNA or RNeasy 
MiniKit (Qiagen) for a maximum of 100 μg RNA, following the manufacturer’s instructions. The cDNA was obtained using iScript™ cDNA Synthesis Kit (BioRad) following manufacturer’s instructions. qPCR was performed using iQ SYBR Green Supermix (Biorad) on the CFX96TM Real-time system, C1000TM Thermal Cycler (Biorad). All the samples were analysed in technical triplicates. The primers used are listed in Table S4. The qPCR conditions were 1x (95°C, 3 minutes), 40x (95°C, 15 seconds; 60°C, 30 seconds; 72°C, 45 seconds) and 1x (95°C, 10 seconds; 65°C, 5 seconds; 95°C, 50 seconds). Expression was normalized to the housekeeping genes Gapdh and Actb using the ddCt method. Statistical analysis was performed using a Student’s t-test (two-tailed, unequal variance), *P≤0.05, **P≤0.01.  
FACS sorting and analysis Pre-plated “FCS” BRE;gfp mESCs were resuspended in FACS buffer (100 μg/ml BSA in DPBS), incubated with mouse SSEA1 IgM (1:50, sc21702, Santa Cruz) diluted in FACS buffer 20 minutes on ice, washed with FACS buffer and incubated with secondary antibody Alexa Fluor 647 goat mouse IgM (1:500, A-21238, Life Technologies) diluted in FACS buffer 20 minutes on ice and resuspended in FACS buffer for FACS analysis on a LSR II Flow Cytometer (BD BioSciences) or FACS sorting on a FACSAria III Flow Cytometer (BD BioSciences). Results were processed using FACSDiva version 6.0 software (BD BioSciences).  
Western blotting “2i” mESCs were washed twice with ice cold DPBS and scraped in lysis buffer [(50 mM Tris/HCl pH7.5, 170 mM NaCl, 0.5% NP40 (ICN Biomedicals), 400 mM sodium orthovanadate (Sigma-Aldrich), 45 mM sodium pyrophosphate, 1 mM sodium floride (Sigma-Aldrich), 10 mM EDTA and 1:100 protease inhibitor cocktail (Sigma-Aldrich)]; “FCS” mESCs were first pre-plated 45 minutes at RT and lysed in lysis buffer for 
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30 minutes on ice, with pipetting every 10 minutes. After centrifugation at 4ºC for 10 minutes at 24.000 G, the supernatant was collected. Protein concentration was measured using Pierce BCA Protein Assay Kit (Thermo Scientific) according to manufacturer’s instructions. Samples were run on 10% or 8% acrylamide gels, detection was done using Western Lighting Ultra (Perkin Elmer), according to manufacturer’s specifications and imaging was made using a Fuji LAS 3000 mini (R&D Systems). Primary antibodies were rabbit PSMAD5 (1:1000, ab76296, Abcam, antibody cross-reacts with PSMAD1/8, personal communication EM), mouse SMAD1 (1:500, LS-C184471, Lifespan Biosciences, antibody cross-reacts with SMAD5, personal communication EM), mouse GFP (1:500, sc9996, Santa Cruz), rat Tubulin (1:1000, MAB1864, Millipore) and secondary antibodies were donkey mouse HRP (1:25000, 715-035-150, Jackson Immuno Research), donkey rabbit HRP (1:25000, 711-035-152, Jackson Immuno Research) and donkey rat HRP (1:25000, 712-035-150, Jackson Immuno Research). 
 
RNA-sequencing (RNA-seq) and reduced representation bisulfite sequencing (RRBS) For RNA-seq and RRBS, “serum” BRE:gfp mESC were preplated, immunostained for SSEA1 as described above and GFP- and GFP++ subpopulations from 3x different passages were FACS sorted; and two independent S1fl/flS5fl/fl mESC lines and four independent S1-/-S5-/- mESC clones grown in “2i” were collected.  RNA was isolated using RNeasy MiniKit (Qiagen), RNA integrity number (RIN) was measured using a 2100 Bioanalyzer (Agilent Technologies). The sequencing libraries were generated using TruSeq Stranded Total RNA kit (Illumina) and sequenced on an Illumina Hiseq 2000 sequencer.  DNA was isolated using Wizard Genomic DNA purification kit (Promega) and 1 µg gDNA was used for digestion by MSP1 enzyme. Following o/n incubation at 37°C, digestion reaction were terminated by adding 0.5 M EDTA and the DNA was further purified on a GeneJET PCR purification column. Libraries were prepared using NEBNext Ultra DNA library preparation kit (Illumina) and methylated adapters added. Subsequently, adapter ligated fragments were bisulfite converted using EZ DNA-methylation Gold kit (Zymo Research). After 14 PCR cycles, the product was purified using AMPure XP beads. Quality of libraries was checked on a High sensitivity DNA chip (Agilent) and sequencing was done on an Illumina HiSeq2500 PE 2x50bp.  
RNA-seq and RRBS data analysis 
RNA-seq expression data: To map the sequenced reads, a STAR (version 2.4.1d) index was created based on the mouse mm10 transcriptome (Ensemble build GRCm38) and paired-end reads were directly aligned to this index. A count table for annotated genes was produced using featureCounts version 1.4.6 and genes were further classified in different biotypes based on Vega gene and transcript annotation (http://vega.sanger.ac.uk/info/about/gene_and_transcript_types.html). The raw counts were imported in the R package DESeq2 for differential expression. To determine significantly DEGs between GFP++ and GFP- or S1-/-S5-/- and S1fl/flS5fl/fl mESCs we made use of a design matrix to block respectively for time and strain specific effects and applied a cut-off of 0.01 and/or 0.05 on the p-values (P) adjusted for multiple testing hypothesis. For intuitive visualization and comparison of gene expression levels, we calculated Transcript Per Million (TPM) values. 
RNA-seq hierarchical clustering: Unsupervised hierarchical clustering of all samples was performed on the DESeq2 based variance normalized counts using Euclidean distance and complete linkage. 
RNA-seq gene ontology: Enrichment analysis for gene ontology (GO) terms was made with the R package topGO based on DEGs (P < 0.05) and utilizing Fisher’s exact test. 
RNA-seq motif sequence analysis: To perform simple motif analysis, we defined promoter regions as ± 2Kb from the transcription start site (TSS) and counted the occurrences for putative binding sites of SMAD1/5 (GCCG and GGCGCC) for all (up and down) DEGs (P<0.01) between S1-/-S5-/- and S1fl/flS5fl/fl mESCs; and, as comparison, the promoter region of all genes belonging to gene biotypes: protein-coding, pseudogenes and long non-coding RNAs. One-sided Fisher’s Exact was used to determine significant overrepresentation of these motifs in promoter regions of DEGs relative to the genome wide promoter regions. 
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RRBS Genome specific region assignment: Sequencing reads were mapped to mouse genome mm10 using bismark version 0.14.1 and analysed further with the R package methylKit. In brief, we considered only CpGs located in regions with a depth of coverage of at least five reads and filtered out the top 0.01% CpGs. To normalize for read coverage between samples we used a median-based scaling factor. Only CpGs covered in all compared samples were retained for further analysis. The genome was binned in 600bp tiles as these were considered optimal for robust detection of Differentially Methylated Regions (DMRs) based on a pairwise comparison analysis of a range of tiles (100bp to 1000bp with 100bp increments). To visualize global methylation changes we pooled sample replicates. The methylation level of each sampled tile was estimated as the number of reads reporting a C, divided by the total number of reads reporting a C or T within that tile. Furthermore, tiles were annotated to the closest gene based on the distance to its TSS. To assign tiles to genes we used the Ensemble GRCm38 transcriptome. To assign tiles to enhancers we used mESC mm9 enhancers regions available for download at http://chromosome.sdsc.edu/mouse/download.html and converted these to mm10 coordinates using CrossMap version 0.1.8. Tiles were assigned to promoters if they overlap within the ± 2Kb region around a TSS. We used a CpG observed/expected ratio of 0.325 to distinguish low- and high-CpG density promoters as described (Etchegaray et al., 2015). Regions that do not belong to any of the aforementioned regions (e.g. intergenic space) are described as “no annotation” for simplification. 
RRBS global methylation profile: To quantitatively assess global DNA-methylation changes, we created histograms for tiles (methylation change > 20%) and performed a one-sided two-sample Kolmogorov-Smirnov test to determine significant distribution differences between populations.  
Analysis of published single cell RNA-seq data and SMAD1/5 ChIP data 
Single cell RNA-seq: Expression levels of DNA methyltransferases, 5-methylcytosine hydroxylases, BMP responsive genes, BMP signaling pathway genes, pluripotency genes and early differentiation genes were extracted from the transcriptomes of 38x “serum” mESCs single cells deposited in Gene Expression Omnibus under accession number GSE42268 (Sasagawa et al., 2013). Data was analysed and visualized using R statistics version 3.0.1. 
SMAD1/5 ChIP-on-chip data: To calculate the enrichment of SMAD1/5 targets identified by ChIP-on-chip (Fei et al., 2010), we used gene set enrichment analysis as described (Subramanian et al., 2005). Hits were not weighted and p-values were calculated by permuting genes.  
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Chapter 4 or Molecular phenotyping of Zeb2-deficient mouse 
embryonic stem cells 
4.1 Summary 
 In human ESCs the transcription factor Zeb2 regulates neuroectoderm versus mesendoderm formation, but it is unclear how Zeb2 affects the global transcriptional regulatory network in these cell-fate decisions. We generated Zeb2 knockout (KO) mouse ESCs, subjected them as embryoid bodies (EBs) to neural and general differentiation and carried out temporal RNA-sequencing (RNA-seq) and reduced representation bisulfite sequencing (RRBS) analysis in neural differentiation. This shows that Zeb2 acts preferentially as a transcriptional repressor associated with developmental progression and that Zeb2 KO ESCs can exit from their naïve state. However, most cells in these EBs stall in an early epiblast-like state and are impaired in both neural and mesendodermal differentiation. Genes involved in pluripotency, epithelial-to-mesenchymal transition (EMT) and DNA-(de)methylation, including Tet1, are deregulated in the absence of Zeb2. The observed elevated Tet1 levels in the mutant cells and the knowledge of previously mapped Tet1-binding sites correlate with loss-of-methylation in neural-stimulating conditions, however after the cells initially acquired the correct DNA-methyl marks. Interestingly, cells from such Zeb2 KO EBs maintain the ability to re-adapt to 2i+LIF conditions even after prolonged differentiation, while knockdown of Tet1 partially rescues their impaired differentiation. Hence, in addition to its role in EMT, Zeb2 is critical in ESCs for exit from the epiblast state, and links the pluripotency network and DNA-methylation with irreversible commitment to differentiation.  
4.2 Introduction 
 Naïve mouse embryonic stem cells (mESCs), primed epiblast stem cells (EpiSCs) and embryonic germ cells are pluripotent cells that can be as cell culture models to study pluripotent cell states and fate decisions that occur during embryogenesis (Brons et al., 2007; Evans and Kaufman, 1981; Leitch et al., 2010; Martin, 1981; Matsui et al., 1992; Tesar et al., 2007), transitions that require changes of the transcriptome and methylome. The ground-state of self-renewing mESCs can be achieved by simultaneous addition of chemical inhibitors (of MAPK and GSK3 signaling) and LIF (referred to as 2i+LIF) (Ying et al., 2008). When compared to a population of naïve ESCs, ground-state ESCs display higher and more homogeneous expression of key pluripotency genes, lower levels of differentiation markers and reduced DNA-methylation (Leitch et al., 2013; Marks et al., 2014).   DNA-methylation status has profound effects on embryonic gene expression. It is controlled by DNA (cytosine-5)-methyltransferases (Dnmt3a/3b/3l) that are highly active in ESCs and 
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early embryos and establish new methylation patterns and by Dnmt1 that copies the patterns onto daughter cells (Goll and Bestor, 2005; Okano et al., 1999). Active demethylation is orchestrated by Ten-eleven translocation methylcytosine dioxygenases (Tet) (Kohli and Zhang, 2013; Tahiliani et al., 2009). Tet1 levels are high in ESCs and decrease upon differentiation, correlating with exit from pluripotency, and Tet1 steers mesendoderm versus trophectoderm decisions in pre-implantation embryos (Ito et al., 2010; Koh et al., 2011). Tet1 is also important during somatic reprogramming for genome demethylation as well as activation/maintenance of Oct4 and Nanog (Costa et al., 2013; Gao et al., 2014; Takahashi and Yamanaka, 2006).    Zeb2 (Sip1, Zfhx1b) downregulates E-cadherin (Cdh1) and thereby steers EMT (Comijn et al., 2001), which is relevant to stem cell fate, but also tumorigenesis (Kim et al., 2014; Pieters and van Roy, 2014). Mutations in ZEB2 cause Mowat-Wilson syndrome (MOWS; OMIM#235730), including defects in the central and peripheral nervous system (CNS, PNS) (Cacheux et al., 2001; Mowat et al., 1998; Wakamatsu et al., 2001). Many in vivo studies confirm the critical roles of Zeb2 in embryogenesis and neurodevelopment in particular. Zeb2 KO mice die shortly after E8.5 and have multiple defects, including in somitogenesis (Maruhashi et al., 2005), the neural plate and neural crest cells (Van de Putte et al., 2003). Cell-type specific Zeb2 KO mice develop defects in e.g. the CNS (van den Berghe et al., 2013; McKinsey et al., 2013; Seuntjens et al., 2009) and PNS (Jeub et al., 2011; Van de Putte et al., 2007; Weng et al., 2012). Such studies in embryonic brain revealed cell autonomous, but also non-autonomous Zeb2 actions. In human (h) ESCs, Zeb2 regulates cell fate: upon Zeb2 knockdown (KD) they commit towards mesendoderm, while Zeb2 overproduction enhances neurogenesis (Chng et al., 2010). ZEB2 is controlled by Nanog, Oct4 and Sox2 in hESCs, but key genes downstream of Zeb2 in ESCs, and during early neural development, remain to be determined, and Zeb2 KO hESCs have not been reported. In order to enter lineage commitment, the pluripotency network in ESCs and EpiSCs needs to be distinguished (Festuccia et al., 2013; Trott and Martinez Arias, 2013). The list of factors promoting exit from naïve or ground state is growing, yet more key players remain to be identified (Betschinger et al., 2013; Kaji et al., 2006; Leeb et al., 2014). Exit from pluripotency beyond the primed epiblast state requires efficient, irreversible silencing of the transcriptional pluripotency network (including Oct4 and Nanog silencing, which persist in EpiSCs), acquisition and maintenance of DNA-methyl marks, and initiation of differentiation.    Using Zeb2 KO ESCs we identified Zeb2 as a critical player for initiating and executing the differentiation programs. Upon withdrawal of 2i+LIF from Zeb2 KO ESC populations, some cells only sometimes commit to differentiation, but instead the gross population usually stalls as pluripotent, epiblast-like cells that maintain the ability to re-adapt to 2i+LIF even after prolonged exposure to differentiation protocols. The defective silencing of the pluripotency program prevents these Zeb2 KO cells from undergoing neural and general (including mesendodermal) differentiation. RNA-seq revealed that Dnmt and Tet family mRNA levels are deregulated in Zeb2 KO cells. Such cells correctly acquire methyl marks early during neural differentiation, but do not maintain these and revert to a more naïve methylome state. Tet1 levels depend on the presence of Zeb2 and in Zeb2 KO cells (displaying elevated Tet1) Tet1 KD rescues their ability to exit from their pluripotent state and re-enter lineage commitment.  
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4.3 Results 
 
4.3.1 ESC differentiation is impaired in absence of Zeb2 
 We generated Zeb2 KO (Higashi et al., 2002; Van de Putte et al., 2003) along with Zeb2flox/flox control mESCs (Ctrl). In 2i+LIF, these ESC lines as population maintain high Nanog and Oct4 (Supplemental Figure S4.1A), proliferate comparably (Figure S1B) and have a high and similar clonogenic capacity (±70%, not shown), showing that Zeb2 is dispensable for pluripotency and self-renewal in ground-state conditions.    Because of the documented role of Zeb2 in neural development (van den Berghe et al., 2013; Chng et al., 2010; Miquelajauregui et al., 2007; Mowat et al., 1998; Seuntjens et al., 2009) we investigated neural differentiation (ND) of Zeb2 KO ESCs, subjecting them as embryoid bodies (EBs) to ND using retinoic acid (modified from ref. Bain et al., 1996) (Figure 4.1A). In Ctrl EBs the very low Zeb2 mRNA levels increased between day (d)0-d4 after withdrawal of 2i+LIF as well as during the acquisition of neural fate (between d4-6) and remained high till the end of our 15-day ND protocol (Figure 4.1B). The first Zeb2-positive (Zeb2+) cells are detected by immunohistochemistry (IHC) on d6, being intense from d8 (not shown) till the end of the experiment (Figure 4.1C). Absence of neural progenitor (Nestin+), neuronal (βIIITubulin+, Map2+) and astroglial (GFAP+) markers (immunofluorescence (IF); Figure 4.1D-F; for quantifications of neural conversion for the ESC lines discussed here and for other lines, see Figure S7 online, here panel C) showed that ND was abolished in Zeb2 KO EBs. Thus, Zeb2 is crucial for mESCs to acquire neural fate, in line with observations that Zeb2 KD in hESCs makes these cells favor mesendoderm over neuroectoderm fate (Chng et al., 2010).    To validate whether Zeb2 genetic inactivation of in mESCs would also yield increase in mesendoderm, we subjected Zeb2 KO ESC to general differentiation (GD; Figure S4.1C) allowing commitment to all cell fates for 15d, and monitored Zeb2 mRNA/protein in Ctrl cells (Figure S4.1D,E) and stained for mesoderm, endoderm and neural markers, respectively (Figure S4.1F-H; Figure S4.7E-G). This showed that Zeb2 KO mESC have impaired early differentiation not restricted to ND, but which affects all three germ layers.   
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Figure S4.1, related to Figure 4.1. Genetic inactivation of Zeb2 in mouse ESCs does neither impair 
ESC proliferation nor Oct4/Nanog production in pluripotency-supporting conditions. 
A. Control (Ctrl) and Zeb2 knockout (KO) ESCs, grown in 2i+LIF, were co-stained by indirect IF for Nanog (red) and Oct4 (green). Results are representative of 3 experiments performed. Bar: 25 µm. B. Cell proliferation of Ctrl (blue) and Zeb2 KO (red) ESCs grown in 2i+LIF. SDs are of 3 biological replicates. C. Scheme of the general differentiation (GD) protocol; FBS= fetal bovine serum). D. Zeb2 mRNA levels increased in Ctrl ESCs submitted to GD, albeit to lower relative levels as in ND (see Fig. 1B). E. Ctrl EBs were stained for Zeb2 (brown) on d6 and d15 of GD. Scale bars: 50 µm. F-H. IHC and IF analysis to document differentiation towards mesoderm (Desmin, panels F), endoderm (Hnf4α; panels G) and neural 
cells (βIIITubulin; panels H). Scale bars: 50 µm. Results shown are from one experiment and representative for 3 experiments. In contrast to Ctrl cells, very few Desmin+ cells were detected in Zeb2 KO EBs after d15 in GD, while Hnf4α levels appear reduced in Zeb2 KO EBs. The neural commitment defects first observed in ND were re-confirmed in GD as βIIITubulin+ cells were absent in Zeb2 KO EBs.    Gene expression changes in Zeb2 KO mESCs after exposure to differentiating cues were also analyzed via 40 marker mRNAs for neuroectoderm, mesoderm, endoderm and pluripotency, respectively, using RT-qPCR on d0, 4, 6 and 15 in Ctrl and Zeb2 KO cells, in ND and GD. Importantly, Zeb2 “rescue” ESC lines were included in this RT-qPCR analysis (d0 and d15; Figure S4.2F,G) by introducing Zeb2 (N-tagged with Flag3/Strep-tag) as cDNA in R26 (see Supplemental Experimental Procedures online) of Zeb2 KO cells (hereafter named R26_Zeb2). This restored the differentiation of these ESCs (IHC/IF, RT-qPCR, see Figure S4.2A-E; Figure S4.7C,E-G). The expression heatmap (Figure 4.1G) with samples clustered based on quantile-normalized expression values showed clear separations between d15 Ctrl and R26_Zeb2 cells both in GD and ND, the d6 Ctrl in ND, and the rest of the samples including d15 Zeb2 KO cells, further supporting our observation that Zeb2 KO ESCs stay largely uncommitted and display overall reduced differentiation capacity. 
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Figure 4.1 (previous page) Knockout of Zeb2 impairs ESC neural differentiation (ND) (for general 
differentiation, see Figure S1 in the online version of Stryjewska, Dries et al., 2016).  
A. Scheme of the 15-day ND protocol; RA: retinoic acid. B. RT-qPCR of Zeb2 in Ctrl ESCs during ND. SD of 2 technical replicates is shown. C. IHC for Zeb2 (brown) in Ctrl embryoid bodies (EBs) (Ctrl) on d6 and d15 of ND. D-F. Ctrl and Zeb2 KO (KO) ND-EBs stained for Nestin (red, panel D) on d12, βIIITubulin (green, panel E) on d15 and co-stained for MAP2 (green) and GFAP (red) on d15 (panel F). Scale bars: 50 µm. Results shown are from one experiment and are representative for 3 experiments. G. Heatmap for samples collected in pluripotency and during ND and GD with clustering based on Spearman correlation distances of quantile-normalized RT-qPCR values.  Stem cell work performed by Stryjewska, bio-informatics by Dries.   
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Figure S4.2, related to Figure 4.1. (previous page) The differentiation defects are rescued in 
R26_Zeb2 ESC lines. 
A-E. IHC and IF of R26_ZEB2 line after 15 days of general (GD) or neural (ND) differentiation A. Zeb2 (brown) in GD. B. βIIITubulin (green), ND. C. Oct4 (green) and Cdh1 (red), ND. D. Hnf4a (brown), GD. E. 
Tet1 (brown). Scale bar: 50 μm. F. RT-qPCR for marker genes representative for three-lineage differentiation, pluripotency and DNA-methylation, respectively, in Ctrl, Zeb2 KO and R26_Zeb2 lines on d0 (blue) and 15 (red) of ND. Results are representative of 3 experiments performed. SD of 2 technical replicates is shown. G. RT-qPCR for marker genes (see above) in Ctrl, Zeb2 KO and R26_Zeb2 lines on d0 (violet) and 15 (green) of GD. Results are representative of 3 experiments performed. SD of 2 technical replicates is shown. Experiment carried out by Stryjewska.  
4.3.2 Zeb2 acts preferentially as a transcriptional repressor associated with 
developmental progression 
 Temporal RNA-seq of Ctrl and Zeb2 KO ESCs would show in more detail Zeb2-dependent effects on early cell-state/fate decisions and identified potential mediators of the impaired differentiation phenotype downstream of Zeb2. Here we chose ND wherein we can distinguish three stages that correspond in Ctrl cells to (i) ground-state ESCs (d0, very low Zeb2 mRNA/protein), (ii) multipotent progenitors (d4, low Zeb2, cultured in presence of serum, induction of markers of 3 lineages is observed) (for details, see Figure S3A-C online; trophectoderm markers are documented in Figure S3D online) and (iii) early neural progenitors (d6, high Zeb2). For each stage we performed RNA-seq for 3 independent experiments. Principal component analysis (PCA) illustrated that both Ctrl and Zeb2 KO on d0 are situated close together, but on d4 they already follow different trajectories (Figure 4.2A). This coincides with the first induction of Zeb2 (between d0-4 in Ctrl; Figure 4.1B) indicating that Zeb2 influences cell-fate decisions very early-on when cells normally exit from their ground-state and undergo lineage priming.   To gain insight into what processes might be involved in the establishment of the early differences between Ctrl and Zeb2 KO cells, we identified the top positive and negative genes that contribute to principal component 2 (PC2, which separates the lineage trajectories of Ctrl and Zeb2 KO samples on the PCA plot) and performed gene ontology (GO) analysis using Gorilla software (Eden et al., 2009). This revealed that the top-100 genes associated with Zeb2 KO cells were enriched for terms that relate to peptide biosynthesis and metabolism, while the top-100 genes associated with Ctrl cells were mainly enriched for epigenome-related terms, such as histone modification and chromatin organization (for the gene lists, see Table SIII online).   We next applied a time-series analysis (see Experimental procedures) on our RNA-seq data set to assess the effect of the factor “time” and identify genes that have a different dynamic expression profile in KO vs. Ctrl cells (online Table SIV, RNA-seq_Time_Series). Gene set enrichment  (GSEA) analysis (Subramanian et al., 2005) of genes displaying this different dynamic behavior showed strong negative enrichment for various differentiation/developmental categories within the top-10 hits (Figure 4.2B) and further confirmed that at least the vast majority of Zeb2 KO cells in EBs indeed remain uncommitted. We also (re-)confirmed that Zeb2 KO cells do not acquire neural fate (using Pax6, Zfp521 and 
Neurog1; Figure S4.3A). The early-neuroectoderm markers Gbx2 and Hoxa1 previously shown 
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to be correctly induced upon differentiation in Zeb2 KD hESCs (Chng et al., 2010), were not induced in Zeb2 KO mESCs. This indicates that genetic inactivation of Zeb2 results in a more severe neural acquisition phenotype than the KD (Figure S4.3A). We examined the expression of other cell lineage markers in our RNA-seq data to exclude that Zeb2 KO cells would preferentially induce non-neural fates (Figure S4.3B-D). Although a small increase in those markers was observed in Ctrl EBs, they were either almost absent (for mesoderm, Figure S4.3C) or markedly lower (trophectoderm and endoderm; Figure S4.3B,D) in Zeb2-deficient EBs.   
 
Figure S4.3 Differentiation marker genes. 
A-D. Dynamic expression levels in Ctrl and Zeb2 KO cells for selected neural (A) endoderm (B), mesoderm (C) [and trophectoderm (D), see text] genes at three stages in ND (d0, d4, d6, respectively). Average trend for selected genes in Ctrl and KO cells is modeled by simple linear regression line.  
 
Figure S4.4, related to Figure 4.2. Analysis of temporal RNA-seq. 
A. GO analysis for top-100 genes in the PC2 in the Ctrl cells. B. GO analysis for top-100 genes in the PC2 in the Zeb2 KO cells. 
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 While this RNA-seq data analysis significantly expands our previous characterization of the cells and confirms that Zeb2 inactivation globally affects ESC differentiation, it also provided the possibility to discover potential Zeb2-dependent candidate genes responsible for the impaired differentiation of Zeb2 KO ESCs. Therefore we performed pairwise RNA-seq analysis at all three time-points and identified differentially expressed genes (DEGs) (p-value < 0.01 and log2 Fold Change (FC) > 1; online Table SV, RNA-seq_Pairwise). Consistent with the divergent PCA trajectories we observed an increase in both number of DEGs and their FC over time (Figure 4.2C).    Upon neural induction the majority of genes that were either up or down on d4 (multipotent progenitor stage) maintained this status on d6 (early neural progenitor), 69% and 72%, respectively. Numbers of DEGs increased between d4-6. To further filter for direct transcriptional regulation by Zeb2 we performed binding motif analysis within promoters (2kb up and downstream of the transcription start site, TSS) of DEGs. We searched for two motifs, the E-box sequence 5’-CACCTG-3’ and 5’-CACCT-3’, interspaced by 45bp max (Remacle et al., 1999). The genes upregulated during differentiation in Zeb2 KO cells showed an increase in enrichment for the selected Zeb2-binding motifs (Figure 4.2D, red bars and line), while the opposite trend was observed for downregulated genes (Figure 4.2D, green bars and line). This suggests that Zeb2 functions preferentially as a transcriptional repressor during differentiation.   
4.3.3 Zeb2 KO ESCs stall in an epiblast-like state 
 Zeb2-deficiency leads to impaired differentiation of ESCs and Zeb2 preferentially acts as repressor. We therefore investigated whether the pluripotency network was properly silenced in Zeb2 KO ESCs, in particular the genes associated with the naïve state and known as rapidly downregulated upon withdrawal of 2i+LIF (Leeb et al., 2014). Klf4, Tbx3, Zfp42, Prdm14, Essrb, 
Nr0b1 and Dppa3 were all properly downregulated in both Zeb2 KO and Ctrl ESCs (Figure 4.2E, upper panel). However, a significant set of factors that are part of a larger pluripotency network or involved in initiation of differentiation were not at all or only partially downregulated, such as Lefty2, Tcea3, Dppa5a, Utf1 and Tdgf1 (Chambery et al., 2009; Jia et al., 2012; Kim et al., 2013; Park et al., 2013; Qian et al., 2015) (Figure 4.2E, lower panel). This group also included Pou5f1 and Nanog, key players in the acquisition of pluripotency and early development (Chambers et al., 2003; Nichols et al., 1998). All genes in the latter group contain putative binding sites for Zeb2 within 2kb from their TSS, suggesting that Zeb2 is a candidate direct repressor of (at least some) genes involved in pluripotency maintenance. In line with the role of Zeb2 in EMT (Comijn et al., 2001; Lamouille et al., 2014) we observed that in Zeb2 KO cells Cdh1expression remains high, Epcam is strongly induced and Cdh2, Snai-1/2, Twist1 and Zeb1 were not induced to the same extent in differentiation conditions (Figure 4.2F). This confirms that these ESCs have defective EMT consistent with previously documented roles of Zeb2, including downregulation of Cdh1, in other cell types.    Both Dnmt3b (Figure 4.2H) and Dmt3l (Figure 4.2G) have putative Zeb2-binding sites and were upregulated in Zeb2 KO during differentiation. Together with other genes they determine 
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DNA-methylation at this stage, hence we monitored Dnmt1, Dnmt3a and Tet1, Tet2 and Tet3 expression (Ito et al., 2010; Jackson et al., 2004; Koh et al., 2011; Okano et al., 1999; Tahiliani et al., 2009). In addition to high expression of all three Dnmt3 genes, the Tet1/2 to Tet3 expression switch is only partially achieved; it normally occurs during transition from pluripotent stem cells to differentiated cells (Koh et al., 2011), but in our case Tet3 induction is limited and Tet1 expression is higher (Figure 4.2G).          
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Figure 4.2 Analysis of temporal RNA-seq. 
A. Principal component analysis based on transcripts per million (TPM). B. GSEA-P for DEG in time-series analysis. The height of the bar plot represents significance and the corresponding negative enrichment score is indicated (blue). C. Bar plot displays numbers of DEGs using pairwise DESeq2 test (|log2FC| > 1 and p < 0.01). Colors represent binned absolute log2FC levels. D. Promoter analysis for putative bipartite Zeb2-binding motifs (CACCT/CACCTG sequences with maximum gap of 45bp; see main text) of DEGs between Zeb2 KO vs. Ctrl. Red bar = selective analysis for upregulated DEG, demonstrates statistical overrepresentation (Fisher’s exact test p-value = 1.044e-08). Green bar = selective analysis for downregulated DEG points to underrepresentation. E-H. TPM (transcripts per million) bar plots at the indicated time points for pluripotency-related genes (E), selected EMT genes (F) and selected methylation-related genes (G) and epiblast (H). PCR analysis performed by Stryjewska, bio-informatics by Dries. 
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 Although EBs are inherently heterogeneous, all our aforementioned results indicate that at least part of the cells are stalled in an epiblast-like cell state in which early epiblast markers are induced whereas a number of pluripotency genes gets downregulated (Buecker et al., 2014; Hayashi et al., 2011). We observed a strong increase of expression of the established post-implantation epiblast genes Otx2, Pou3f1 (Oct6), Dnmt3b, Zic2 and Fgf5 (Buecker et al., 2014; Iwafuchi-Doi et al., 2012) (Figure 4.2H). This data suggests that at least a fraction of Zeb2 KO cells undergoes lineage priming and acquires epiblast-like cell (EpiLC) features.    
4.3.4 Zeb2 KO ESCs display less efficient ESC-to-EpiLC conversion 
 To test whether Zeb2 KO cells could acquire to epiblast-like fate, we subjected them (in parallel with the Ctrl line) to a 48h-long ESC-to-EpiLC conversion (Hayashi et al., 2011) and examined the transcriptional changes, using high-throughput qPCR (see Experimental procedures), of a set of markers shown to be comparably and differentially expressed, respectively, between ESCs and EpiLCs (Based on: Buecker et al., 2014). To evaluate whether EpiLC acquisition depends on the presence of Fgf2+ActivinA, we included also samples of 48h-long differentiation in pure N2B27. There were no obvious morphological differences between Ctrl and Zeb2 KO cells after 48h ESC-to-EpiLC conversion and both lines acquired more flat morphology (Fig. 4.3A).   First, we analyzed expression of Nanog, Oct4 and Sox2, which according to Buecker and co-workers are comparable between ESCs and EpiLCs (Buecker et al., 2014). Nanog was downregulated in both Ctrl and Zeb2 KO lines after 48h, but in the Zeb2 KO cells it was still expressed at higher levels (for Nanog downregulation, see (Hayashi et al., 2011)). Oct4 was retained in Ctrl cells and slightly increased in the Zeb2 KO cells after 48h, while Sox2 was downregulated and retained, respectively (Figure 4.3B). Next, we looked at Nr0b1, Prdm14, 
Zfp42, Esrrb, Klf2 and Klf4, which should be expressed at higher level in ESCs as compared to EpiLCs. All these markers were found downregulated in both lines, but in the Zeb2 KO line 
Nr0b1, Zfp42 and Klf2 continued to display higher mRNA levels as compared to Ctrl cells, whereas Prdm14, Esrrb and Klf4 mRNA reached after 48h similar levels in both lines (Figure 4.3C). Last, we analyzed Dnmt3a, Dnmt3b, Fgf15, Fgf5, Otx2 and Pou3f1, a set of markers expected to be expressed at lower levels in ESCs as compared to EpiLCs. With the exception of 
Dnmt3a in the Zeb2 KO line, all markers were induced in both Ctrl and KO cell lines. In particular, Dnmt3b and Otx2 are induced in Ctrl and Zeb2 KO lines to the same extent, while Fgf5 and Pou3f1 show higher mRNA levels in Ctrl vs. Zeb2 KO cells. Fgf15 in EpiLC conversion is expressed at higher levels in the Zeb2 KO line as compared to Ctrl and after 48h in N2B27 its expression is comparable in both lines (Figure 4.3D). Taken together, the results obtained in ESC-to-EpiLC conversion and 48h of N2B27 are comparable, meaning that the transcriptional changes of genes analyzed are not influenced by the presence of Fgf2+ActivinA in the medium.   We conclude that, at population level, Zeb2 KO cells present with a less efficient conversion to EpiLC phenotype, likely resulting from a combination of both naïve and primed states. Since epiblast fate requires more efficient pluripotency gene silencing than observed in the Zeb2 KO cells and a significant induction of markers such as Fgf5 and Pou3f1, we suggest that - in our EBs 
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- a fraction of Zeb2 KO cells remains in naïve  ESC  state, while the remaining cells may still undergo EpiLC conversion. Single-cell mRNA analysis is needed in future experiments to provide insight into the proportions of cells that stay in the naïve vs. primed state as well as revealing the presence of (few) cells progressing towards differentiation.  
 
Figure 4.3 Zeb2 KO ESCs display less efficient ESC-to-EpiLC conversion.  
A. Phase-contrast images of Ctrl and Zeb2 KO cells in 2i+LIF and after 48h of EpiLC conversion. Scale bar: 
50μM. B-D: RT-qPCR analysis of Ctrl and Zeb2 KO samples on d0, after 48h in EpiLC medium and after 48h N2B27 in medium. B. Transcripts comparable between ESC and EpiLC (Nanog, Pou5f1, Sox2). C. Transcripts higher in ESC vs. EpiLC (Nr0b1, Prdm14, Zfp42, Esrrb, Klf2, Klf4). D. Transcripts lower in ESCs vs. EpiLCs (Dnmt3a, Dnmt3b, Fgf15, Fgf5, Otx2, Pou3f1). The three categories (B,C,D) used here are based on Buecker et al. (Buecker et al., 2014). Results shown are from one experiment; error bars are from 3 biological samples.  
 
4.3.5 Pluripotent potential is retained in Zeb2-deficient embryoid bodies 
 Pou5f1 (Oct4) and Nanog, two crucial pluripotency-supporting factors maintained in epiblast cells, remained high (as seen by western blotting and RT-qPCR, Figure S4.5A,B) and were present in a large fraction of cells in Zeb2 KO ND-EBs till d15 (Figure 4.4A,B). Again this observation could be extended to GD-EBs (Figure S4.5C,D; d15). In addition high numbers of Cdh1+ cells were observed in Zeb2 KO EBs (Figure 4B) and this was also seen at protein and mRNA levels on d15 (Figure S4.5A,B). R26_Zeb2 rescue partially restored downregulation of Oct4 (and Cdh1) mRNA/protein (Figure S4.2C). To confirm that this is the direct result of Zeb2 
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binding a ChIP-qPCR was carried out over the Zeb2-binding motif (Figure 4.4C,D). This showed enrichment of Flag-tagged Zeb2 (using R26_Zeb2 ESCs) Cdh1 promoter (Comijn et al., 2001; Van de Putte et al., 2003) and its new candidate target Nanog.   To document the persistence of the pluripotent state upon differentiation in Zeb2 KO cells, we dissociated Ctrl and Zeb2 KO EBs on d15 (in ND or GD), sorted the living cells and plated these at 500 cells/well as single cells in 2i+LIF. Alkaline phosphatase (AP)+ ESC colonies derived from EBs subjected to differentiation (Figure 4.4E,F) were quantified on d9 (Figure 4.4G). In a typical experiment, Ctrl cells subjected to ND did not give rise to AP+ cells, whereas 
Zeb2 KO cells in 2i+LIF yielded on average 8 colonies/well. In GD, Ctrl cells gave rise to less than 1 (calculated 0.2) AP+ colony/well, whereas for Zeb2 KO cells this was 4 colonies/well on average. Based on AP read-out, this shows these latter cells have the remarkable ability to re-adapt to 2i+LIF, like ESCs and EpiSCs, and that they form AP+ colonies even up to d15 of differentiation treatment. Without assessment at single-cell level, we cannot discriminate whether these AP+ colonies arose exclusively from epiblast-like or more naïve Zeb2 KO cells since both cell types can adapt to 2i+LIF. Teratoma formation, using EBs subjected to ND for 12 days showed that Ctrl EBs failed to form teratomas, while Zeb2 KO EBs gave rise to teratomas in 4 weeks (Figure S4.5E). These data show, therefore, that Zeb2 genetic inactivation leads to maintenance of pluripotency even after prolonged differentiation. 
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Figure 4.4 Pluripotency genes are not efficiently downregulated during differentiation in Zeb2 
knockout (KO) ESCs.  
A. Control (Ctrl) and Zeb2 KO (KO) EBs stained for Nanog (brown) on d4, d6 and d15 of ND. B. Ctrl and KO EBs co-stained for Oct4 (green) and Cdh1 (red) on d4, 6 and 15 of ND. Panels A-B show results from one experiment that is representative for 3 experiments. Scale bar: 50µm. C-D. Zeb2 ChIP (using anti-Flag antibody) on Cdh1 C. and Nanog promoter. D. Results shown are from one experiment and representative for 3 experiments. E-F. Ctrl and KO ESCs subjected to ND (E) and GD (F) for 15 days, dissociated and plated at 500 cells/well in 2i. The resulting ESC colonies (indicated by arrows) were visualized by staining for AP, and panel G represents the average number of AP+ colonies obtained after plating the cells.  
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Figure S4.5, related to Figure 4.4. Pluripotency gene expression is not silenced during 
differentiation in Zeb2 KO cells.  
A. Western blot analysis for Cdh1, Oct4 and Nanog in Ctrl and Zeb2 KO (KO) EBs during ND. B. RT-qPCR analysis of in Ctrl and KO ESCs (D0) and EBs on d15 of ND for Oct4, Nanog and Cdh1. Results are representative of 3 experiments performed. SD of 2 technical replicates is shown C. Ctrl and Zeb2 KO EBs stained for Nanog (brown) on d15 of GD. D. Ctrl and KO EBs co-stained for Oct4 (green) and Cdh1 (red) on d15 of GD. Panels (C-D) show results from one experiment that is representative for 3 experiments. Scale bar: 50 µm E. Teratoma formation assay with EBs subjected to ND for 12 days. 
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4.3.6 The Zeb2 KO embryoid bodies, subjected to neural differentiation, fail to 
maintain the initially acquired DNA-methylation 
 
Zeb2 KO EBs show impaired cell differentiation and deregulated expression of the core methylation machinery genes. This prompted us to examine the acquisition and maintenance of CpG-methylation (meCpG) that accompanies the decision of irreversible ESC differentiation. Retaining the same time/sample setups as for RNA-seq and again using ND, single-base profiles were generated of methylation by RRBS in both Ctrl and Zeb2 KO on d0, d4 and d6. The genome of ground-state (d0) ESCs was globally hypomethylated (see also: Hackett et al., 2013). On d4 both cell populations gained methylation in agreement with our observation that they are in an epiblast-like (for KO) or multipotent (Ctrl) state. However a significant drop of meCpG was observed in the d6 Zeb2 KO cell population, suggesting that part of the CpG methylation is lost (Figure 4.5A). The progressive accumulation of meCpG in our EBs has a striking resemblance with that observed in vivo (Auclair et al., 2014), i.e. our d0 population profile is similar to blastocyst-stage embryos (between E3.5-E4.5), while d4 and d6 Ctrl populations have a similar distribution profile as epiblast embryos (E6.5). In contrast KO d6 resembles early-epiblast embryos (E5.5) with a reduction in meCpG at both gene bodies and 10kb-flanking regions (Figure 4.5B) (Auclair et al., 2014).     
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Figure 4.5 Analysis of temporal RRBS during neural differentiation.  
A. Distribution histogram for individual meCpGs on d0, d4 and d6 in Ctrl and Zeb2 KO populations. B. meCpG distribution at gene bodies and 10kb-flanking regions of protein-coding genes. C. Density plots for pairwise comparisons of meCpG (in 400bp-tiles) between d0-d4 in Ctrl (top) and d4-d6 in KO (bottom) cells. D. Density plot for pairwise comparison of meCpG (in 400bp-tiles) on d6 between Ctrl and KO. In C,D the density points increase from purple to dark red. E. Enrichment plot of Tet1-binding peaks centered around demethylated regions on d6 in a pairwise comparison between Zeb2 KO vs. Ctrl. F. Violin plots showing gain and loss-of-methylation over time in identified genomic regions, i.e. enhancers, CpG islands (CGI), canyons, transposable elements (TE), high-CpG content promoters (HCP), low-CpG content promoter (LCP), exons, introns, other non-defined genomic regions, and globally at the whole-genome (genome) in Ctrl and Zeb2 KO cells.   We further investigated changes in the (de)methylation process by considering CpGs covered in all samples and averaging methylation in 400bp-tiles, with a total of 184564 tiles. This identified differentially methylated regions (DMRs) (absolute methylation change >20% and q-value <0.05) in both a time and pairwise-dependent manner (online Table SVI, RRBS_Pairwise). Both Ctrl and KO cells significantly gained methylation in respectively 33.8% and 33.5% of all tiles between d0-4 (Figure 4.5C, left panels; Figure S4.6A). During this period no single significant loss-of-methylation was observed (Figure S6B). Next, between d4-6 Ctrl cells maintained a very stable level of methylation with only little gain or loss-of-methylation, 
i.e. 0.1% of all tiles (Figure 4.5C, right top panel; Figure S6A-B). In agreement with the observed overall lower methylation at d6 (Figure 4.5A-B), KO cells had 10 times more tiles (1806 or 1% of all tiles) with significant loss-of-methylation and only 90 tiles (0.05% of all tiles) with gain-of-
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methylation (Figure 4.5C, right bottom panel; Figure S6A-B; see also Table SVII, RRBS_Temporal). Furthermore, analysis of these aforementioned DMR in both Ctrl and KO cells revealed that these regions initially acquired methylation in both Ctrl and KO cells at d4, but this methylation was only maintained in Ctrl cells (Figure S4.6C).   To investigate whether demethylation was selective for specific genomic regions, we profiled the methylation dynamics of enhancers, CpG islands (CGI), canyons, transposable elements (TE), high CpG-content (HCP) and low CpG-content promoters (LCP), exons and introns. As reported before (Jeong et al., 2014a), resistance to gain-of-methylation occurs for canyons and high-CpG regions (CGI and HCP), while all other regions (enhancers, TE, LCP, exons and introns) were susceptible to gain-of-methylation. In contrast, the Zeb2 KO population is unable to maintain this methylation initially acquired in all aforementioned genomic regions (Figure 4.5F).  
 
Figure S4.6, related to Figure 4.5. RRBS.  
A-B. Bar plot showing gain (GOM, panel A) and loss-of-methylation (LOM; panel B) between consecutive time points in Ctrl and Zeb2 KO ESCs. C. Violin plots to illustrate distribution and dynamic behavior of DMRs (both GOM and LOM) over time.  
 
 
 Chapter 4  132
4.3.7 Failure to maintain acquired DNA-methylation during neural differentiation 
is associated with Tet1-binding; Tet1 knockdown in Zeb2 KO ESCs facilitates 
silencing of Nanog, Oct4 and Cdh1 and partially rescues the lineage differentiation 
phenotypes 
 Regions that lose methylation in d6 Zeb2 KO populations initially acquired methylation comparable to Ctrl (Figure S4.6C). We also compared d6 of both Ctrl and Zeb2 KO populations and as expected observed a similar number of tiles with loss-of-methylation (1938, or 1% of all tiles) (Figure 4.5D) and we observed also an increased level of Tet1 (Figure 4.2). We therefore asked whether the regions that lose methylation correlate with Tet1-binding. Figure 4.5E shows that regions that lose methylation in Zeb2 KO cells are enriched for Tet1-binding in normal ESCs: we could do this by combining analysis of published ChIP-seq data for Tet1 in mESCs (Wu et al., 2011) with our region-specific loss of methylation data on d6 (compared between Ctrl and 
Zeb2 KO). This strongly suggests that the observed demethylation in the Zeb2 KO cells is an active process mediated by elevated Tet1 levels in agreement with DNA-demethylation being initiated at Tet1-binding sites (Habibi et al., 2013).   Tet1 remains high in the Zeb2 KO EBs even on d15 of differentiation in contrast to its normal downregulation during ND and GD (Figure 4.6A,B). To test whether high Tet1 levels lead to inefficient silencing of Nanog, Oct4 and Cdh1 and hence a block in differentiation of these cells, we transduced control and Zeb2 KO ESC lines with a lentivirus expressing shRNA directed against Tet1 (called Ctrl_Tet1shRNA, Zeb2KO_Tet1shRNA, respectively). Tet1 was almost undetectable in Ctrl and Zeb2 KO lines targeted with Tet1 shRNA (Figure 4.6C,D; for quantifications of Tet1 staining, see Figure S4.7A). In 2i+LIF, the Tet1 KD lines maintained their undifferentiated characteristics (not shown). We subjected these Tet1shRNA lines to ND and GD, respectively, along with the same lines receiving control non-targeting shRNA (Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA). These control shRNA lines behaved as expected in differentiation (Figure 4.6E-J), and Zeb2 was indeed absent from Zeb2KO_CtrlshRNA and Zeb2KO_Tet1shRNA EBs at the end of GD (Figure 4.6H) and ND (data not shown). After 15 days, Zeb2KO_Tet1shRNA cells subjected to either ND or GD efficiently decreased Nanog, Oct4 and Cdh1 mRNA to low levels at the end of GD (Figure 4.6E,F; ND data not shown; for quantifications of Oct4 and Cdh1, see Figure S4.7B,D). In Zeb2KO_Tet1shRNA lines subjected to GD, partial rescue of differentiation to mesoderm (Figure 4.6I; for quantifications of Desmin, see Figure S7G) and endoderm (Figure 4.6G; for quantifications of Hnf4a and Sox17, see Figure S4.7E,F) was observed, but not to neuroectoderm, (data not shown). Partial rescue of ND was observed only when 
Zeb2KO_Tet1shRNA cells were subjected to ND (Figure 4.6J; for quantification of βIIITubulin, see Figure S4.7C). Thus, Tet1 remains high in Zeb2 KO cells during differentiation, and forced downregulation of Tet1 in these cells in such conditions enables decreasing Nanog, Oct4 and 
Cdh1 transcription and partially rescues differentiation. We conclude that Zeb2-deficiency during differentiation leads to higher Tet1, which is associated with improper reduction of 
Nanog and Oct4, resulting in impaired differentiation.   
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Figure 4.6 Tet1 knockdown in Zeb2 knockout ESCs facilitates their definitive pluripotency exit and 
partially restores their neural (ND) and general differentiation (GD) defect.  
A. RT-qPCR of Tet1 mRNA in Ctrl (blue) and Zeb2 KO (red) lines on d0, d4, d6 and d15 of ND. SD of two technical replicates is shown. B. Ctrl and Zeb2 KO EBs stained for Tet1 (brown) on d4, d6 and d15 of GD. 
C. RT-qPCR of Tet1 mRNA on d0 (violet) and d15 (green) in Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA lines. SD of 2 technical replicates is shown. D. Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA EBs co-stained for Tet1 (brown) on d15 of GD. Scale bar B,D: 50µm. E-J. Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA EBs stained for the indicated markers. In: E. Nanog (brown) on 15 of GD. F. Oct4 (green) and Cdh1 (red) on d15 of GD. G. Hnf4a (brown) on d15 of GD. H. Zeb2 (brown) on d15 of GD. I. Desmin (brown) on d15 of GD. J. 
βIIITubulin (red) on d15 of ND. Scale bar: 75µm. E-I: scale bar: 50µm. In all panels, results shown are from one experiment and representative for 3 experiments. Experiments performed by Stryjewska.    
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Figure S4.7, related to Figures 4.1 and 4.6. Tet1 knockdown in Zeb2 knockout ESCs facilitates their 
definitive pluripotency exit and partially restores their neural (ND) and general differentiation 
(GD) defect.  Quantifications of staining of EBs (each EB indicated as individual data point): A. Tet1 on d15 of GD. B. Oct4 on d15 of ND. C. βIIITubulin on d15 of ND. D. Cdh1 on d15 of ND. E. Hnf4a on d15 of GD. F. Sox17 on d15 of GD. G. Desmin on d15 of GD. Statistical analysis: Non-parametric Mann-Whitney test. Error bars show mean with 95% confidence intervals. p-val: ****: <0.0001, ***:<0.001, 0.01<**<0.05:, *<0.05. 
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4.4 Discussion 
  Using Zeb2 genetic inactivation in ESCs for the first time as well as rescue in such Zeb2 KO cells via re-introduction of R26-driven Zeb2-cDNA, Zeb2 is shown critical for these cells to undergo three-lineage differentiation. We propose that Zeb2 drives lineage commitment and specification by acting on multiple sets of Zeb2-dependent genes. First, Zeb2 is an important EMT-inducer (Comijn et al., 2001; Vandewalle et al., 2005). Zeb2 KO ESCs retain epithelial characteristics when subjected to differentiation. Their phenotype appears even more severe than the recently described KO in ESCs of another known EMT-regulator, Snai1, which still differentiate (Lin et al., 2014). Second, the downregulation of important pluripotency network regulators depends on Zeb2. In contrast to Ctrl, Zeb2 KO ESCs retain high Tet1, Oct4 and Nanog during differentiation. In ESCs, Tet1 is involved in a positive regulatory loop with Nanog and Oct4. Tet1 co-operates with Nanog, while the KD of Nanog weakens Tet1-binding to its targets (including Oct4, Esrrb). Tet1 was also shown to act downstream of Oct4, and downregulation of Oct4 leads to decreased Tet1 (Costa et al., 2013; Gao et al., 2014; Ito et al., 2010; Koh et al., 2011). Tet1 acts downstream of histone deacetylase Sirt6 to control ESC fate in differentiating conditions (Etchegaray et al., 2015). Also, like in our system, the Tet1 KD allowed silencing of 
Oct4 and Nanog and rescued the Sirt6 KO differentiation defect. Thus, Tet1 has a global inhibitory role in regulating key pluripotency genes during ESC differentiation, and this work identifies Zeb2 as an (indirect) upstream factor important for achieving correct Tet1 levels.   We describe a link between Zeb2 and regulation of DNA-methylation status. Acquisition of DNA-methyl marks during embryogenesis is thought to be unidirectional (Auclair et al., 2014), but studies in ground-state naïve ESCs and EpiSC, respectively, show that the methylomes are interconvertible in vitro when different conditions are applied (Habibi et al., 2013; Hackett et al., 2013). Our RRBS showed that correct DNA-methylation patterns are initially acquired by Zeb2 KO cells, but that this pattern cannot be sustained: Zeb2 KO cells revert the methylome to a more naïve state, which agrees with the maintenance of their undifferentiated phenotype associated with persistence of Nanog and Oct4. Remarkably, this reversion in Zeb2 KO cells is facilitated in absence of additional cues or signals, like LIF and/or 2i. We hypothesize that Tet1 levels are maintained by the key pluripotency genes in Zeb2 KO cells. Steady-state high-Tet1 would then actively demethylate the genome and contribute to preserving high-Nanog and high-Oct4 in the mutant cells. Enrichment of Tet1-binding at regions that lost methylation in 
Zeb2 KO cells further supports this hypothesis. Tet1 KD in these Zeb2 KO cells facilitated downregulation of Nanog and Oct4 as well as Cdh1, but their differentiation phenotype was only partially rescued.   The aforementioned discussed results raise the question on how it is possible that Zeb2 KO ESCs, in which Tet1 mRNA is not downregulated, can still undergo DNA-methylation. First, the main function of Tet1 may be to actively catalyze demethylation rather than prevent methylation per se. We hypothesize that between days 0-4 the gain-of-methylation in both Ctrl and Zeb2 KO cells is driven by the very early events linked to the withdrawal of 2i+LIF and entering the primed state of pluripotency. We have however not documented that what seems 
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like an equal total gain in Ctrl and KO cells, also occurs with the same dynamics (because we analyzed in detail only days 0 and 4 of differentiation) and altogether reflects precisely that these cells undergo the same changes. In other words, Ctrl cells could be entering 3-lineage differentiation program(s) (which we were able to confirm by analyzing their transcriptional profile) whereas Zeb2 KO cells could be stalled in the epiblast-like state and both changes would manifest by the same gross methylation pattern. It has been previously published that there is a large gain of methyl marks in ESCs when they transit from ground (2i+LIF) to serum+LIF conditions, both of which maintain functional pluripotency. Hence, the observed acquisition of methyl marks can be partially a reflection of entering the metastable state by the Zeb2 KO cells.      It has previously been shown that Dnmt1 KO ESCs show decreased total DNA-methylation levels, whereas DNA of Dnmt +/- mutant ESCs is still highly methylated (Lei et al., 1996). It could be that the observed loss of DNA-methylation in our Zeb2 KO ESCs on d6 is partially caused by decreased Dnmt1 levels that cannot sustain the acquired methylation pattern in the presence of high Tet1, which continuously catalyzes DNA-demethylation. Interestingly, the expression of 
Dnmt3a/3b/3l was higher in Zeb2 KO as compared to Ctrl ESCs. We hypothesize that the observed increase in de novo methyltransferase gene expression could be a counter-acting mechanism to sustain the balance between DNA-methylation and demethylation. The end result, loss of DNA-methylation, could hence be due to high constant levels of Tet1 that on itself is sustained by the pluripotency genes.   Using GO analysis (done on PC2), we also noted that aberrant chromatin changes and histone modifications could contribute to the differentiation phenotype in Zeb2 KO ESCs. ESCs have a unique, open chromatin that changes rapidly upon cell differentiation, thereby influencing transcriptional regulation and cell identity (Marks et al., 2014; Mikkelsen et al., 2007; Orkin and Hochedlinger, 2011). Given the differences in the transcriptional profile of Ctrl vs. Zeb2 KO ESCs we hypothesize that, in addition to the DNA- methylation related phenotype followed-up here, Zeb2 KO ESCs might also have a different chromatin (more ESC-like) structure, which contributes to their undifferentiated phenotype.   It is also likely that Zeb2 controls other important cell fate regulators at multiple stages of differentiation in addition to the pluripotency genes and Tet1 investigated here. For example, similar to described in vivo functions of Zeb2 in myelinogenesis in embryonic CNS (Weng et al., 2012), Zeb2 may also counteract genes that are inhibitory for neural conversion during ESC differentiation; it may also act as an activator of other target genes depending on its co-factors (Conidi et al., 2011; Hegarty et al., 2015) which altogether would then promote neurogenesis. Subsequent work will have to encompass the mapping of the genome-wide binding sites of Zeb2 in mESCs. As the current anti-Zeb2 antibodies fail in such studies (not shown), these studies will require an endogenous tagging approach within Zeb2 to identify Zeb2 DNA-binding sites and also stage-relevant protein partners of Zeb2.  
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Conclusion and/or Summary 
 The transcription factor Zeb2 is critical for exit from the epiblast state in mouse ESCs and links the pluripotency network and DNA-methylation with irreversible commitment to differentiation. Zeb2 KO ESCs display impaired differentiation by stalling in an epiblast-like state. Using RNA-seq, we conclude that in differentiating conditions EMT, pluripotency, lineage commitment and DNA-(de)methylation genes are deregulated in Zeb2 KO embryoid bodies. Using RRBS, we demonstrate that these cells cannot maintain their initially acquired DNA-methylation marks in neural-stimulating condition and do not effectively downregulate Oct4, 
Nanog and Tet1 in differentiation conditions. Tet1 KD partially rescues the impaired differentiation of the KO cells.      
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4.5 Experimental Procedures 
ESC lines All experiments on live mice used for deriving embryos for establishing the ESCs were performed in the Leuven lab according to institutional (KU Leuven P153/2012), national (lab license LA1210584, Belgian government) and international (2010/63/EU) guidelines and regulations. KU Leuven approved the experiments and confirmed that all experiments were done conform to the regulatory standards. Two independent ESC derivations were performed. First, control lines were derived by interbreeding 
Zeb2flox/flox CD1 mice (CD1 background: Higashi et al., 2002). Blastocysts were plated on mitomycin-C inactivated mouse embryonic fibroblasts (mitC-MEFs) in ESC derivation medium + LIF, and allowed to attach, and were re-fed daily. After 5-6 days, the inner cell mass was separated from the trophectodermal layer, trypsinized and replated on mitC-MEFs. They were further grown until subconfluency and expanded. From these ESCs, Zeb2 KO lines were derived by nucleofection of linearized, blasticidin-selectable (48h) pcDNA6-His-eGFP:Cre vector to low-passage ESCs using Amaxa A-23 (Lonza www.lonza.com, Braine-l’Alleud, BE). Five control ESC lines and two KO lines, confirmed as such by genotyping (details available on request), were established. Secondly, Zeb2+/- mice were crossed with R26-iPSC mice that contain a RMCE cassette in the ROSA26 (R26) locus (Haenebalcke et al., 2013a). The second R26 allele contained the LacZ reporter  (Soriano, 1999). New control and RMCE-compatible Zeb2 KO ESC lines (3 clones; mixed 129/Bl6 background) were derived using a protocol (Pieters et al., 2012) in which pluripotin was replaced with 1 µM PD0325901 and 3 µM CHIR99021. To obtain R26_Zeb2 lines, RMCE technology (Haenebalcke et al., 2013b) was used to insert N-terminally Flag epitope (Flag) tagged, wild-type Zeb2 cDNA into R26 of Zeb2 KO ESCs.  
ESC cultures and sorting 
ESC maintenance: ESCs were maintained feeder-cell free in 2i+LIF medium. N2B27 was prepared as described (Gaspard et al., 2009). For 2i+LIF medium, 1 μM PD0325901 (Axon, 1408; Axon Medchem www.axonmedchem.com, Groningen, NL), 3 μM CHIR99021 (Axon, 1386) (Ying et al., 2008) and 1,000 U LIF/ml (Millipore, ESG1107; Merck Millipore www.merckmillipore.com, Zwijndrecht, BE) were added. 
Directed neural differentiation: On d0, 3x106 ESCs were plated in a 10-cm bacterial petri dish in EB medium (KO DMEM (Invitrogen, 10829018; Thermo Fisher Scientific www.thermofisher.com, Merelbeke, BE), 15% fetal bovine serum (FBS, Life Technologies, 10270106; Thermo Scientific www.fishersci.be/be, Aalst, BE), 0.1 mM non-essential amino acids (NEAA), 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol, 50 U/ml of penicilline/streptomycine, P/S). On d2 the EB medium was refreshed; on d4 it was changed to N2B27+retinoic acid (Sigma-Aldrich, R2625; www.sigmaaldrich.com, Overijse, BE ; 500 nM) and refreshed on d6. Between d8-15 EBs were cultured in N2B27, which was refreshed every other day. 
General EB differentiation: On d0, 3x106 ESCs were plated in a 10-cm dish in EB medium (KO DMEM (Invitrogen, 10829018), 10% FBS, 0.1 mM NEAA, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol, 50 U/ml of P/S and changed every other day till d15. EBs on d15 were dissociated using Liberase (Roche, 05401020001; Roche Biochem Reagents at www.sigmaaldrich.com, Overijse, BE). Living cells were stained with propidium iodide (Sigma-Aldrich, P4864) shortly before sorting. ESC-to-EpiLC conversion: ESCs were differentiated according to Hayashi et al. (Hayashi et al., 2011). Briefly 105 ESCs were plated per well of a 12-well plate coated with fibronectin (16.7 μg/ml, Millipore, FC010) in N2B27 containing Activin A (20 ng/ml, Peprotech, 120-14E), bFGF (12 ng/ml, Peprotech, 100-18C) and KSR (1%, Gibco, 10828010; Gibco via www.thermofisher.com, Merelbeke, BE). Medium was changed after 24h. The EpiLCs were collected after 48h.  
shRNA-mediated knockdown  Control shRNA was used by combining MISSION Target shRNA in control vector SHC002 (Sigma-Aldrich). The Tet1 shRNA (shTet: 5′-tcatctacttctcacctagtg-3′) was cloned into pLKO1. Control and Tet1 lentiviruses were produced by standard methods (see www.addgene.org/tools/protocols/pLKO).  
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Chromatin immunoprecipitation (ChIP) 107 ESCs (from the R26_Zeb2 line) were used per experiment. Cells were cross-linked for 10 min with ice-cold 1% formaldehyde, sonicated using a Branson Digital Sonifier (10 pulses, 30 sec ON;60 sec OFF, amplitude 10). 10 µg of anti-Flag (Sigma-Aldrich, F3165) and 10 µg of control mouse IgG (Santa Cruz, sc-2025; Santa Cruz Biotechnology www.scbt.com via Bio-Connect, Huissen, NL) were used. Chromatin isolation and ChIP were done as described (Lee et al., 2006). Phenol-chloroform purified DNA was used as template for qPCR to amplify the proximal promoters of Nanog and Cdh1. For primers, see Table SII.  
Immunohistochemistry (IHC) and indirect immunofluorescence (IF) EBs were fixed overnight with 4% paraformaldehyde followed by progressive alcohol-assisted dehydration and paraffin embedding. 6-μm sections were used for IHC and IF, which were carried out on Ventana Ultra Discovery (Roche; www.ventana.com via Roche, Vilvoorde, BE). The following antibodies were used: Zeb2 (custom antibody; Seuntjens et al., 2009), βIIITubulin (Abcam, ab78078; www.abcam.com, Cambridge, UK), Oct4 (Abcam, ab19857), Nanog (Abcam, 80892), Cdh1 (BD Transduction Labs, 610182; www.bd.com, Erembodegem, BE), Tet1 (Millipore, 09-872), Desmin (Abcam, ab8592-500), Hnf4a (Abcam, ab41898), Sox17 (R&D Systems, AF1924; www.rndsystems.com, Abingdon, UK) and Alexa Fluor tagged secondary antibodies (Jackson Immunoresearch; www.jacksonimmuno.com, via Bio-Connect, Huissen, NL; 1:1000). For Figure 1A, ESCs were fixed for 10 min with ice-cold paraformaldehyde and blocked for 30 min at 24°C with 0.1% Triton X100-1% BSA in PBS. Anti-Oct4 (Abcam, ab19857) and anti-Nanog (Abcam, 80892) (both 1:1000) were used as antibodies, with DAPI as nuclear counterstain (Life Technologies, D1306). For the quantifications presented in Figure S7 (for Oct4, Hnf4a, Sox17, Tet1 and βIIITubulin), we manually quantified (using Fiji software) the number of positive cells as well as total numbers of DAPI+ cells and show the results as percentage (of +cells/total) instead of showing absolute cell numbers, because embryoid bodies have varying sizes. For the two non-nuclear markers, E-cadherin and Desmin, we used Fiji software to calculate the total area of staining and we normalized it to the total area of DAPI staining. We made the graphs and did the statistical analysis using Prism7 software.   
High-throughput real-time PCR In a first step non- or unreliably expressed genes were removed based on quality information and a minimum threshold of 50% detection in all samples. Next, low quality samples were removed based on outlier detection of aggregation scores of all assay expression probabilities, calculated in all samples. Subsequently Ct values of the samples were quantile normalized and possible missing values were imputed using expression information of biological replicates. An overall limit-of-detection (LOD) was determined as the sum of the 75% quantile of normalized Ct values and a constant, i.e. 10. To compare between assay levels and display on the graphs we retrieved log2 expression values by subtracting the LOD score with normalized Ct values and obtained rough absolute expression estimations by raising 2 to the power of the log2 score.  
RNA-seq analysis Total RNA was isolated using a Qiagen RNeasy (Qiagen, 74104; www.qiagen.com, Antwerp, BE). cDNAs were generated with Truseq RNA kit and sequenced (Illumina TruSeq v3 protocol on HiSeq2000, with a single read 36bp and 7bp index). Sequenced fragments were mapped to the mouse genome GRCm38 (Ensembl) using Tophat2 (v2.0.13). A count table for annotated genes was generated with featureCounts (v1.4.6); genes were further classified in different biotypes based on Vega gene and transcript annotation (vega.sanger.ac.uk/info/about/gene_and_transcript_types.html). RNA-seq expression data: to compare counts between samples we converted them to Transcript Per Million (TPM) values. To retain only informative genes we filtered based on biotype, expression and standard variability using the aforementioned TPM values. First we removed all genes belonging to short non-coding categories, in the next step we selected only these genes that have at least 5 transcripts/million in at least 3 samples and, finally, we removed the 20% lowest variable genes. The raw counts were imported in the R-Package 
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DESeq2 (Love et al., 2014) to test for differential expression between pairwise time-points of KO and Ctrl samples or to perform time-series analysis, therefore we created a design matrix that controls for differences at d0 and allows to assess the effect of factor time on gene expression between KO and Ctrl samples. RNA-seq clustering: we used Principal Component Analysis (PCA) or unsupervised hierarchical clustering based on 1 – Spearman correlation distance scores with average linkage. RNA-seq gene 
ontology: to identify biological processes that are negatively enriched in Zeb2 KO, we sorted genes according to their pi-value (-log10(q-value) * logFC) based on DESeq2 time-series analysis. The obtained ranked list was input for the GseaPreranked tool with only –nperm 3000, -set_max 500 -set_min 10 deviating from the default parameters. RNA-seq motif sequence analysis: for imple motif analysis between KO and Ctrl at d6 we defined promoter regions as ± 2Kb from the transcription start site (TSS) and counted the occurrences for putative binding site of Zeb2 (double YACCTG sequences with maximum gap of 40bp) for all (up and down) DEGs (p<0.01 and absolute log2 FC > 1) and, as background, the promoter regions of all genes. One-sided Fisher’s exact test was used to determine significant over or under representation of this motif in promoter regions of DEGs relative to the genome-wide promoter regions. 
Data deposition: the RNA-seq data have been deposited as data set GSE75618 and are available at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75618.  
DNA-methylome analysis by RRBS Total DNA was isolated by digestion with proteinase K and precipitation with isopropanol. RRBS was performed by NXT-Dx (www.nxt-dx.com) using the premium RRBS kit (Diagenode). RRBS processing: the quality of sequencing reads was assessed by FastQC (v0.11.3_devel) and Trim Galore (v0.3.7) in –rrbs mode. These reads were then mapped to genome GRCm38 (Ensembl) using bismark (v0.14.1) with parameters –bowtie2 –maxins 1000, allowing a maximum insert size of 1,000bp for paired-end sequences. To extract methylation information in a CpG context from both strands we used bismark_methylation_extractor with parameters –paired-end –no_overlap –comprehensive. We used the R-package methylKit  (Akalin et al., 2012) and custom R-scripts to further analyze the data. In brief, we considered only CpGs with a minimum sequencing depth of 5x and removed the top 0.1% with highest coverage. To visualize global percentage methylation, histograms were created with 5%-methylation bins. For all further analyses we only retained CpGs that were present in all samples.  RRBS genomic 
regions: genomic coordinates for genes were retrieved from GRCm38 and only coordinates for protein-coding genes were used. We downloaded mm9 enhancer coordinates provided at http://chromosome.sdsc.edu/mouse/download.html ,converted them to mm10 coordinates using CrossMap (v0.1.8), and extended them in both directions with 1kb. CpG islands (CGI) and transposable elements (TE) were retrieved via the UCSC table browser for GRCm38/mm10, with the CpG Islands and RepeatMasker tracks, respectively. The genomic coordinates for Canyons were retrieved from (Jeong et al., 2014b). We used a CpG observed/expected ratio of 0.29 to distinguish low and high-CpG density promoters (Etchegaray et al., 2015). Regions that do not belong to any of the aforementioned regions (e.g. intergenic regions) are described as “other”. RRBS data analysis: to identify differentially methylated regions (DMRs) and analyze global methylation dynamics/differences we averaged methylation in 400bp-tiles containing at least 3 CpGs. Tiles with more than 20% difference in methylation and a q-value < 0.05 were assigned as significant DMRs, or simply DMRs. Data deposition: the methylome analysis data have been deposited as a data subset of GSE75618 and are available at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75618.    
Analysis of published Tet1-binding peaks in ESCs Data for Tet1 ChIP-seq for mouse ESCs was downloaded from GEO (GSM659803, GSM659799). Reads were aligned to GRCm38 using bowtie with parameters –e 70 –k 1 –m 1 –n 2 –concise. Peaks were indicated with MACS software using default parameters. To study enrichment of Tet1 at demethylated regions, peaks were assigned to the closest demethylated region. 
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Chapter 5: Zeb2 regulates cell number output and cell fate in 
embryonic and adult mouse SVZ neurogenesis  
 
5.1 Summary 
 In the adult mouse brain, subventricular zone (SVZ) neural stem cells (NSCs) generate olfactory bulb (OB) destined interneurons throughout life. These NSCs produce distinct interneurons, however many molecular players that regulate adult neurogenesis remain to be identified. We identify Zeb2 as a novel transcription factor regulating postnatal SVZ-OB interneuron output. First, Zeb2 knockout (using a Gsh2-Cre approach) in the lateral ganglionic eminence (LGE), which in the embryo provides significant numbers of precursor cells for the SVZ, was found to cause a collapse in numbers of migrating neuroblasts towards the OB. RNA-seq of cells collected from the SVZ tissue lining the lateral wall of the forebrain vesicles two days after birth revealed increased striatal-type interneuron gene expression in the mutant SVZ. Sox6, characteristic of both cortical and striatal interneurons, was highly induced in Zeb2-deficient SVZ cells. Sox6 overproduction in wild-type SVZ tissue similarly lead to a reduction in OB interneuron numbers, suggesting Sox6 is part of a Zeb2 regulatory program and acts downstream of Zeb2. Second, tamoxifen-inducible inactivation of Zeb2 in the adult forebrain (using a Glast-CreERT approach) resulted in a similar phenotype as seen after embryonic removal of Zeb2 in the embryonic LGE. Also here, Zeb2-KO cells failed to migrate towards the OB and a strong increase in Sox6-positive cells in the mutant adult SVZ was found. Hence, besides its other known functions in embryonic brain development we identified here a new function of Zeb2 in the SVZ and regulation of OB interneuron fate specification and output.  
5.2 Introduction 
 With thousands of new neurons being produced every day in adult rodent brain (as determined in studies in both rat and mouse), the subventricular zone (SVZ) is the most prominent location of two acknowledged sites of adult neurogenesis, the second being the dentate gyrus of the adult hippocampus (Curtis et al., 2012; Brus et al., 2013; Braun and Jessberger, 2014; Bond et al., 2015; Alunni and Bally-Cuif, 2016), while other candidate regions for limited neurogenesis including in injured brain have been proposed in the mouse and other mammals (Gould, 2007; Bonfanti and Peretto, 2011; Robel et al., 2011). In the mouse, the SVZ is architecturally an admirably well-organized (Alvarez-Buylla et al., 2008) and vascularized niche (Sawada et al., 2014; Licht and Keshet, 2015) where radial glial-like neural stem cells (NSCs, B cells, in particular the B1 cells; Lim and Alvarez-Buylla, 2014; Platel and Bordey, 2016) with often ascribed astrocyte-like properties generate - including after traumatic brain injury in a gliogenic 
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environment (Chang et al., 2016; Götz et al., 2015, 2016) - via a transient identifiable cell compartment (the C cells) large numbers of immature neuroblasts (A cells) that migrate through the rostral migratory stream (RMS) to the olfactory bulb (OB) (Lalli, 2014; Capilla-Gonzalez et al., 2015). Upon arrival in the OB, these A cells disperse radially amongst the OB granular and glomerular layers and mature eventually into inhibitory GABAergic interneurons, which integrate in the existing cellular network in the OB (Gengatharan et al., 2016; Lim and Alvarez-Buylla, 2016). Although B1 cells of the SVZ derive from NSCs that reside in different anatomical regions of the embryonic telencephalon (including the cortex, septum and the medial ganglionic eminence (MGE)) (Merkle et al., 2004), the majority of SVZ B1 cells originate from NSCs in the LGE (Young et al., 2007).    While the relationship between embryonic NSCs and adult B1 cells is obvious (Kriegstein and Alvarez-Buylla, 2009; Urbán and Guillemot, 2014), it was recently demonstrated that the later postnatal NSC lineage diverges already from this pattern during embryogenesis (Fuentealba et al., 2015, Furutachi et al., 2015). These lineage tracing studies revealed that postnatal B1 cells originate from specific embryonic NSCs that appear to separate from the other forebrain NSC lineages around mid-fetal development. This “special” population of B1 cells surprisingly remains largely quiescent until the reactivation of these cells during postnatal life (Fuentealba et al., 2015). Other studies have also suggested that NSCs committed to produce specific interneuron subtypes at specific developmental time points will become restricted to different domains of the adult neurogenic niche. To our opinion this picture may need intensive reconsideration after studying this at higher, perhaps single-cell resolution. In any case, the location where B1 cells reside in the postnatal SVZ may (co-)determine the types of OB interneuron they will generate (Merkle et al., 2007; Ventura and Goldman, 2007, Alvarez-Buylla et al., 2008, Fuentealba et al., 2015; for a recent review, see Lim and Alvarez-Buylla, 2016), with this regional specification proposed of being already established at early times during embryogenesis. Furthermore, evidence is emerging that cell-intrinsic transcriptional programs not only underlie the generation of various OB interneurons, including the factors Pax6 and SP8 (Hack et al., 2005; Waclaw et al., 2006; Kohwi et al., 2007; Young et al., 2007; Lopez-Juarez et al., 2013; Merkle et al., 2014; Azim et al., 2016). Taken together, the postnatal SVZ can at present be viewed as a mosaic of NSCs originating from different pallial and subpallial developing brain regions, and the various cell groups are considered to carry unique combinations of transcription factors. It is still unclear which factors (and epigenetic mechanisms) are master regulators of OB interneuron production, diversity and/or maturation and whether postnatal neurogenesis output can be modulated by changing the dose of e.g. such factors (Jones and Connor, 2011; Hsieh, 2012; Gonzales-Roybal and Lim, 2013; Ninkovic and Götz, 2013; Genin et al., 2014).   Zeb2 regulates cortical interneuron specification and guided migration in the embryonic ventral telencephalon (VT) (McKinsey et al., 2013; van den Berghe et al., 2013; Chapter 6 below). Zeb2 is a DNA-binding, multi-domain transcription factor (for recent reviews, see Conidi et al., 2011; Hegarty et al., 2015; see also Chapters 1, 4 and 6 here). This large protein contains two separated clusters of zinc fingers that each (via two fingers in each cluster) serve direct binding to CACCT(G), i.e. often E2-box type sequences, in gene regulatory regions (Remacle et al., 1999). In humans, mutation (mainly large deletion) of one ZEB2 allele causes 
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Mowat-Wilson syndrome (MOWS, OMIM #235730; Zweier et al., 2002; Garavelli et al., 2003; Ishihara et al., 2004), characterized by severe intellectual disability, typical craniofacial features and other congenital malformations, including seizures and epilepsy, agenesis of the corpus callosum, congenital heart defects and Hirschsprung disease (Mowat et al., 2003; Garavelli et al., 2005; Zweier et al., 2005). Cell-type specific Zeb2-KO mouse embryos have helped to explain neurodevelopmental features seen in MOWS patients (intellectual disability: Seuntjens et al., 2009; seizures and epilepsy: McKinsey et al., 2013; van den Berghe et al., 2013). Other conditional knockout mice revealed other embryonic functions of Zeb2 in myelinogenesis in the mouse CNS, Schwann cell maturation, remyelination in the PNS in adult mice (Weng et al., 2012; Quintes et al., 2016; Wu et al., 2016), the inner nuclear layer cell lineages during retinogenesis in the eye (Menuchin-Lasowski et al. 2016), embryonic and adult hematopoiesis, (Goossens et al., 2011; Li et al., 2016) and maturation of several types of immune cell (Omilusik et al., 2015; van Helden et al., 2015; Scott et al., 2016).    Our team recently documented the Zeb2-positive (Zeb2+) domains in the embryonic forebrain, including in the its ventral part, where it is also present in the LGE (van den Berghe et al., 2013). In addition, Zeb2 is present in the postnatal SVZ (Stappers and co-workers, our own data) as well as in the cells migrating through the RMS and the majority of granule and periglomerular cells in the OB (Nityanandam et al., 2012; Stappers and co-workers, our own data, including as taken up in Beclin et al., 2016). Upstream of Zeb2 the miR-200 cluster appears to control Zeb2 levels in order to prevent premature neural maturation. Inactivation of Zeb2 in the SVZ (data from Stappers et al. in this chapter and from our team in Beclin et al., 2016) lead to a massive increase in calretinin (CR)-positive cells in the SVZ and RMS. These findings suggest a role for Zeb2 in establishment and/or regulation of the postnatal neurogenic niche. Using both loss and gain-of-function approaches, we show that Zeb2 regulates appropriate neuronal cell number output from this niche in early postnatal life in the mouse. Genetic inactivation of Zeb2 specifically in the developing and adult SVZ, respectively, resulted in severely reduced numbers of neuroblasts migrating towards the OB. RNA-seq analysis followed by bio-informatics analysis strongly suggested that cells derived from Zeb2-KO B1 cells display two days after birth a more striatal interneuron identity, possibly due to upregulated expression of Sox6. In line with this, overproduction of vector-encoded Sox6 by electroporation in wild-type SVZ recapitulates the effect of Zeb2 deletion, while re-introduction of full-length, wild-type Zeb2 in the Zeb2-KO SVZ in this experimental set-up partially rescues the observed defects. Taken together, our results reveal a novel and essential role for Zeb2 and downstream Sox6 in OB interneuron generation.  
5.3 Results 
 
5.3.1 Zeb2 is present in the SVZ and OB in mouse embryos and adult mice Zeb2 was detected in the mouse VT at E14.5 (van den Berghe  et al., 2013), including the LGE (Figure 5.1A) where the majority of pre-B1 cells reside (Kriegstein and Alvarez-Buylla, 2009). The clear presence of Zeb2 in one of the major precursor zones of the postnatal SVZ prompted 
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us to document the presence of Zeb2 protein during SVZ establishment and OB development in more detail. Zeb2 persisted in the LGE and developing SVZ during embryogenesis (Figure 5.1A,B) and in the early postnatal and adult SVZ (Figure 5.1C,D). In the latter, it was present in B (GFAP+) and A cells (Dcx+; Figure S5.1F-H) as well as in the cells migrating towards the OB through the RMS (Figure S5.1E; as observed previously, Nityanandam et al., 2012). In the OB, Zeb2 was detected throughout the granule cell (GCL) and periglomerular (PGL) layers of both the developing and adult OB (Figure S5.1A-D,E-F), but not in the mitral and tufted cell layer (MCL, Figure S5.1C).   
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Figure 5.1 (see previous page) Zeb2 inactivation in the SVZ early B cell progenitors (using Gsh2-
Cre) impairs neuroblast migration towards and hence the correct organization of the olfactory 
bulb. 
A-D. Coronal sections through the developing (A-C) and adult (D) brain highlighting the presence of Zeb2 protein in the E14.5 LGE (A) and developing SVZ at different embryonic and early postnatal stages (E18.5 and P5 in panels B and C, respectively) and in the SVZ at adult age (P50 in D, with indicated box enlarged). Scale bar represents 100 µm.  
E-G. Immunohistochemical staining for Cre-activated GFP (brown), showing Cre-targeted cells in coronal sections through the control (E-G) and Zeb2-mutant (E’-G’) OB at different developmental and early postnatal ages. At E16.5, first signs of defects in the mutant OB were observed (E’): targeted cells cluster together more and fail to populate the outer, developing GCL (arrowheads in E panels). Moreover, fewer cells arrive in the developing OB. This phenotype tops at P5 (F panels). Here, targeted cells cluster in 2 ring-like structures in the mutant OB compared to the control OB (arrowheads in F panels). The RMS was almost depleted of targeted cells in the mutant OB compared to the control OB  and the MCL did not mature in a tightly organized 2-3 thick cell layer (red arrowheads in F panels). At P17, the mutant OB (G’) appeared smaller and more rounded compared to the control (G) and the different layers are severely disorganized. Scale bars represent 100 µm.  
H. Quantification of the GFP-Dcx overlap in the mutant and control OB. There was a significant reduction in the percentage of GFP-Dcx overlap in the Gsh2|cKO OB compared to Gsh2|control littermates (85.1±5.5% vs 60.1±5.0%, respectively, p<0.05, n=5). I. Quantification of the Dcx-driven mean fluorescent intensity (MFI) in the mutant and control OB. This MFI was significantly reduced in the Gsh2|cKO OB compared to Gsh2|control littermates (2.4±0.40 vs 3.9±0.44, respectively, p<0.05, n=4).  
Abbreviations used: CC: corpus callosum; CTX: cortex; EPL, external plexiform layer; GCL, granule cell layer; GFP: green fluoresecnet protein; IPL, internal plexiform layer; LGE: lateral ganglionic eminence; LV, lateral ventricle; MCL, mitral cell layer; PGL, periglomerular layer; RMS, rostral migratory stream; SVZ: subventricular zone.  Experiments performed by Stappers, Bresseleers, Francis and Seuntjens.    
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Figure S5.1 Presence and conditional deletion of Zeb2 in the OB and LGE (Gsh2-Cre approach). 
A-D. Coronal section through the OB at developmental stages (A-C) and in adult mice (D) showing the presence of Zeb2 protein in different cell layers of the OB. Scale bar represents 100 µm. E-H. Zeb2 staining is strong in Dcx+ neuroblasts in the adult OB (E), RMS (F) and SVZ (G). Also the GFAP+ B cells residing in the adult SVZ contain Zeb2 (H). Scale bars represent 50µm. I. Schematic overview depicting the Zeb2 presence in the adult SVZ, RMS and OB. Black rectangles indicate the area’s magnified in panels E-H. J-K. Coronal section through the control (J) and mutant (K) forebrain at E14.5 immunostained for Zeb2 and showing efficient removal of Zeb2 in the LGE and part of the MGE. Dotted boxes in J and K represent the magnified area in J’ and K’ respectively. Scale bar represents 100 µm.  Experiments performed by Stappers, Francis and Seuntjens. 
 
 
5.3.2 Inactivation of Zeb2 in the developing and adult SVZ severely disrupts the 
migration of neuroblasts to the OB To assess a possible role for Zeb2 (often still named Sip1 in the nomenclature of previously made mouse lines) in SVZ establishment and adult OB neurogenesis, we used the Gsh2-Cre mouse line to inactivate Zeb2 in the LGE of the VT (Fogarty et al., 2007) and the inducible Glast-CreERT2 mice for inducible removal of Zeb2 from the B cells in the adult SVZ (Mori et al., 2006). Both lines were first crossed with a Cre-sensitive fluorescent reporter mouse line (R26RCAG-
loxPstop-eGFP or RCEfl/fl; Sousa et al., 2009) to trace Cre activity. We refer to Gsh2Cre+;Sip1fl/wt as Gsh2|control mice and to Gsh2Cre+;Sip1fl/ko as Gsh2|cKO mice; a similar convention is used for the 
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Glast-CreERT2 based mice analogous to previous studies (Seuntjens et al., 2009). We confirmed Zeb2 removal specifically from the LGE by E14.5 in Gsh2|cKO mice (Figure S5.1J-K) and from the B cells in the adult SVZ at P50 (see Experimental Procedures; Figure S5.2A) in Glast|cKO mice (Figure S5.2, all panels B-E).    Zeb2 removal from the LGE had a major impact on OB development (Figure 5.1, all panels E-G, E’-G’). The first morphological differences could already be detected at E16.5 when Gsh2|cKO OB interneurons failed to distribute correctly among the different developing GCLs. Instead, they seemed to cluster together in the deep primitive GCLs presumably due to failure in migrating out towards the circumference of the OB (arrowheads in Figure 5.1E,E’). This defect aggravated during OB maturation and at P5 the GCLs seemed depleted of Zeb2 (GFP+) mutant interneurons compared to the GCLs of the control OB.    Less Zeb2-KO interneurons were able to reach the OB as less GFP+ cells were found in the core of the OB, where the RMS arrives (Figure 5.1F,F’). Zeb2-deficient cells cluster in two clearly discernable GFP+, ring-like domains: one was closely associated with or even invading the intermediate plexiform layer (IPL) and MCL, while a second one was found in the deep GCLs surrounding the RMS (arrowheads in Figure 5.1E,E’). At P17, the Gsh2|cKO OB appeared smaller and more rounded compared to control littermates and, while GFP+ cells distributed more amongst the GCLs, the establishment of fully matured layers was impaired (Figure 5.1G,G’). Moreover, the IPL seemed invaded by GFP+ cells, whereas normally only few cell bodies are found here. The mitral cells can still be found, but they failed to form a smooth single-cell layer of robust appearance. Yet they appear to have retained their morphological features (data not shown). Not only the IPL was invaded by GFP+ cells, also the EPL, which is normally devoid of cell bodies, contained more cells compared to control littermates. The glomeruli, where dendrites of mitral and tufted cells connect with olfactory sensory neuron (OSN) axons, appeared to be established normally (Figure 5.1F,F’).    Because the Gsh2|cKO phenotype seemed to maximize at postnatal day (P) 5, we decided to focus further analysis of the Gsh2|cKO SVZ around this time point. To assess the number of neuroblasts that arrived in the Gsh2|cKO OB at P5, we used staining for Dcx, a marker for A cells (neuroblasts). To faithfully quantify the number of Dcx+ cells, we measured the Dcx-driven mean fluorescence intensity (MFI) combined with analyzing the percentage of overlap between Dcx and GFP using the CoLocalizerPro Software (see Experimental Procedures; experiments performed by Stappers). We found a significant decrease in the Dcx-driven MFI in the Gsh2|cKO OB compared to controls (2.4±0.40 vs 3.9±0.44, respectively; Figure 5.1I, p<0.05), indicating that indeed fewer Dcx+ neuroblasts have arrived at P5 in the Gsh2|cKO OB. These results were confirmed by assessing the Dcx+;GFP+ neuroblasts arriving in the mutant OB. We found a 25% decrease in Dcx-GFP overlap in the Gsh2|cKO OB compared to Gsh2|control OBs (85.1±5.5% vs 60.1±5.0%; Figure 5.1H, p<0.01).    A similar phenotype was found when Zeb2 was solely removed from the adult SVZ using the inducible Glast-CreERT2 approach (Figure 5.2). Likewise, we traced the targeted cells by means of GFP-staining. This Cre-mouse line targets besides the SVZ B1 cells also the adult GLAST-
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positive astrocytes in the whole brain parenchyma. Zeb2 inactivation led to an increase in GLAST+ cells. However, this effect was independent of the role of Zeb2 in the SVZ. When focusing on the latter, we found that less neuroblasts arrived in the Glast|cKO OB, as seen from the reduced size of the RMS (dotted line in Figure 5.2A,B and A’,B’). The Dcx-driven MFI in the RMS region was significantly reduced in the Glast|cKO (3.9±0.26 vs 2.4±0.30; Figure 5.2D, p<0.05) as well as the Dcx-GFP overlap compared to controls (63.3±2.6% vs 48.8±2.8%; Figure 5.2C, p<0.05), suggesting that the Dcx+ neuroblaqsts that arrived in the OB had not been targeted by Cre. Thus, also in the adult SVZ, Zeb2 inactivation results in a decline in Dcx+ neuroblasts in the mutant OB, suggesting that Zeb2 is essential for postnatal OB interneuron production and/or migration. 
 
 
 
Figure 5.2 Tamoxifen-controlled Zeb2 deletion in the adult SVZ impairs neuroblast migration.  
A-B. Severe decrease in the numbers of GFP+ cells arriving in the Glast|cKO OB through the RMS (B) compared to the Glast|control (A). White rectangles indicate the area that is magnified in panels A’,B’; black dotted lines in the latter panels outline the RMS. Scale bars represent 100 µm. C. Quantification of GFP-Dcx overlap in the Zeb2-mutant and control OB. In the Glast|cKO OB the overlap was reduced by 20% compared to the Glast|control OB (63.3±2.6% vs 48.8±2.8%, respectively, p<0.05, n=4 for cKO and n=3 for control). D. Quantification of the Dcx-driven MFI. A severe reduction of Dcx-driven MFI in the Glast|cKO OB is seen compared to the Glast|control OB (3.9±0.26 vs 2.4±0.30, respectively, p<0.05, n=4 for cKO and n=3 for control).  Experiments performed by E. Stappers. 
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Figure S5.2 Tamoxifen-controlled deletion of Zeb2 (Glast-CreERT2 approach) in the adult SVZ. 
A. Experimental design for tamoxifen injection to obtain efficient GlastCreERT2-mediated removal of 
Zeb2 in the adult SVZ. B. Immunohistochemical staining for Zeb2 at the level of the SVZ showing fewer Zeb2+ cells in the Tamoxifen-activated Cre Zeb2-mutant (B’) versus control (B). Scale bars represent 100µm. C-E. Staining for Zeb2 and GFP. Almost no Zeb2+;GFP+ cells are found in the mutant OB (C’), RMS (D’) and SVZ (E’) compared to the respective controls (C-E). Scale bars represent 100µm.  Experiments performed by Stappers.  
 
5.3.3 The most prominent cause of defective OB development in Zeb2-KO is a 
proliferation deficit possibly emanating from less efficient activation of quiescent 
B1 cells  Upon Zeb2 removal in the LGE, fewer neuroblasts are found in the mutant OB. As Zeb2 is known to affect migration of cortical interneurons (van den Berghe et al., 2013; see Chapter 6 here), we investigated the intrinsic migration capacity of the neuroblasts. For this, we excised the SVZ of P2 Gsh2|control and Gsh2|cKO mouse brains, fragmented these biopsies and cultured them as explants in matrigel (Figure S5.3). We found a 57% reduction in the average outgrowth out of Gsh2|cKO SVZ explants after 48h in explant culture compared to Gsh2|control SVZ cells (Deryckere and Seuntjens, data not shown). This indicates that Zeb2-depleted neurons migrated less far out of SVZ explants than Gsh2|control neurons. Hence, we conclude firstly that the mutant neurons were still able to migrate, but secondly they seem to migrate slower or less efficiently ex vivo compared to control cells. We cannot tell at this point whether this slower migration may result from the neurogenesis defect, which results in fewer cells available to form a long chains of cells, which is the typical way these cells migrate. To investigate whether Zeb2-depleted neuroblasts are delayed in vivo, we electroporated Cre-TdTomato vectors in the 
Zeb2fl/wt and Zeb2fl/KO SVZ at P2 and let the pups mature into adulthood until 54 dpe (corresponding to P56) (Figure S5.3A-B). Also here, several weeks after Zeb2 removal, significantly less TdTomato+ cells were found in the Zeb2fl/KO compared to the Zeb2fl/wt OB 
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(Figure S5.3, B panels), suggesting that a reduced migration speed alone cannot account for the observed OB interneuron deficits.    
  
Figure S5.3 A reduced migration defect does not account for the OB interneuron defects in Zeb2-
cKO mice. 
A. Experimental design. Cre-TdTomato vectors were electroporated in P2 Zeb2fl/wt and Zeb2fl/KO SVZ and analyzed at P56. B-B’. Representative image of a coronal section through the control (B) and mutant (B’) OB at P56. At 54dpe, still fewer TdTomato+ cells are found in the Zeb2fl/KO OB compared tot the Zeb2fl/WT OB. Scale bar represents 100 µm.  
Abbreviations used: GCL, granule cell layer; IPL, internal plexiform layer.  Experiments performed by Deryckere and Seuntjens.     We next hypothesized that a decrease in neurogenesis could account for a decrease in the number of Gsh2|cKO neuroblasts in the OB. Stappers and co-workers therefore engaged in multiple analyses of cell proliferation in the SVZ and the RMS (Figures 5.4 and S5.4):  
  In the SVZ (staining for Ki67) they found a 28% reduction in Ki67+ cells in the Gsh2|cKO SVZ compared to the Gsh2|control (see Figure 5.4, panel E, with the statistical numbers in the legend). Furthermore, when they solely looked at the targeted cells (i.e. GFP+ cells), they found a 39% reduction in Ki67+;GFP+ cells indicating that Zeb2 deletion indeed influenced cell proliferation (Figure 5.4, panel E and legend). However, when they compared the ratio of Ki67+;GFP+ cells over the total number of Ki67+ cells, they found no significant difference in the fraction of cells that proliferated (Figure 5.4, panel G and legend), suggesting that the proliferation deficit is caused by a general reduction in the numbers of cells that are able to proliferate.  
  To further verify these findings and analyze cell cycle exit in the Gsh2|cKO SVZ, they injected Gsh2|cKO and Gsh2|control pups intraperitoneally with BrdU, 24h prior to dissection (see Experimental Procedures; see also Seuntjens et al., 2009). They again found a significant reduction in both the number of BrdU+ cells and BrdU+;GFP+ cells (Figure 5.4, panel E and legend) in the Gsh2|control versus Gsh2|cKO SVZ. When they analyzed the ratio of BrdU+;GFP+ cells over the total number of BrdU+ cells here, they again did not detect a significant difference (Figure 5.4, panel G). This provides support to the initial interpretation that the proliferation capacity of the (fewer) cells is likely not affected in the Gsh2|cKO SVZ. 
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At the same time, we have to interpret this with caution because we cannot exclude that Zeb2 removal also causes, in a non-cell autonomous fashion, defects on other cells as observed before (Seuntjens et al., 2009). 
  A decrease in the number of proliferating cells might be caused by premature differentiation, which in terms of proliferation might be reflected in an increased number of cells exiting the cell cycle. Stappers and co-workers therefore analyzed cell cycle exit and cell cycle length and calculated the quitting fraction in both the total population of proliferating cells as well as the targeted population, i.e. the GFP+ cells. We however found no significant differences in cell cycle exit (36.2±3.4% vs 30.5±3.6%, p=0.28 and 57.0±3.8% vs 52.3±6.3%, p=0.54, respectively, Figure S5.4A), cell cycle length (27.2±1.8% vs 23.5±3.7%, p=0.40 and 46.4±5.3% vs 51.1±7.5%, p=0.62, respectively, Figure S5.4B) and quitting fraction (63.8±3.4% vs 69.5±3.6%, p=0.28, Figure S5.4C) between the Gsh2|control and Gsh2|cKO SVZ. They also did this for the RMS (Figure S5.4D-F, see also below).    Because OB neurogenesis is not restricted to the SVZ itself (Yuan et al, 2015, Alonso et al, 2008; Gritti et al, 2002), but continues in part while the cells are on their way towards the OB through the RMS, Stappers and co-workers did a similar analysis in the RMS as the one for the SVZ (Figure 5.4). They quantified Ki67+;BrdU+ cells in the RMS at 2 different levels of the OB for each animal. They found similar results as compared to these measured in the SVZ, i.e. a significant decrease in the number of Ki67+ cells (5.1±0.3 vs 2.6±0.1 cells/mm2, p<0.005), BrdU+ cells (3.8±0.3 vs 2.2±0.1 cells/mm2, p<0.05), Ki67+;GFP+ cells (3.9±0.3 vs 1.7±0.1cells/mm2, p<0.01) and BrdU+;GFP+ cells (2.7±0.3 vs 1.2±0,1 cells/mm2, p<0.005) (all in Figure 5.4, panels F and H) in the Gsh2|cKO compared to the Gsh2|control RMS. Unlike in the SVZ, they however found a reduction in the fraction of Ki67+;GFP+ cells over the total number of Ki67+ cells (77.5±4.7% vs 65.4±3.12%, p=0.05) and a significant decrease in the fraction of BrdU+;GFP+ cells over the total number of BrdU+ cells in the RMS (71.4±2.8% vs 57.3±2.2%, p<0.01), which is not surprising knowing that besides moderate impact on non-targeted cell populations in this RMS, which may be less subject to growth factor control, less cells migrate towards the Gsh2|cKO OB. When we analyzed cell cycle exit and cell cycle length, we again found no significant differences (Figure S5.4).   
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Figure 5.4  (previous page) Cell proliferation is affected in the Zeb2-mutant (Gsh2-Cre) SVZ and 
RMS.  
A. Schematic overview of a coronal section through the P5 mouse brain depicting the SVZ (left panel) and the RMS (middle and right panels). The boxed areas indicate the regions that are shown in panels B-D and B’-D’. Scale bars represent 100µm. ‘ 
B-D and B’-D’. Immunofluorescent staining for GFP (green), BrdU (red) and Ki67 (blue) at P5 in the SVZ reveals a strong decrease of absolute numbers per indicated surface area of BrdU+ and Ki67+ cells in the Gsh2|cKO SVZ (B’) compared to control (B) littermates. The same is true for the Gsh2|cKO RMS (C-C’ and D-D’).  
E-K. Quantification of the results, documenting Ki67+, BrdU+, GFP+;Ki67+ and GFP+;BrdU+ cells in the SVZ (in E) and RMS (in F). In the SVZ, we found a 28% reduction in Ki67+ cells in the Gsh2|cKO SVZ compared to the Gsh2|control (6.1±0.3 vs 3.9±0.3 cells/mm2, p<0.001, n=5). Furthermore, when solely looking at the targeted (GFP+) cells, we found a 39% reduction in Ki67+;GFP+ cells (2.5±0.3 vs 1.4±0.2 cells/mm2, p<0.001, n=5), indicating that Zeb2 inactivation indeed influenced proliferation. To further verify these findings, we also injected Gsh2|cKO and Gsh2|control pups intraperitoneally with BrdU, 24h prior dissection and found a significant reduction in the number of BrdU+ cells (4.6±0.2 vs 2.5±0.6 cells/mm2, p<0.001) and BrdU+;GFP+ cells (2.0±0.1 vs 1.3±0.1 cells/mm2, p<0.005). However, when calculating for the SVZ (see panel G) the ratio of Ki67+;GFP+ over the total amount of Ki67+ cells, and the ratio of BrdU+;GFP+ over the total amount of BrdU+ cells, we found no significant difference in the fraction 
of cells that proliferated (40.2±2.8% vs 33.9±3.0%, p=0.16 and 42.40±2.8% vs 42.35±2.2%, p=0.99, respectively for these stainings), suggesting that the proliferation deficit is caused not by an affected 
proliferation capacity of individual mutant cells, but by a global reduction of the numbers of cells able to 
proliferate. Similar conclusions follow from the analysis at the RMS level (panels F and H; numbers not given 
here). 
I. Quantification of the percentage overlap between GFAP, Nestin and EGFR, respectively, with GFP. The percentage overlap between cells was significantly increased for GFAP (33.3±5.9% vs 57.9±7.1%, p<0.05, n=5 for cKO and n=4 for control), whereas the overlap between Nestin and EGFR, respectively, with GFP was severly reduced (87.5±2.7% vs 71.0±2.9%, p<0.005, n=5 and 65.9±4.4% vs 50.7±2.1%, p<0.05, n=5, respectively).  
J. Quantification of the number of Olig2+ and GFP+;Olig2+ cells in the control and mutant SVZ. There was a significant reduction in the number of Olig2+ cells in the complete as well as targeted (GFP+) population (numbers not given here).  
K. Quantification of GFP-Dcx overlap in the mutant and control SVZ. A slight increase was found when comparing the mutant and control SVZ (33.2±7.8 vs 47.6±7.8, p=0.1, n=5).  Experiments performed by Stappers.                     
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 SVZ B1 cells originate from embryonic pre B1 cells (Merkle et al., 2007). These pre-B1 cells are embryonic radial glial (RG) cells that become quiescent, but can be activated during postnatal life (Fuentealba et al., 2015). B1 cells are GFAP+ and become Nestin+ upon activation. Stappers and co-workers therefore analyzed the co-localization of targeted cells, i.e. GFP+ cells, with GFAP and Nestin in the Gsh2|control and Gsh2|cKO SVZ. Interestingly, they found a 41% increase in GFAP-GFP co-localization (33.3±5,9% vs 57.9±7,1%, p<0.05, Figure 5.4, panel I) and a concomitant 17% decrease in Nestin-GFP overlap (87.5±2.7% vs 71.0±2.9%, p<0.005). These results suggest that in the Gsh2|cKO SVZ fewer B1 cells are activated. Moreover, as Nestin is maintained in a fraction of C cells, the immediate progeny of activated B cells, a decrease in Nestin-GFP co-localization might also reflect a reduction in C cell numbers. Therefore, the the presence of epidermal growth factor receptor (EGFR) was documented. Its levels are high in proliferating C cells (Kim  et al., 2009, Mamber  et al., 2013). A significant decrease in EGFR-GFP co-localization was found (65.9±4.4% vs 50.7±2.1%, p<0.05). Based on these findings, indeed the decrease in proliferation in the Gsh2|cKO SVZ might be caused by a decrease in the number of dividing B1 and C cells. Next, we wondered whether these findings would also reflect in the number of oligodendrocytes produced in the Gsh2|cKO SVZ and the number of Dcx+ neuroblasts still present in the Zeb2-depleted SVZ. For this, Stappers and co-workers quantified the Dcx-GFP co-localization and the numbers of Olig2+ and Olig2+;GFP+ cells in the Gsh2|cKO and Gsh2|control SVZ. They found a slight increase in Dcx-GFP co-localization (33.2±5.9% vs 47.6±5.1%, p=0.1, Figure 5.4, panel K) and decreased numbers of Olig2+ cells (487.0±40.7 vs 338.0±26.1, p<0.05) and Olig2+;GFP+ cells (184.6±20.8 vs 111.2±8.7, p<0.05, Figure 5.4, panel J).    In addition, to be sure that there was no massive cell death ongoing in the Gsh2|cKO SVZ, they stained for cleaved-caspase 3 (CC3), but found no significant differences between the Gsh2|cKO and Gsh2|control SVZ, neither for the total number of CC3+ cells nor the CC3+;GFP+ cells (57.4±3.0 vs 61.4±4.0, p=0.45 and 38.4±3.4 vs 39.2±2.5, p=0.85, respectively, Figure S5.4, panel G).                   
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Figure S5.4 Proliferation is reduced in the Zeb2-depleted SVZ and RMS.  
A,D. Cell cycle exit analysis in the Gsh2|control and Gsh2|cKO SVZ (A) and RMS (D). The ratio of Ki67+;Brdu+ cells over the total amount of BrdU+ cells was quantified in both the targeted (GFP+) as well as complete population. We found for the SVZ no significant changes in cell cycle exit between the Gsh2|control and Gsh2|cKO RMS (49.8±4.3% vs 46.6±3.7%, p=0.58 and 58.7±7.3% vs 44.7±2.3%, p=0.11, respectively). B,E. Cell cycle length analysis in the Gsh2|control and Gsh2|cKO SVZ (B) and RMS (E). The ratio of Ki67+;BrdU+ cells over the total amount of Ki67+ cells was quantified in both the targeted (GFP+) as well as complete population, but no significant differences were found (34.0±1.5% vs 32.9±2.2% p=0.70 and 43.3±4.5% vs 36.2±1.9%, p=0.18, respectively). C,F: calculations of the quit fraction for SVZ (C) and RMS (F), respectively. G. Quantification results for the cell death marker CC3 in the control and mutant SVZ. There was no significant difference found in the absolute number of CC3+ and  GFP+;CC3+ cells between the mutant and control SVZ (57.4±3.0 vs 61.4±4.0, p>0.05, n=5 and 38.4±3.4 vs 39.2±2.5, p>0.05, n=5, respectively).  Experiments performed by Stappers.        
 Chapter 5  164
 Our team then performed a similar analysis with Glast|control and Glast|cKO mice (Figure S5.5A-G) and found comparable results, i.e. a reduction in proliferation in the Glast|cKO SVZ (274.0±24.1 vs 139.7±13.9 Ki67+ cells and 48.7±3.8 vs 23.7±4.1 Ki67+;GFP+ cells, Figure S5.5A-C), an increase in GFAP-GFP overlap (56.2±5.2% vs 96.7±2.7%, Figure S5.5D) and a reduction in Nestin-GFP and EGRF-GFP overlap (69.6±3.1 vs 52.1±2.6% and 85.1±5.2% vs 62.8±4.3% respectively, Figure S5.5D). They also found severe reductions of numbers of Olig2+ (47.5±7.68 vs 18.0±2.08; Figure S5.5E, p<0.05) and Olig2+;GFP+ cells (19.3±2.87 vs 10.7±1.86; Figure S5.5E, p=0.069) in the Glast|cKO SVZ. There were neither significant differences in Dcx-GFP overlap (28.4±5.4% vs 15.4±2.3%, Figure S5.5F) nor in the number of CC3+ and CC3;GFP+ cells in the Glast|cKO compared to the Glast|control SVZ (10.0±2.08 vs 9.0±2.0 and 5.33±0.67 vs 5.33±0.88, respectively; Figure S5.5G, p>0.05).   
 
Figure S5.5 Proliferation is also severely affected in the Glast|cKO SVZ. 
A. Schematic overview of a coronal section through the adult mouse brain, indicating with a boxed area the region that is magnified in the B panels. B. Cell proliferation was assessed by staining for Ki67. Representative immunofluorescent images for GFP and Ki67 are shown for the Glast|control and Glast|mutant SVZ. White rectangles indicate the region that is magnified and white dotted lines indicate the walls of the LV. Scale bars represent 100µm. C. Quantification results for Ki67+ and GFP+;Ki67+ cells in the mutant and control SVZ. We found a 49% reduction in the absolute number of Ki67+ cells (139.6±27.9 vs 274.0±27.9, p<0;001, n=3) and a 71% reduction of GFP+;Ki67+ cells (23.6±5.55 vs 84.6±5.55, p<0.01, n=3) in the Glast|cKO SVZ compared to the Glast|control.  Experiments performed by Stappers. 
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 Taken together, this extensive phenotypic analysis suggests that the significant decrease of neuroblasts arriving in the Gsh2|cKO OB results from both an altered cell migration as well as proliferation, with the latter possibly being caused by a decreased activation of quiescent B1 cells, which is also reflected in the production of Olig2+ cells. Nevertheless, slightly increased numbers of Dcx+ neuroblasts were found in the Gsh2|cKO SVZ compared to controls, indicating that these neuroblasts might be ‘stuck’ or perhaps are misspecified. 
 
5.3.4 RNA-seq followed by bio-informatic analysis indicates misspecification of 
Zeb2-depleted cells which may be triggered by Sox6 upregulation Previous transcriptome studies on Zeb2-depleted VT indicated that cortical interneurons trans-fate to a striatal signature in the mutants and also are misguided via misregulation of the guidance cue receptor Unc5b (van den Berghe et al., 2013), showing the power of transcriptomic analysis in phenotyping. Zeb2 deletion, both in the LGE and the adult SVZ induced a cell proliferation deficit. It is however not clear whether the reduction in proliferation can completely account for the reduced numbers of neuroblasts in the mutant OB. Moreover, the results also suggested an accumulation of Dcx+ cells in the mutant SVZ, indicating that these cells might be misspecified. To gain more insight in the molecular mechanism underlying the several defective processes after Zeb2 deletion in the LGE, Therefore, Gsh2|control and Gsh2|cKO transcriptomes were compared after RNA-seq of fluorescence-activated cell sorted (FACS) SVZ-derived cells (see Experimental Procedures). Cells were isolated from the respective SVZ tissues at P2 and RNA-seq was performed on 5 and 6 biological repeats for cKO and control, respectively. Correlation analysis confirmed that the respective samples cluster in two highly different groups (Figure S5.6A), premising Zeb2-deletion as the major cause of the differences in gene expression found between these samples. The control and cKO samples grouped together according to the first principal component (PC1) in a principal component analysis (PCA, Figure S5.6B) and the decrease of mapped reads found on the floxed exon7 confirmed the efficiency of Zeb2 exon7 removal (Higashi  et al., 2002; Figure S5.6C).    Differential expression analysis using DE-Seq identified 661 significantly upregulated and 536 such downregulated genes in Gsh2|cKO compared to Gsh2|control cells (Table S1). Genes related to cell cycle regulation (Ccnb1, Ccnd1, Cdk1, Myc, Hmgb2,…) and proliferation (such as 
Wnt5a) were significantly down regulated in the Gsh2|cKO SVZ, supporting our findings of a decrease in proliferation in the Zeb2-mutant SVZ. Moreover, the results suggested that cells born in the mutant SVZ were misspecified. We found no less than 6 genes related to striatal interneuron identity to be in the top-20 of most significant differentially expressed genes (Figure 5A, genes indicated by pink rhombus). These genes included Calretinin (CR), Somatostatin (Sst), Neuropeptide Y (NPY) and Nitric oxide synthase 1 (Nos1), all acknowledged markers for GABAergic striatal interneurons (Marin et al., 2000; Xu et al., 2008) and the LIM homeobox protein 6 (Lhx6) gene, encoding a transcription factor essential for, amongst others, the regulation of striatal interneuron generation (Marin et al., 2000; Zhou et al., 2015). Strikingly, each of these factors was significantly upregulated in the absence of Zeb2, while in normal conditions the majority of striatal interneurons originate in the MGE and not the LGE (Marin et al. 2000; Xu et al., 2008). This independently supports our assumptions of a possible misspecification of cells born in the Zeb2-mutant SVZ.  
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Figure S5.6 Transcriptomic changes associated with loss of Zeb2 critical exon 7 in cKOs. 
A-B. Clustering (A) and PCA analysis (B) indicate that Gsh2|control and Gsh2|cKO samples are clearly distinguishable. C. IGV views of the Sip1 locus showing absence of reads on the deleted exon7 in the cKO samples.    The upregulation of CR and Sst was confirmed through qPCR (14.6 and 10.7-fold up respectively, Figure 5.5L). Immunohistochemicals taining for CR (Figure 5.5B,C), NPY (panels D,E) and Sst (panels F,G) also revealed a strong increase of stained cells for all three striatal interneuron markers in the Gsh2|cKO SVZ. Furthermore, we found a significant downregulation of medium spiny neuron (MSN) marker genes (FoxP1, Adora2a and Pp1r1b) in the Zeb2-mutant SVZ as well as a significant downregulation of several transcription factor encoding genes 
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known to be essential for the generation and differentiation of these MSNs (Ctip2, Sp9, Ebf1, 
Isl1) (Lobo et al.. 2006, 2008; Arlotta et al., 2008; Ehrman et al., 2013; Lu et al., 2014; Precious et al., 2016; Zhang et al., 2016). Hence, It seems that striatal aspiny neuron production is upregulated in the Gsh2|cKO SVZ at the expense of MSNs.     To find possible Zeb2-dependent genes in this process, we focused our further analysis on transcription factors that are possibly implicated in striatal interneuron production/ specification. Sox6, typically present in MGE-derived (i.e. cortical and striatal) interneurons, but not in LGE-derived OB interneurons (Azim et al., 2009; Batista-Brito et al. 2009), was the most significantly upregulated (4.6-fold) transcription factor in the Gsh2|cKO SVZ. Since previous studies showed that Sox6 is essential for cortical interneuron generation and diversity (Azim et al., 2009; Batista-Brito et al. 2009), it could also be involved in the misregulation of the Zeb2-mutant cells in the Gsh2|cKO SVZ. RT-qPCR confirmed the upregulation of Sox6 mRNA in the Gsh2|cKO SVZ cells (3-fold up, Figure 5.5L) and also staining revealed a significant increase in Sox6+ and Sox6+;GFP+ cells in the Gsh2|cKO SVZ (167.3±2.9 vs 801.7±123.3 and 101.0±1.5 vs 543.0±31.6 resp., Figure 5.5, H panels, quantification in J). Furthermore, also in the Gsh2|cKO striatum Sox6+ and Sox6+;GFP+ cells were significantly increased (613.0±128.7 vs 1517.7±86.0 and 345.3±59.6 vs 1000.0±59.7 respectively, Figure 5.5H-I,K). Moreover, we also found a strong increase in the number of Sox6+ and GFP+;Sox6+ cells in the Glast|cKO SVZ compared to control littermates (81.0±9.5 vs 42.3±6.5; p<0.05 and 69.3±14.1 vs 33.3±7.2;p=0.08, respectively, Figure 5.5M.                        
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Figure 5.5 (next page) Transcriptome analysis of Gsh2|cKO SVZ derived cells reveals an 
upregulation of genes related to striatal interneuron identity. 
A. Volcano plot representing the differentially expressed genes in the Gsh2|cKO SVZ. Several genes (indicated by pink and red rhombuses) related to striatal interneuron identity were significantly upregulated. B-G. The expression of CR (B-C), SST (D-E) and NPY (F-G), all three markers of striatal interneurons, is increased in the Gsh2|cKO SVZ compared to the Gsh2|control SVZ, confirming their upregulation found through the RNA-seq analysis. Dotted rectangles represent the magnified area’s in B’-G’ respectively. Scale bars represent 100µm. H-I. Immunofluorescent staining for Sox6 at P5 in the control (H) and mutant (I) SVZ. Black dotted rectangles in H and I indicate the regions that are magnified in H’-H” and I’-I” respectively, representing a region from both the mutant and control SVZ (H’-I’) as well as from the mutant and control striatum (H”-I”). Here a representative immunofluorescent image for GFP and Sox6 is shown in which the increase in GFP+;Sox6+ cells in both regions is visualized. Scale bars represent 100µm. J. Quantification of the number of Sox6+ and GFP+;Sox6+ cells in the Gsh2|cKO and Gsh2|control SVZ (167.3±2.9 vs 801.7±123.3, p<0.01, n=3 and 101.0±1.5 vs 543.0±31.6, p<0.001, n=3, respectively). K. Quantification of the number of Sox6+ and GFP+;Sox6+ cells in the Gsh2|cKO and Gsh2|control striatum (613.0±128.7 vs 1517.7±86.0, p<0.005, n=3 and 345.3±59.6 vs 1000.0±59.7, p<0.005, n=3, respectively). 
L. qRT-PCR results confirming the upregulation of Sox6, CR and Sst mRNA in the Gsh2|cKO SVZ. M. Quantification of the number of Sox6+ and GFP+;Sox6+ cells in the Glast|cKO and Glast|control SVZ (81.0±9.5 vs 42.3±6.5, p<0.05, n=3 and 69.3±14.1 vs 33.3±7.2, p=0.08, n=3, respectively).  Experiments performed by Stappers and Dries.                              
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      These results thus imply that Sox6 expression is dependent on intact Zeb2 and might act downstream of Zeb2 in regulating the specification of newborn cells in the postnatal SVZ. We next wanted to verify whether overproduction of Sox6 in the wild-type postnatal SVZ could also induce a decrease in OB interneuron migration and thus recapitulate this Zeb2-KO phenotype. We electroporated vectors encoding TdTomato and Sox6 in the SVZ of CD1 mice at P3. Brains were collected 7 dpe and TdTomato+ cells were counted in the OBs. Upon Sox6 overproduction in WT P3 postnatal SVZ a strong reduction in TdTomato+ cells was found in the OB compared to controls (88.95±9.7 vs 242.7±21.2; Figure 5.6, B panels, quantification in C), supporting our hypothesis that Sox6 acts downstream of Zeb2, but depends on intact Zeb2.  
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Figure 5.6 Overexpression of Sox6 in the Zeb2WT SVZ results in a reduced number of neuroblasts 
in the mutant OB. A. Experimental design. Sox6-TdTomato vectors were electroporated in the P2 CD1 (Zeb2/WT) SVZ. As control, TdTomato vectors were electroporated in the P2 CD1 SVZ. B. Schematic overview of a coronal section through the mouse brain depicting the SVZ. Boxed area indicates the region that is shown in C. C. Sox6 expression is found in electroporated cells (arrowheads). Boxed area indicates the region that is magnified, showing single staining for myc-tagged Sox6 (in green) and TdTomatp (in red). Scale bar represents 100 µm. D-D’. Representative image of a coronal section through the control (B) and mutant OB (B’) at P10 showing an immunofluorescent staining for TdTomato. Scale bar represents 100 µm. E. Quantification of the number of TdTomato+ cells/mm2 in the OB 7 days after electroporation. We found a significant reduction in the number of TdTomato+ cells in the mutant compared to control OB (88.95±9.7 vs 242.7±21.2, p<0.05, n=3).  
Abbreviations used: GCL, granule cell layer; IPL, internal plexiform layer.  Experiments performed by Stappers, Deryckere and Seuntjens. 
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5.4 Discussion 
 The SVZ that lines the lateral ventricles in the rodent brain is the most prominent region of adult neurogenesis and therefore one of the most studied neurogenic niches (Brus et al., 2013; Braun and Jessberger, 2014; Bond et al., 2015; Alunni and Bally-Cuif, 2016; for a review, see Lim and Alvarez-Buylla, 2016). Key questions are whether the cellular output of the niche is hardwired or plastic and what factors regulate the output of the niche and determine the fate of the newly formed neurons. In addition, understanding the cellular and molecular mechanisms that continuously regulate the generation of new neurons in normal and injured brain can provide key insights into postnatal neurogenesis not only for the rodent brain, but also for human brain and can also explain several neurodevelopmental disorders. We unmask Zeb2 as a novel essential transcription factor for the generation of OB interneurons and proper functionality of the young and adult postnatal niche. Tweaking the levels of Zeb2 using an acute electroporation model also gives a unique insight into the plasticity of the postnatal niche and the potential to quickly adapt to environmental changes.    Zeb2 is a multi-faceted factor that operates in more than one biological system (tissue or organ) and is crucial in numerous cellular processes include proliferation, migration, (de)adhesion, specification and differentiation, many of which are recapitulated during embryonic and postnatal neurogenesis (for a review on Zeb2, with focus on its functions in the nervous systems, see Hegarty et al., 2015). It exerts its functions both through acting cell autonomously but also non-autonomously and can do this by regulating transcription via various interacting co-factors downstream of growth factor actions, including BMP signaling. Consequently and not surpsingly Zeb2 removal from the LGE as early as E11.5 results in a very complex phenotype wherein each of these processes seem affected, here in neurogenesis and neuronal migration. The Gsh2-Cre approach used here to inactivate Zeb2 results in targeting a large proportion of the SVZ niche, but not all cells. However, it also affects the proliferation capacity of the non-targeted cells, suggesting that Zeb2 may restrict the release of factors that affect proliferation or potentially drive cells into a quiescent state.    Here, different scenarios can be envisaged. In a first one, Zeb2 inactivation would induce premature cell cycle exit or differentiation, as suggested recently by Beclin et al. (2016). The miR-200 cluster affects postnatal neuronal output in the SVZ by downregulating Zeb2, an acknowledged target of these miRs (Hill et al., 2013). Indeed, we showed that Zeb2 inactivation massively increased the number of CR+ neurons in the niche, suggesting it would be depleted of B1 cells because of premature neurogenesis. Left with a limited number of NSCs however, it becomes difficult to explain that re-introduction of wild-type Zeb2 by electroporation in a Zeb2-KO SVZ can result in an approximately 300% increase (Deryckere and Seuntjens, unpublished results) in the output of the niche in terms of number of cells. Hence we believe this scenario to be less likely. In a second scenario, Zeb2 would be necessary for the generation and differentiation of OB interneurons through activation of the quiescent stem cell pool. Our current data partly support this scenario. First, although Zeb2 is present in all cell states, its levels keep increasing from B1 over C to A cells. Zeb2 levels tend to increase upon progression 
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of cell state in cell commitment, differentiation and maturation in tissues, such as the hematopoietic, immune and central nervous system. Second, careful histochemical analysis showed that markers of C cells and activated B cells are reduced, while markers of quiescent NSCs increased. Whether Zeb2 inactivation catalyzes the transition to a quiescent state or whether it might block exit from the quiescent state is at this point unclear. Recently, in another context, Zeb2 was identified as crucial for exit from the epiblast state in cultured mouse ESCs (Stryjewska et al., 2016). Single-cell RNA-seq studies start to map the transcriptome of the different stem cell states in the SVZ (C. Mayer and G. Fishell, pers. comm.) and will co-enable workers in the field to test several concepts, including whether e.g. lineage is a poor predictor on interneuron positioning in the forebrain (Mayer et al., 2016; also applicable to interneuron studies reported in chapter 6). Upon comparison of such data set (from C. Mayer, see above) with ours we could confirm some features of quiescent stem cells such as increase of Id2 expression, and we found markers of C cells significantly decreased. However, not all features of claimed quiescent NSC were fully recapitulated, which could be due to the fact that our study was a bulk analysis of all targeted cells together, which can mask subtle differences of gene expression in different cell types. Alternatively, and hence representing a third scenario, B1 cells chose an alternative path of differentiation that does not include the transition through an actively dividing C-type of cell. Indeed, our RNA-seq analysis clearly showed upregulation of striatal interneuron markers at the expense of medium spiny neurons markers. Previous findings showed that by repressing Nkx2-1, Zeb2 potentially controls a fate decision in the MGE during brain development, and loss of Zeb2 drives cells into a striatal interneuron fate at the expense of cortical interneurons (McKinsey et al., 2013). In the current Gsh2-Cre model, Zeb2 inactivation might affect a similar pathway, resulting in an increased MGE territory, concomitant reduced LGE area and loss of medium spiny neurons. We therefore needed to include a model that bypassed the embryonic effects of Zeb2 deletion.   By introducing Cre in only a few cells in the early postnatal niche of Cre-negative control mice, we could study whether individual Zeb2-KO B1 cells were capable of generating OB interneurons without the confounding effects caused by its embryonic deletion. Cre activity in the P3 Zeb2fl/wt SVZ recapitulates the in vivo OB phenotype (Deryckere and Seuntjens, data not shown) and acute deletion of Zeb2 in a small cohort of cells in the normally developed postnatal SVZ still severely affects OB interneuron output. Moreover, cells not affected by such electroporation are not able to compensate for the (partial) loss of Zeb2, indicating that Zeb2 is necessary for SVZ output on a cell-autonomous level. Furthermore, re-introducing full-length, wild-type Zeb2 in the Gsh2|cKO SVZ can (partially) restore SVZ OB interneuron output, highlighting the strong plasticity of the young postnatal niche and an essential role for Zeb2 in regulating its functionality. While a number of transcription factors have already been reported to influence SVZ neurogenesis at different levels (e.g. including self-renewal, neuronal versus glial lineage commitment , OB interneuron diversity and possibly generation of the different OB interneuron types, none have been identified – a ssuggested by the RNA-seq analysis here – as candidate regulators of fate determination between OB interneuron and striatal interneuron.     The RNA-seq studies also support the indicated proliferation defect in the Zeb2-mutant SVZ. Several genes associated with cell cycle regulation (Ccnb1, Ccnd1, Cdk1, Myc, Hmgb2) are downregulated. However, the fraction of targeted cells positive for Ki67, for BrdU or for both in 
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the total number of dividing cells does not differ between the controls and cKOs. It therefore seems that not the proliferation capacity per se is affected, but rather the number of cells that are able to proliferate.  This can be caused by either an increase in the number of quiescent B1 cells (or a disturbed activation of the latter; Fuentealba et al., 2015) or by premature activation of quiescent B1 cells, leading to a progressive exhaustion of activated B1 cells. B1 cells, both quiescent as well as actively dividing, are GFAP+ (Kamphuis et al., 2012; Mamber et al., 2012; Doetsch et al., 1997). It is hypothesized that activated B1 cells co-express Nestin and subsequently loose GFAP as they further develop into actively proliferating C cells (Imura et al., 2006). C cells on the other hand are often positive for both EGFR and Nestin (Walker et al., 2010; Mamber et al., 2012). In the Zeb2-mutant SVZ, we seem to count more GFAP+ cells and less Nestin+ and/or EGFR+ cells, suggesting that more B1 cells retain their quiescent state (and thus remain GFAP+) at the expense of C cells (reflected in reduced Nestin and EGFR). However, our transcriptome analysis of Gsh2|cKO and control SVZ tissue shows that genes associated with Hedgehog signaling (i.e. Shh itself, Smo, Megalin, Ptc) are significantly downregulated in the 
Zeb2-mutant cells at P2. A recent study showed that specific removal of Patched in NSCs during adulthood upregulates Hh signaling in quiescent NSCs, leading to a large accumulation of these cells in the SVZ and a progressive exhaustion of the activated NSC pool (Daynac et al., 2016). A downregulation of Shh signaling in the Zeb2-mutant cells can therefore possibly result in premature activation of quiescent B1 cells, shortly upregulating proliferation followed by a rapid reduction in the number of cells able to proliferate, which remains to be tested in additional experiments, for following our RNA-seq analysis we decided to focus on misspecification.    
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5.5 Experimental Procedures 
Animals  Mice were maintained in a CD1/Swiss background and were kept at KU Leuven in accordance to Belgian and EU regulations. Mice carrying a floxed (exon 7) Sip1 allele (Sip1fl/fl) (Higashi et al., 2002) were crossed with the Gsh2-Cre (Fogarty et al., 2007) and Glast-CreERT2 (Mori et al., 2006) mouse lines and with 
RCEfl/fl reporter mice (Sousa et al., 2009).  
Tamoxifen administration Induction of Cre expression in GlastCreERT mice was obtained by injecting 1mg tamoxifen (Sigma) per mouse, 2 times per day (preferably 1 in the morning and 1 in the evening) and this for 5 consectutive days. The induction protocol was initiated at P35 and mice were sacrificed 10 days after the last injection (P50) after which brain tissue was collected and processed for further analysis (Figure S5.2A).  
BrdU injections For proliferation and cell cycle exit analysis, BrdU (Millipore, 20mg/kg body weight) was injected intraperitoneally at P4. Brains were collected 24hrs after BrdU injections.  
Tissue processing Brains were analysed at embryonic, early postnatal and adult stages. Coronal sections from embryonic brains were prepared as described (Seuntjens et al., 2009). For all postnatal ages, mice were deeply anesthetized with an intraperitoneal injection of pentobarbital before intracardiac perfusion with PFA fixative, whereafter the brains were removed and fixed overnight. For general marker analysis, overnight fixation was followed by progressive dehydration and paraffin embedding after which 6-µm thick coronal sections were made. After focal electroporation, brains were maintained in PBS at 4°C after which 100µm thick vibratome sections were made.   
Immunohistochemistry Paraffin brain sections were processed for immunohistochemistry using an automated platform (Ventana Discovery, Roche). Primary antibodies used: rabbit anti-Sip1 (custom made, 1:100), chicken anti-GFP (Abcam, 1:100), guinea pig anti-Dcx (Millipore, 1:100), rat anti-Ki67 (Abcam, 1:100), mouse Anti-BrdU (Millipore, 1:50), mouse anti-GFAP (Cy3-labeled, 1:100), mouse anti-Nestin (Millipore, 1:50), rabbit anti-Olig2 (ProTech, 1:100), rabbit anti-Pax6 (1:100), anti-CC3 (Cell Signaling, 1:50), goat anti-CR (Millipore, 1:200), rat anti-Sst (Abcam, 1:50), anti-NPY (Abcam,1:50) and rabbit anti-Sox6 (1:100). Secundary antibodies used (all from Jackson ImmunoResearch): donkey anti-chicken Alexa 488, donkey anti-mouse Cy3, donkey anti-goat Cy3, donkey anti-rat Cy3, donkey anti rabbit Cy3 and donkey anti-guinea pig Cy3. Sections were photographed using a Leica DMR microscope connected to a Spot camera (Visitron Systems). The number of marker+, GFP+, and GFP+;marker+ cells was quantified using imageJ or the marker-driven MFI and marker/GFP overlap was measured using ImageJ or the ColocalizerPro software respectively. At least three animals were used for each genotype. Results are represented as mean ± SD. Statistical significance was determined using the Student’s t test.  Vibratome brain slices were preincubated for 1 hr with PBS containing 0.3% triton (PBST) and 10% normal donkey serum. Primary antibodies (rabbit anti-rfp; chicken anti-GFP, Abcam) were added overnight at 4°C. After washes in PBST, secondary antibodies (donkey anti-rabbit CY3 and donkey anti-chicken Dylight 488, both at 1:500, Jackson ImmunoResearch) were applied overnight at 4°C. Slices were washed in PBST and mounted in Mowiol. For each condition, we quantified (via ImageJ software) the total amount of RFP+ cells. Pictures were taken with a Leica confocal microscope and at least three animals were used for each genotype. Results are represented as mean ± SD. Statistical significance was determined using the students t-test.   
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Focal electroporation  Pups (at P2) were anesthetized by hypothermia and placed under a cold light to facilitate visualization of the lateral ventricles by transillumination. Up to 1.5µl of plasmid mixture (6µg/µl plasmid DNA, 3% Fast Green) was injected into the left ventricular cavity through a very thin, manually pulled glass capillary. Electroconductive gel (Signagel®, Parker Laboratories) was placed on both electrode paddles to avoid damaging the pups and to achieve successful current flow. Five 100V electric pulses were applied (50ms duration, 950ms intervals), with the positive electrode positioned in the dorso-lateral region to direct the negatively charged DNA to the subventricular zone. After the pulses, the pups were placed on a thermal plate to recover, after which they were returned to their mother.   
FACS of SVZ-derived cells  P2 SVZ tissue lining the lateral wall of the ventricles of Gsh2|cKO and Gsh2|control brains was isolated in ice-cold HEPES-buffered Leibovitz’s L15 medium (Invitrogen) and cut in small pieces. Cells were dissociated by incubation in Papain solution (150 ml per brain of 12 U/ml) (Sigma) supplemented with DNaseI (30 U/ml) (Roche) for 30 min at 37°C followed by mechanical dispersion, washed with Dulbecco’s PBS (Lonza) and passed over a 70 mm cell strainer (BD Falcon). Highly fluorescent cells were sorted using an AriaI (BD Biosciences). Sorted cells were immediately lysed in TRIzol LS (Invitrogen) and RNA was extracted using the RNeasy Micro kit (QIAGEN).   
RNA-Seq and data analysis RNA-seq library was prepared for analysis according to the Illumina TruSeq protocol (http://www.illumina.com). Briefly, poly(A)-tailed mRNA was copied into cDNA fragments, end repaired, (A)-tailed, ligated with adaptors, and en- riched by PCR. RNA-seq library stocks were pooled and sequenced for 36 bp using the HiSeq 2000. Low quality single-end reads were first removed using 
fastq_quality_filter (FASTX-Toolkit) and high standard quality of all data was confirmed with FastQC. Reads were then mapped to the mouse genome GRCm38 using Tophat2 (v2.0.13). A count table for Ensembl annotated genes was generated with featureCounts (v1.4.6). Samples were clustered based on correlation distances and average linkage and principal component analysis was applied to reduce dimensionality and visualize the samples in a two dimensional space. To assess differentially expressed genes DESeq2 was used using a pairwise contrast matrix (Ctrl vs KO). Read coverage is visualized with the IGV browser (Broad Institute).  
qPCR  RNA was obtained from FACS-sorted P2 Gsh2|cKO and Gsh2|control SVZ cells and cDNA was made via the SuperScript III First-Strand Synthesis System (Invitrogen). qPCR was carried out in duplicate on a LightCycler 480 Instrument (Roche) using SYBR Green PCR Master Mix (Roche). 
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Chapter 6 or Molecular phenotyping of Zeb2-deficient 
GABAergic interneurons of embryonic mouse ventral 
forebrain 
6.1 Preface 
 Part of the challenge in studies involving cell-type specific genetic inactivation of a gene, here 
Zeb2, in the mouse embryo or the adult mouse is not only to document histomorphological defects, here of embryonic and early post-natal forebrain development. Indeed, one also has to provide one or more molecular mechanisms for how these defects (like misspecification of cells and/or misallocations of cells) come about. Trying to elucidate these mechanisms by documenting different markers in the defective region or cell types is for embryologists a standard part of these analyses, however transcriptomic analysis of the targeted cells can in an unbiased way identify sets of misregulated genes in the absence of the transcription factor Zeb2 that reveal expected, but also novel functions of – in this case – Zeb2 and Zeb2-depedent genes.    This Chapter presents the results of the work of many embryologists and cell biologists, significantly guided by transcriptomics (RNA-seq) and bio-informatic processing of the data (which is my major contribution to this work and is elaborated on in more detail mainly in section 5.4.5 below) for identifying a novel role of Zeb2 in the GABAergic interneurons’ guided migration in the embryonic mouse ventral forebrain, where they eventually end-up in the brain cortex as inhibitory neurons. If defective or not reaching in sufficient numbers their final location, this may contribute to seizures and epilepsy, defects that are observed with MOWS patients. Here, transcriptomics helped to identify Unc5b as an overproduced guidance receptor in Zeb2-deficieint cortical interneurons that in normal neurons is critically Zeb2-dependent, which is the core message of the published article. In addition, the same transcriptomics and bio-informatics processing reveals – as what we consider – subtle defects in cell fate determination of these interneurons and also reveals other important Zeb2-dependent processes that hitherto remain unexplored.  
6.2 Summary 
 GABAergic interneurons mainly originate in the medial ganglionic eminence (MGE) of the embryonic ventral telencephalon (VT) and migrate tangentially to the cortex, guided by membrane-bound and secreted factors. We found that Sip1 (Zfhx1b, Zeb2), a transcription factor enriched in migrating cortical interneurons, is required for their proper differentiation and correct guidance. The majority of Sip1 knockout interneurons fails to migrate  to  the  neocortex  and  stalls  in  the  VT.  RNA-sequencing  reveals  that  Sip1 knockout interneurons do 
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not acquire a fully mature cortical interneuron identity and contain  increased  levels  of  the  repulsive  receptor  Unc5b.  Focal  electroporation  of Unc5b-encoding vectors in the MGE of wild-type brain slices disturbs migration to the neocortex, whereas reducing Unc5b levels in Sip1 knockout slices and brains rescues the migration defect. Our results reveal that Sip1, through tuning of Unc5b levels, is essential for interneuron guidance.  
6.3 Introduction 
 The mammalian telencephalon is critical to higher brain functions such as processing of sensory and motor input, learning, and memory. This higher-order information processing relies on 
both excitatory projection neurons and inhibitory γ-aminobutyric acid (GABA)ergic interneurons, which are essential to modulate the electrical activity of the projection neurons onto which they synapse. In the cortex, interneurons comprise a minority (20-30%) of neurons compared to excitatory neurons, but they display a remarkable diversity and can be classified based on morphological, physiological, molecular, and synaptic features (Markram et al., 2004; Ascoli et al., 2008). In mice, cortical interneurons originate in the medial and caudal ganglionic eminences (MGE and CGE) and preoptic area (POA) (Fogarty et al., 2007; Miyoshi et al., 2007, 2010; Gelman et al., 2009; Rubin et al., 2010). Besides cortical interneurons, the MGE also generates interneurons destined for the striatum and hippocampus, and oligodendrocytes and projection neurons for the globus pallidus, amygdala, and septum (Kessaris et al., 2006; Xu et al., 2008).    The specification, migration and integration of cortical interneurons are complex, but precisely orchestrated processes, and disturbances in interneuron development and function have been linked to various neurodevelopmental disorders (Levitt et al., 2004). Once specified in the ganglionic eminences, interneurons migrate to different telencephalon structures, including the neocortex. For this, they need to interpret guidance information supplied by a range of cues in the surrounding ventral telencephalon (VT). Cortical interneurons have the surface receptor EphA4 and are repulsed by ephrinA5 in the ventricular zone (VZ) of the MGE and by ephrinA3 in the striatum (Zimmer et al., 2008; Rudolph et al., 2010). Neuropilin receptors (Nrp1, Nrp2) prevent cortical interneurons from entering the striatum, which produces the repulsive Sema3a and Sema3f ligands (Marın et al., 2001). Deletion of Robo1 results in an increased influx of interneurons in the striatum and cortex (Andrews et al., 2006; Andrews et al., 2008). Robo1 interacts with Nrp1 and modulates semaphorin-neuropilin/plexin signaling to direct cortical interneurons around the striatum (Hernandez-Miranda et al., 2011). Different isoforms of neuregulin-1 act as short- and long-range attractants for migrating cortical interneurons, which express the receptor gene ErbB4 (Flames et al., 2004). Stromal-derived factor-1 (SDF1, Cxcl12) and its receptors Cxcr4 and Cxcr7 are implicated in chemotaxis and positioning of interneurons in the cortex (Stumm et al., 2003; Li et al., 2008; Lopez-Bendito et al., 2008; Sanchez-Alcaniz et al., 2011; Wang et al., 2011). Transcription factors are ideal candidate proteins to specify but also sort the different types of interneuron through controlling the synthesis of such guidance cues and receptors (for recent reviews, see Chedotal and Rijli, 
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2009; Corbin and Butt, 2011). Persistent expression of Nkx2-1 allows a subset of MGE-derived interneurons to downregulate Nrp2 and migrate into the striatum, whereas interneurons destined to the cortex downregulate Nkx2-1, maintain high Nrp2 mRNA and protein levels, and avoid the striatum (Nobrega-Pereira et al., 2008). However, evidence for a functional link between other transcription factors and guidance cues for migrating interneurons remains limited.    Zeb2 (also named Sip1, Zfhx1b) is a transcription factor implicated in embryonic development and in epithelial-to-mesenchymal transition (EMT) (for a recent review, see Conidi et al., 2011). Zeb2 contains two clusters of zinc fingers that mediate binding to two spaced E-box sequences in regulatory regions of its target genes. Furthermore, it has domains that bind activated Smads, CtBP-1/2, and the chromatin-remodelling corepressor complex NuRD, respectively (Verschueren et al., 1999; van Grunsven et al., 2007; Verstappen et al., 2008). In humans, mutations in one ZEB2 allele cause Mowat-Wilson syndrome (MOWS; OMIM#235730), characterized by severe intellectual disability and typical facial features, and many patients present with seizures, corpus callosum agenesis, Hirschsprung disease, and congenital heart disease (Zweier et al., 2002; Garavelli and Mainardi, 2007).    Using various conditional knockout (KO) mice, our laboratory has previously shown that Zeb2 regulates, in a non-cell-autonomous manner, hippocampal development and the timing of cortical neurogenesis and gliogenesis (Miquelajauregui et al., 2007; Seuntjens et al., 2009). Here, using both loss and gain-of-function approaches in vivo and ex vivo, we show that Zeb2 is essential for cortical interneuron migration. Genetic inactivation of Zeb2 leads to a severe reduction in the number of interneurons in the embryonic and postnatal cortex. Comparative RNA-seq combined with bio-informatics analysis of sorted control versus sorted mutant cells from embryonic mouse forebrains have shown that Zeb2 KO MGE-derived interneurons do not acquire a fully mature cortical interneuron identity and that these cells contain increased levels of the guidance receptor Unc5b. Based on this observation, additional experiments performed in embryonic brain slices kept ex vivo, demonstrate that overproduction of transfected vector-encoded Unc5b in wild-type (WT) MGE largely abrogates interneuron migration to the cortex, while reduction of Unc5b levels in Zeb2 mutant interneurons in vitro or in vivo rescues their migration defect. Thus, this work discovered a role for Zeb2 as a critical transcription factor regulating Unc5b mRNA levels during cortical interneuron migration.             
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6.4 Results 
 
6.4.1 Zeb2 is abundantly present in migrating cortical interneurons 
 We documented the presence of Zeb2 in the mouse VT by immunohistochemistry at E14.5 (Figure 5.1; see also Figure S1 of the online version of Van den Berghe et al. 2013 publication, as for all supplemental figures of this Chapter). Zeb2 is present at low levels in the VZ of the MGE and at higher levels in the mantle zone (Figures S1A, S1A’, S1B, and S1B’). In the LGE, we detected Zeb2 in a sickle shape pattern in the subventricular zone (SVZ), and in scattered Zeb2+ cells in the mantle zone (Figures S1A, S1A’, S1B, and S1B’). Zeb2 was also present in the CGE (Figures S1C and S1C’). Furthermore, Zeb2+ cells were found across the pallial-subpallial boundary (PSB) and in the SVZ/ intermediate zone (IZ) and cortical plate (Figure S1A).  
  
Figure 6.1 Zeb2 Is present in MGE-derived migrating cortical interneurons. (A) Crossing the Nkx2-1-Cre mouse with the RCEfl/fl reporter mouse labels the POA and MGE (except for the most dorsal part) and its derivatives. (B–D) Tracing experiments combined with Zeb2 immunohistochemistry at E14.5 show many Zeb2/GFP double-positive (+) cells migrating through the LGE: (B) Many Zeb2+/GFP+ cells enter the cortex (C) and are found in the SVZ/IZ (D), suggesting that these cells are MGE-derived cortical interneurons (white arrowheads, Zeb2+/GFP+ cells; open arrowhead, Zeb2+/GFP cell; asterisk indicates Zeb2+ cortical projection neurons). See also Figure S1 of van den Berghe et al. (2013). Experiments performed by van den Berghe and Seuntjens.   To assess whether these cells were MGE-derived interneurons destined to the cortex, we traced them by crossing the Nkx2-1-Cre mouse line (Kessaris et al., 2006) with RCEfl/fl (i.e., R26RCAG-loxP-stop-loxP-EGFP) reporter mice (Sousa et al., 2009). As shown previously (Kessaris et al., 2006; Fogarty et al., 2007), cells derived from the POA and MGE, except those from its most dorsal part, were labeled. We monitored green fluorescent protein (GFP) and Zeb2 in the E14.5 telencephalon (Figure 1) and confirmed that Zeb2 was present at low levels in the VZ of the MGE and at increasingly higher levels in the mantle zone (Figure 1A). Most GFP+ cells migrating 
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through the LGE contained Zeb2 (Figures 1A and 1B). The majority of MGE-derived cells crossing the PSB were Zeb2+ (Figure 1C) and they maintained high Zeb2 levels while migrating through the neocortex (Figure 1D), demonstrating that Zeb2 is present in MGE-derived migrating interneurons. Zeb+ but GFP-negative cells were also observed in the cortical SVZ/IZ (Figure 1C), presumably representing CGE-derived interneurons.  
6.4.2 The absence of Zeb2 hampers migration of GABAergic interneurons to the 
cortex without affecting early regionalization of the ventral telencephalon 
 We investigated the role of Zeb2 in interneurons by genetically inactivating Zeb2 (critical exon 7) using the Nestin-Cre mouse line (Tronche et al., 1999), which inactivates Zeb2 in the entire embryonic CNS and the Nkx2-1-Cre line (for details on the crossing schemes, see Supplemental Experimental Procedures in the online manuscript van den Berghe et al. 2013). We refer to Nestin-Cre;Zeb2fl/KO as ‘‘Zeb2|Nestin’’ (KO) mice and to the Nestin-Cre;Zeb2fl/WT control mice as ‘‘WT|Nestin’’ mice; a similar convention is used for crosses with other Cre lines. We confirmed 
Zeb2 removal/inactivation from the entire telencephalon in Zeb2|Nestin mice (Figures S1E and S1E’), and in the POA/MGE (except its most dorsal portion) in Zeb2|Nkx2-1 mutants (Figures S1F and S1F’) when compared to control mice at E12.5 (Figures S1D and S1D’). At E12.5, when the first MGE-derived interneurons reach the dorsal telencephalon in control embryos (Figures 2A and 2A’), none or only few GABAergic interneurons (marked by Gad67) migrated in the cortical anlage of Zeb2|Nestin and Zeb2|Nkx2-1 mice (Figures 2B, 2’B’, 2C, and 2C’).    At E16.5, hardly any Gad67+ cells were found in the Zeb2|Nestin cortex (Figures 2E and 2I; control in Figures 2D and 2H), while several were still present in the Zeb2|Nkx2-1 cortex (Figures 2F and 2K), although lower in number than in controls. Those Gad67+ cells in the Zeb2|Nkx2-1 mutant cortex might have originated from the untargeted CGE. Lineage tracing with the RCEfl/fl reporter in the Nkx2-1 model confirmed that the migration of MGE-derived cells to the cortex was severely compromised in the absence of Zeb2 (Figures 2M, 2M’, 2N, and 2N’).    We substantiated these observations using two additional Cre mouse lines: Dlx5/6-Cre, which targets the entire VT, except its VZ (Stenman et al., 2003), and Gsh2-Cre, which produces Cre in the LGE, CGE, and a portion of the MGE (Kessaris et al., 2006). Both Zeb2|Dlx5/6 and Zeb2|Gsh2 brains had reduced numbers of Gad67+ cells in the cortex, comparable to those found in Zeb2|Nestin and Zeb2|Nkx2-1 mutants, respectively (Figures 2J and 2K). In contrast to Zeb2|Dlx5/6 and Zeb2|Nestin mice, which die at birth, Zeb2|Nkx2-1 and Zeb2|Gsh2 mice are viable. Interestingly, in the latter animals, we occasionally observed myoclonic seizures during the third postnatal week. 
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Figure 6.2 Hampered tangential migration of Zeb2 mutant cortical GABAergic interneurons.  (A and A’) In situ hybridization for Gad67 mRNA at E12.5 detects GABAergic interneurons that start invading the cortical anlage in control embryos (arrowhead) (magnification in A’). (B, B’ , C, and C’) None or only few Gad67+ interneurons are detected in the cortex of Zeb2|Nestin (B and B’) and Zeb2|Nkx2-1 (C and C’) mutants. (D–L) In E16.5 control embryos, GABAergic interneurons are spread throughout the cortical plate (D and magnification in H; G is a schematic representation of sections shown in D–F and indicates the area of the magnifications in H–L). In the Zeb2|Nestin mutant, almost no interneurons are detected in the cortex at E16.5 (E, I). Zeb2 deletion in the MGE (Nkx2-1-Cre, F and K) or in the CGE, LGE, and a portion of the MGE (Gsh2-Cre, L) mainly reduces the number of interneurons in the cortical MZ and IZ. In the Zeb2|Dlx5/6 mutant, only few interneurons are found in the cortex (J). (M, M’, N, and N’) The RCEfl/fl reporter mouse line shows that the majority of the Zeb2 mutant Nkx2-1-Cre-derived cells (M and M’) do not migrate to the cortex when compared to a WT control (N and N’). Scale bar in (C’) corresponds to 50 mm (A’–C’), and scale bar in (L) and (N0 ) to 100 mm (H–L, M’, N’). (Figure 1C), presumably representing CGE-derived interneurons. Experiments performed by van den Berghe and Seuntjens.   Next, we assessed whether the lack of Zeb2 modified the expression of acknowledged MGE/VT markers. We performed in situ hybridization for Mash1, Dlx2, Nkx2-1, and Lhx6, and immunohistochemistry for Gsh2 in E12.5 control and KO sections. At this stage, all markers were still present in their appropriate domains in Zeb2|Nestin and Zeb2|Nkx2-1 embryos (Figures 3A–3E), suggesting that deletion of Zeb2 did not affect early regionalization of the VT.  
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Figure 6.3 Zeb2 deletion does not influence early regionalization of the ventral telencephalon. (A and A’) The expression domain of Mash1, an important regulator of neurogenesis, is unchanged upon 
Zeb2 deletion. (B and B’) Dlx2 is expressed in the ganglionic eminences (MGE, LGE, and CGE) and its expression is not changed in the Sip1|Nkx2-1 and Sip1|Nestin mutants at E12.5. (C and C’) Gsh2 immunoreactivity marks the LGE and CGE, but also to a lesser extent the MGE. Gsh2 levels are not changed in the MGE of Zeb2 mutants, suggesting that the MGE does not adopt an LGE or CGE identity. (D and D’) Expression of Nkx2-1 is not affected in Zeb2 mutants. (E and E’) Lhx6, a direct target gene of Nkx2-1, was also correctly expressed in the Zeb2 mutants at E12.5. Experiments performed by van den Berghe and Seuntjens. 
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6.4.3 Defective migration of Zeb2-deleted cortical interneurons is due to removal 
of cell-autonomous effects of Zeb2 
 In the cortex, Zeb2 controls a non-cell-autonomous feedback mechanism that emanates from Zeb2+ postmitotic neurons to progenitor cells, thereby timing neurogenesis and gliogenesis (Seuntjens et al., 2009). We therefore investigated whether the action of Zeb2 in the MGE would be cell autonomous or not. We performed focal electroporations (Figure 4A) with Cre plasmid pCIG-Cre in the MGE of E13.5 Zeb2fl/fl organotypic brain slices (Figures 4D and 4D’). After 3 days 
in vitro (DIV), we counted the total number of GFP+ cells in the slice and calculated the percentage of GFP+ neurons that reached the cortex. As controls, we electroporated pCIG-Cre in WT slices or a GFP-encoding plasmid (pCIG) in Zeb2fl/fl slices (Figures 4B, 4B’, 4C, and 4C’). In both controls, targeted GFP+ cells migrated to the cortex (58.3% for pCIG in Zeb2fl/fl slices, n = 11; 56.8% for pCIG-Cre in WT slices, n = 13 slices; quantification in E). By contrast, only 14% of the Zeb2-deleted cells (pCIG-Cre in Zeb2fl/fl slices, n = 19 slices, p < 0.001; two independent experiments) migrated to the cortex (Figures 4D and 4E).The failure of the neighboring Zeb2+ cells to rescue the defective tangential migration of Zeb2 mutant interneurons demonstrated that the effects of Zeb2 in interneuron migration are cell-autonomous. 
 
Figure 6.4 Zeb2 has a cell-autonomous role in cortical interneurons. (A) Experimental design to delete Zeb2 in a limited number of MGE cells. pCIG (pCAGGS-IRESeGFP) or pCIG-Cre plasmids were focally electroporated (EP) in the MGE of Zeb2fl/fl E13.5 organotypic brain slices and cultured for 3 DIV. To check for a possible toxic effect caused by Cre accumulation, the pCIG-Cre construct was electroporated in WT slices. (B–D) Representative pictures of each experimental condition. The border between cortex and VT is indicated by the dotted line. Lower panels (B’–D’) with digitally added dots indicate the counted GFP+ cells. (E) We counted the total number of GFP+ cells per slice and calculated the percentage of GFP+ neurons in the cortex. Electroporation of pCIG-Cre in WT MGE or pCIG in Zeb2fl/fl MGE resulted in similar proportions of targeted cells in the cortex (58.28% ± 2.61%, n = 11 slices and 56.83% ± 2.74%, n = 13 slices, respectively). Migration to the cortex of Zeb2-deficient interneurons is strongly decreased (13.63% ± 1.07%, n=19) compared to both controls. Error bars 
represent SEM of two independent experiments. Statistical significance was determined using the χ2 test (*p < 0.001). Experiments performed by van den Berghe. 
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6.4.4 Zeb2-deficient interneurons are intrinsically able to migrate 
 We next investigated whether Zeb2-deficient cells had the intrinsic capacity to migrate. We cultured MGE explants from WT;- and Zeb2;RCE|Nkx2-1 E14.5 embryos in Matrigel (Figure S2A, see online version of van den Berghe et al., 2013) according to Wichterle et al. (1999) and measured the maximum migration distance of the cells from the explants after 1 and 2 DIV (Figures S2B and S2B’). Zeb2 KO interneurons migrated about 15% less far from the explants than WT counterparts after 1 DIV (WT: 252.95 ± 13.70 mm, n = 29 versus KO: 215.77 ± 15.41 mm, n = 27; p = 0.0530; n = number of explants) or 2 DIV (WT: 685.06 ± 33.82 mm, n = 17 versus KO: 579.84 ± 22.68 mm, n = 21; * p = 0.0076) (Figure S2C), suggesting reduced migration speed. If the latter would be the sole cause of the observed reduction in interneuron numbers in the cortex of Zeb2 KO embryos, then the defect could be restored at later stages, when all targeted cells had sufficient time to populate the cortex. However, in Zeb2;RCE|Nkx2-1 mutants, only a few GFP+ cells were found in the cortex at later stages (E18.5; Figures S2D and S2E).   A large group of misrouted Zeb2 KO cells was found in the caudal VT of Zeb2;RCEjNkx2-1 brains at E16.5 (Figures 5A, 5A’, S3A, and S3A’’). This ectopic group of cells was positive for Nkx2-1 (Figures 5B and 5B’) and Lhx6 (Figures 5C and 5C’). Similar ectopia were found in the other Zeb2 mutants (Zeb2|Nestin [see Figures 5.5 and S3]; Zeb2|Dlx5/6 and Zeb2|Gsh2 [data 
not shown]). These GFP+ ectopic cells did not locate to the globus pallidus (GP) area; also, they were Er81 indicating this is not an ectopic GP (Figures S3A and S3A’’, where GP is indicated by an asterisk and ectopic cells by an arrowhead; results not shown). The ectopia was also positive for neuropeptide-Y (NPY), somatostatin (Sst), and Sox6 (Figures 5D and 5E, and data not 
shown), as well as for receptors typically present in migrating cortical interneurons, such as Nrp2 and ErbB4, indicating cortical interneuron features (Figure S3, all panels B and C).   
 
 
 
 
 
 
 
Figure 6.5 (next page) MGE-derived cells form an ectopia in the caudal part of the Zeb2 mutant 
ventral telencephalon. (A and A’) Zeb2 KO MGE-derived cells migrate but locate in a caudal ectopia in the VT as marked by GFP+ staining in Zeb2;RCE|Nkx2-1 brains (E16.5). (B and B’, C and C’). Nkx2-1 and Lhx6 transcripts are also found in this ectopic cell population of all Zeb2 mutant embryos (Zeb2|Gsh2 and Zeb2|Dlx5/6 mutants 
not shown). In Zeb2 mutants, Nkx2-1 and Lhx6 mRNA domains in the caudal MGE are expanded. (D, D’, E and E’) The ectopic cells are also positive for neuropeptide Y (Npy) and somatostatin (Sst), markers of subsets of MGE-derived interneurons. See also Figures S2 and S3 in the online version of van den Berghe et al., 2013. Experiments performed by van den Berghe and Seuntjens.  
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   We investigated whether Zeb2;RCE|Nkx2-1 cells present in the cortex 3 weeks after birth contributed to the cortical interneuron lineages. Quantification of the number of GFP+ cells in the cortex showed there were much less MGE-derived interneurons in the Zeb2 mutants (48% of the control number) (Figure 6E). Furthermore, Zeb2 KO cells largely failed to populate the more medial parts of the cortex and remained clustered in the lateral cortex (KO versus control in lateral, 60.4% compared to 35.8% of the total population of GFP+ cells for each genotype (i.e., 61 compared to 75 cells); intermediate, 25.5% compared to 37.2% [i.e., 26 compared to 78 cells]; and medial, 14.1% compared to 27.0% [i.e., 14 compared to 56 cells]; Figures 6A–6C, 6A’–6C’, 6D, 6E, S4A, S4B, and S4E). Interestingly, the deep layers (marked by Ctip2) seemed to contain fewer GFP+ neurons when compared to control mice (Figures 6A–6C, 6A’–6C’, S4A and S4B). We also analyzed the presence of parvalbumin (PV), Sst, calretinin (CR), and NPY in Zeb2-
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deleted cortical interneurons. Most of the WT;RCEjNkx2-1 cells in the cortex were PV+ or SST+ interneurons, less were NPY+, and almost none contained CR, as expected for MGE-derived cells (Figures 6F–6I, quantification in 6J and 6K). We found significantly fewer PV-, SST-, and NPY-containing interneurons in the cortex of Zeb2;RCE|Nkx2-1 mutants (absolute numbers, p < 0.0001 for PV and SST, p = 0.0128 for NPY) (Figures 6F’-6I’, and 6J). Interestingly, the relative contribution of each of these interneuron subtypes to the total amount of targeted (GFP+) cells was not changed compared to control mice (Figure 6K).   Taken together, Zeb2 KO MGE-derived interneurons have the intrinsic capacity to migrate, yet largely fail to reach the cortex during embryogenesis. Instead, a large portion appears to be misrouted in the VT, indicating a guidance problem. Three weeks after birth, the small number of Zeb2 KO interneurons in the cortex do not distribute properly, yet still contribute to the different interneuron subtypes.                 
Figure 6.6 (next page) Zeb2 mutant cells distribute abnormally in the postnatal cortex but still 
contribute to the different interneuron populations. (A–C and A’–C’)Three weeks after birth, few MGE-derived interneurons are found in the cortex of Zeb2;RCE|Nkx2-1 mice. Compared to the control (A–C), the bulk of Zeb2 KO cells remains in the lateral cortex (A’), while only a minority are found in more medial regions (B’ and C’). (D) Boxed areas represent the three cortical regions in the pictures in A, A’ to C, C’). (E) Quantification of the absolute number of GFP+ cells in each of these regions shows a significant reduction in the intermediate and medial areas (KO versus control in lateral, 61 compared to 75 cells; intermediate, 26 compared to 78 cells; and medial areas, 14 compared to 56 cells). (F–I and F’–I’) Coexpression of GFP with the interneuron markers PV, SST, CR, and NPY was compared between WT;RCE|Nkx2-1 (F–I) and Zeb2;RCE|Nkx2-1 (F’–I’). White arrowheads indicate double-positive cells, empty arrowheads point to GFP+/marker cells and an asterisk marks GFP interneurons. Green and red channels are shown for the indicated cells. (J) The absolute number of GFP/marker double-positive cells was significantly decreased in the Zeb2 mutant (KO versus control for PV, 8 compared to 30 cells; SST, 7 compared to 20 cells; NPY, 1 compared to 3 cells) except for CR (KO versus control for CR, 1 compared to 1 cell). (K) The relative contribution of each of the different MGE-derived cell types was not changed (KO versus control for PV, 32% compared to 40%; SST, 30% compared to 28%; CR, 25% compared to 2%; NPY, 4% compared to 5%). Scale bar in C0 is 250 mm (A, A0 to C, C0 ) and 50 mm in I’ (F, F’ to I, I’). Error bars represent SD. Statistical significance was determined via the Student’s t-test (*p < 0.0001, #p < 0.05). See also Figure S4 of the online version of van den Berghe et al., 2013. Experiments performed by Stappers. 
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6.4.5 RNA-seq reveals that transcript levels of differentiation factors and 
guidance cues are affected in Zeb2 mutant interneurons 
 To further characterize the nature of the Zeb2 KO cells and to understand the cause of the misrouting, we compared control and Zeb2 mutant transcriptomes via RNA-seq of fluorescence-activated cell sorting (FACS) sorted MGE derived cells, obtained from WT;- and Zeb2;RCE|Nkx2-1 telencephali (three biological repeats, Illumina HiSeq-2000 platform at the Centre for Biomics, Erasmus MC), respectively. This approach identified differentially expressed genes irrespective of the cells’ position in the telencephalon. Gene expression levels were derived from the read counts via HT-Seq and normalized across the six samples using DE-Seq (false discovery rate [FDR] < 0.05 cutoff) (Anders and Huber, 2010). Hence, the obtained values are normalized mean read counts allowing direct comparison of control and mutant samples. We assessed the correlation among the three biological repeats (Figure S5A in van den Berghe et al., 2013).    I found that the control samples and the KO samples clustered in two highly different groups, indicating that the expression differences in our samples reflected changes caused by 
Zeb2 deletion. A principal component analysis showed grouping of the samples according to the most important first principal component (Figure 5.7 below, which is Figure S5B in the online version of van den Berghe et al., 2013). The drastic decrease of mapped reads on the floxed exon7 confirmed the efficiency of Zeb2 deletion (Figure 5.7C below). Using differential 
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expression analysis using HT-Seq and DE-Seq I identified 505 significantly upregulated and 366 significantly downregulated genes in Zeb2;RCE|Nkx2-1 compared to control cells (Table 5.1 in annex to this Chapter, which is Table S7 from the online version of van den Berghe et al., 2013).   To study the impact of Zeb2 deletion on differentiation of MGE derived cell populations, we listed the expression differences of transcription factors (TFs) related to these populations in control versus Zeb2 KO cells (Table S1 in online version of van den Berghe et al., 2013). We found that transcript levels of Dlx1, Dlx2, and Lhx6 were not affected. Some TFs present in cortical interneurons (Cux2, Maf, and Mafb) were clearly reduced (gray overstrike when > 2-fold reduction), whereas others (Satb1 and Sox6) were not changed or even increased. Also, the transcript levels for oligodendrocyte TFs Olig1, Olig2, and Sox10 were downregulated, whereas 
Id4, encoding an inhibitor of oligodendrocyte differentiation, was upregulated in the absence of Zeb2. Some TFs related to striatal (Nkx2-1), cholinergic (Lhx8 and Isl1), or pallidal (Gbx1) development were increased in Zeb2 KO cells, but none exceeded 2-fold upregulation. Furthermore, we compared the mRNA levels of 11 additional genes (Cxcr4, Gria1, Ets1, Cxcr7, 
Grik1, Cntnap4, Grip1, Chl1, Cacng2, Csdc2, and Scn1a) previously reported as enriched in embryonic cortical interneurons (Batista-Brito et al., 2008; Marsh et al., 2008; Faux et al., 2010) and included Nrp2, a gene related to migration of cortical interneurons (Nobrega-Pereira et al., 2008). In the Zeb2 KO samples, 10 of these 11 genes were downregulated, whereas Nrp2 was upregulated. Most of the downregulated genes are related to interneuron function or migration in the cortex itself, suggesting that Zeb2 deletion disturbed the maturation of MGE-derived cells to functional cortical interneurons.   
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Figure 6.7 Technical validation of the RNA-seq setup. (A) Heatmap showing the Euclidean distances between the different RNA-seq samples as calculated from the variance-stabilizing transformation (VST) of the count data. Unbiased clustering results in grouping of the three WT versus the three KO samples, indicating that differences between these groups are primarily a result of Zeb2 deletion. (B) Principal component analysis (PCA) of VST count data for the different samples. Plotting the first two PCs shows a clear separation of the WT and KO samples according to PC1. Note that the one sample with slightly higher loading on PC2 (WT2) is the only female sample (we determined the sex of the RNA-Seq samples via RT-PCR for Sry (only on Y-chromosome) and Jarid (X- and Y-chromosome specific allele). (C) Mapped reads (BAM files) for Zeb2 in both WT;- and Zeb2;RCE|Nkx2-1 RNA-seq samples were visualized via the Integrative Genomics Viewer (IGV) (http://www.broadinstitute.org/software/igv/). Zeb2 deletion clearly results in a decrease in reads on the floxed exon 7 (±2kb in length).     Next, we performed an unbiased gene ontology (GO) enrichment analysis using the GOrilla tool (http://cbl-gorilla.cs. technion.ac.il) (Tables 5.2 and 5.3 in annex to this Chapter, which are Tables S2 and S3 of the online version of van den Berghe et al., 2013). Genes related to the GOterms ‘‘cell cycle’’ and ‘‘mitosis’’ were enriched among the downregulated genes (Table S2). However, although proliferation at E12.5 in the MGE of Zeb2|Nestin animals was decreased by 
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25% (n = 5 for each condition, p = 0.0023), cell cycle exit was not affected and we could not detect a similar reduction in proliferation in Zeb2|Nkx2-1 animals (data not shown). On the other hand, genes related to ‘‘axon guidance’’ were enriched (to a factor 6.5; Table 5.3 in annex) among the most upregulated genes in the Zeb2 mutants. As predicted from our observed cell-autonomous action mode of Zeb2, their gene products localized preferentially to the membrane and were implicated in ‘‘signaling by transmembrane receptors’’ (Table 5.3 in annex). Intriguingly, all four genes relating to the GO term ‘‘Netrin receptor activity’’ (i.e., Deleted-in-
colorectal carcinoma [Dcc], Unc5a, Unc5b, and Unc5c) were ranked within the first 294 of all 8,485 genes listed (Enrichment = 28.86; p = 3.76E-6). In fact, many of the ligands or receptors involved in the Netrin/Unc5 pathway had upregulated expression in Zeb2 KO cells (Figure S6A in the online version of van den Berghe et al., 2013). Transcripts encoding the Netrin1 receptor Unc5b (5.3-fold up) and the ligand Netrin1 (Ntn1) itself (2.4-fold up) were particularly increased (Figure S6A there), which was confirmed by quantitative PCR (qPCR) (Figure S6B there).    Taken together, E14.5 Zeb2 KO cells downregulate markers of maturing cortical interneurons, and possess disturbed levels of guidance cues, especially those related to Netrin/Unc5 signaling.   
6.4.6 Increased Unc5b levels lead to aberrant interneuron migration 
 We examined the expression of several receptors and ligands of the Netrin/Unc5 system. Unc5b mRNA was barely detectable in the control MGE, whereas Unc5b+ cells accumulated in the Zeb2;RCE|Nkx2-1 MGE (Figure 5.8 below, specifically panels A, A’, B and B’; corresponding to Figure 7 in the online version of van den Berghe et al., 2013). Ntn1 levels were increased around the striatal area as well as in the caudal ectopia (Figures 5.8C and C’). Unc5c levels increased in the VT of Zeb2 mutants, whereas Dcc expression was unchanged (Figures S6D, S6E–D’, and S6E’ in the online version of van den Berghe et al., 2013). The fibronectin and leucine-rich transmembrane proteins Flrt2 and Flrt3 are also ligands for Unc5b (Karaulanov et al., 2009; Yamagishi et al., 2011). Flrt2 mRNA was abundant in the LGE and striatal anlage in control and Zeb2jNkx2-1 telencephalon (Figures S6F and S6F’ online), whereas Flrt3, present at the border between the LGE and the MGE and at low level in the MGE in the control, seemed to be expanded in the mutant VT (Figures S6G–S6G’ online). Taken together, both qPCR and in situ hybridization analysis confirmed the increased transcript levels of Unc5b and Ntn1 found by RNA-seq in Zeb2;RCE|Nkx2-1 cells.    
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Figure 6.8. Tuning of Unc5b levels is crucial for directed migration of MGE-derived cortical 
interneurons. (A and B) In situ analysis in control and mutant brain sections reveals increased Unc5b levels in the Zeb2|Nkx2-1 MGE (open arrowhead in B and B’) - rostral level (A and B); more caudal level (A’ and B’). (C) Unc5b levels in the MGE were restored to base levels by crossing Zeb2 KO mice with a conditional Zeb2 transgenic mouse line, R26-Zeb2tg/tg(C and C’). Same rostrocaudal levels shown as in (A, A’ and B, B’). (D) Zeb2 and Unc5b levels are inversely correlated, as shown by qPCR on representative E14.5 FACS-sorted control, KO and hemizygous rescue telencephalon samples (WT;RCE-, Zeb2;RCE- and Zeb2;R26-Zeb2tg/wt;RCE|Nkx2-1, respectively). qPCR was performed in duplicate, and error bars represent SD. (E) Scheme of the focal electroporation experiment. (F and G) Plasmids encoding GFP or Unc5b were focally electroporated in the MGE of WT E13.5 organotypic brain slices. After 3 DIV, many GFP+ interneurons were found in the cortex (F), whereas electroporation of mouse (m) Unc5b vector largely disrupted interneuron migration to the cortex (G). (H) We calculated the percentage of GFP or mUnc5b interneurons in the cortex on the total amount of targeted cells per slice (GFP: 47.63% ± 2.78%, n = 16 slices versus mUnc5b: 16.22% ± 2.04%, n = 11 slices, p < 0.0001, c2 test). Error bars represent SEM, and n is the number of slices. (I) Experimental design to rescue directed migration of Zeb2 KO interneurons. (J and K) Nontargeting (NT) siRNA or mouse Unc5b siRNA was co-electroporated with a conditional dsRed-encoding plasmid (CALNL) to mark targeted cells in the Zeb2;RCE|Nkx2-1 brain slices. After 3 DIV, almost no NT siRNA-treated Zeb2 KO cells were present in the cortex (J). Reducing Unc5b levels in Zeb2;RCE|Nkx2-1 interneurons partially rescues the migration to the cortex (K). (L) Quantification of the percentage of Zeb2 KO cells in the cortex upon NT or Unc5b siRNA electroporation (NT siRNA: 9.04% ± 1.36%, n = 16 slices versus Unc5b siRNA: 13.82% ± 1.76%, n = 16 slices, p < 0.0001, c2 test). Error bars represent SEM of two independent experiments, and n is the number of slices. (M–O and M’–O’) Introduction of the R26-Zeb2 transgene rescues the number of GABAergic interneuron in the Zeb2 KO cortex (higher magnifications in M’–O’ taken at the same level as indicated in Figure 5.2G). Rescue of migration to the cortex was also obvious in the piriform cortex (arrowheads). Asterisks in (F) and (G) and (J) and (K) indicate the area of injection, and the dotted line indicates the border between cortex and VT. Scale bars in C’ represent 250 mm (A–C, A’–C’), and 100 mm in O’ (M’–O’). See also Figures S5–S7 of the online version of van den Berghe et al. Experiments performed by van den Berghe and Seuntjens.   
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 To test which candidate cue(s) is (are) likely to (mis)guide cortical interneurons, we focally electroporated WT MGEs with Ntn1 or Unc5b expression vectors. Overproduction of Ntn1 had no obvious effect on interneuron migration when compared to the GFP control (Figures S7A–S7C online). In contrast, using either a mouse or rat Unc5b construct, we found that Unc5b overproduction disrupted the migration of interneurons toward the cortex (mUnc5b: 16.2%, n = 11 versus GFP: 47.6%, n = 16 slices; p < 0.0001) (Figures 5.8E–G below, part of Figure 7 online, quantification in H; Figures S7A, S7B, and S7D online). Interestingly, cells overproducing Unc5b tended to migrate in a ventral direction (Figure 5.8G).    As dependence receptor, Unc5b may also trigger cell death in absence of its ligand. We therefore investigated presence of cleaved caspase-3 as indicator of apoptosis in electroporated slices (Figures S7E and S7F online). We did not observe a difference in cell death in GFP or Unc5b electroporated cells, suggesting that the migration defect induced by Unc5b overproduction is not a consequence of apoptosis. We also never observed increased cell death in the MGE of Zeb2 mutants (E14.5; data not shown).   If too high levels of Unc5b hamper the migration of Zeb2 KO interneurons, then we should be able to rescue their migration by downregulating Unc5b. We therefore electroporated Unc5b small interfering RNA (siRNA) or a non-targeting (NT) mouse siRNA pool in the MGE of Zeb2|Nkx2-1 mutant slices. To visualize targeted Zeb2 KO cells, a conditional dsRed-expressing construct (pCALNL) was co-electroporated (Figure 5.8I). Electroporation of Unc5b siRNA almost doubled the number of Zeb2 mutant cells reaching the cortex (NT siRNA: 9.04%, n = 16 versus Unc5b siRNA: 13.82%, n = 11 slices; p < 0.0001) (Figures 5.8J and K, quantification in L). This indicates that decreasing the levels of endogenous Unc5b partially rescues the migration defect of Zeb2 KO interneurons   In addition, we could also rescue the interneuron migration in vivo by using a Zeb2 complementary DNA (cDNA)-encoded transgene conditionally expressed from the ROSA locus (R26-Zeb2tg/tg). This mouse delivers a relatively small but constant dose of Zeb2 to cells that produce Cre. Because the RCE reporter is also ROSA based, only hemizygous R26-Zeb2 (R26-
Zeb2tg/wt) samples could be obtained from FACS-sorted cells. Introduction of R26-Zeb2tg/wt increased Zeb2 levels, while it reduced Unc5b levels in E14.5 Zeb2 KO cells, as measured by qPCR (representative samples are shown in Figure 5.8D). Introduction of two R26-Zeb2 based alleles (R26-Zeb2tg/tg) in a Zeb2|Nkx2-1 KO mouse abolished the increase in Unc5b levels in the MGE (Figure 5.8C,C’) and rescued the migration of interneurons to the cortex, as seen at E16.5 (Figures 5.8M–O and 5.8M’–O’).    Altogether, our data show that Zeb2 is needed for the proper regulation of the expression level of Unc5b in MGE-derived interneurons. Furthermore, our results also indicate that the local tuning of Unc5b expression in the MGE mantle zone is essential to direct the migratory path of these interneurons to the cortex. 
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6.5 Discussion 
 In this study, we identify Zeb2 as a critical, cell-autonomously acting transcription factor required in GABAergic interneurons, for their efficient migration to the cortex. Deletion of Zeb2 in the MGE results in misrouting of MGE-derived interneurons, indicating a guidance defect. Transcriptome analysis using RNA-seq followed by gain-of-function studies show that increased levels of Unc5b inhibit interneuron migration to the cortex. Moreover, knockdown of Unc5b ex vivo in Zeb2 mutant brain slices or conditional expression of a Zeb2 cDNA-based transgene in 
vivo in a Zeb2 KO background rescues this phenotype. Hence, we identify Unc5b as a key Zeb2-modulated guidance receptor in directed interneuron migration.   The Zeb2 mutant mice studied here recapitulate some features of MOWS, in particular seizures, which are common in MOWS patients (Garavelli and Mainardi, 2007). Defects in cortical interneuron migration typically cause seizures in mice (Powell et al., 2003; Levitt et al., 2004). In line with this, we observed spontaneous seizures in Zeb2|Gsh2 mutant mice during the third postnatal week, but not in young Zeb2|Nkx2-1 mice, suggesting that Zeb2 deletion in CGE as well as MGE-derived interneurons (in Zeb2|Gsh2 mice) is more detrimental than in the MGE alone (as in Zeb2|Nkx2-1 mice). Zeb2 is produced in larger amounts by migrating interneurons than in progenitors, consistent with previous observations (Batista-Brito et al., 2008; Faux et al., 2010). Removal of Zeb2 from the entire CNS (Nestin-Cre) leads to a phenotype similar to that observed in Zeb2|Dlx5/6 mice, in which VZ progenitors of the VT are not targeted, suggesting that Zeb2 functions at the level of the SVZ and/or in postmitotic cells to drive differentiation. Similarly, during neural induction, as well as during mouse ESC differentiation, Zeb2 controls the formation of definitive neural stem cells from progenitor cells (van Grunsven et al., 2007; Dang et al., 2012). In embryonic hematopoiesis, Zeb2 is also essential for stem/progenitor cell (HSC/HPC) differentiation and mobilization, but not for HSC formation itself (Goossens et al., 2011). Likewise, Zeb2 promotes differentiation of oligodendrocyte precursor cells into myelinating cells (Weng et al., 2012).   My transcriptome analysis shows that E14.5 Zeb2 KO cells have reduced levels of several cortical interneuron markers such as Cux2, Maf, Cxcr4, and Cxcr7, which may indicate a differentiation deficit. Persistent levels of Nkx2-1 in particular, instead of its downregulation in WT mice, may even suggest that these interneurons acquire a striatal or cholinergic fate, as claimed in a  parallel study by McKinsey et al. (2013). Unfortunately, at present, no other factors are to our opinion known to be uniquely expressed in embryonic striatal interneurons, making a firm distinction between cortical or striatal interneuron fates based on transcriptome analysis rather difficult and making us a bit more prudent in this conclusion than McKinsey et al. (2013). It cannot be excluded that Zeb2-deficient interneurons remain cortical in character but fail to differentiate fully, either because of the absence of Zeb2 function(s) or rather because of a failure of these cells to be exposed to cortical maturation factors that allow them to articulate a fully mature cortical phenotype. Indeed, once in the neocortex, Zeb2 KO interneurons were able to contribute to the PV+ or SST+ cell populations. Clearly, a large portion of Zeb2 KO cells never reach the cortex. 
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 My unbiased GO analysis shows that axon guidance and cell adhesion factors were enriched among upregulated genes. In addition to other TFs, Zeb2 is known to affect cell-cell adhesion in various contexts such as EMT and cancer, via direct regulation of E-cadherin expression. Because Zeb2 directly represses E-cadherin (Comijn et al., 2001; van Grunsven et al., 2003) gain-of- function or high levels of Zeb2 correlate with deadhesion, increased invasion, and bad prognosis in some cancers (Peinado et al., 2007), whereas loss-of-function of Zeb2 promotes adhesion and leads to delayed/reduced delamination of cranial neural crest cells (Vande Putte et al., 2003). Rather than possibly affecting cell-cell adhesion, our results show that Zeb2 deletion in interneurons deregulates their directed migration. During embryogenesis, an ectopic group of MGE-derived Zeb2 KO cells was found in the caudal VT. A comparable misrouting was described in the Dlx1/2 double-mutant brain, accompanied with ectopia of cortical interneuron-like cells (Marın et al., 2001; Long et al., 2009). Our data indicate that upregulation of Unc5b mRNA levels in interneurons results in their aberrant migration. Overproduction of Unc5b by focal electroporation in cells of the MGE indeed changes their direction of migration without influencing their differentiation into cortical interneurons, leading to a dramatic reduction in migration of interneurons to the cortex. Moreover, using a conditional overexpression approach, we show that Zeb2 levels are inversely correlated with Unc5b levels. On the other hand, Zeb2 chromatin immunoprecipitation on conserved regions of the Unc5b upstream regulatory region and the first intron (100 kb around the transcription start site) did not detect any direct binding of Zeb2, suggesting that Zeb2 represses Unc5b expression indirectly (data 
not shown). Further work is needed to identify the Zeb2 transcriptional target that directly represses Unc5b.    Which ligands could cause the misrouting of these Unc5b overexpressing MGE cells? Ntn1 mediates repellent responses via Unc5b, alone or in combination with the receptor Dcc (Rajasekharan and Kennedy, 2009). Although Netrins have been implicated in cell and axon migration and Ntn1 is present along the migratory routes of GABAergic interneurons, the cortices of Ntn1 KO and Slit1/2KO;Ntn1KO mutants as well as Dcc KO mutants display normal interneuron numbers at birth, suggesting that these proteins are dispensable for tangential migration (Anderson et al., 1999; Marın et al., 2003). However, Ntn1 interaction with α3β1 integrin, which is present on interneurons, promotes their migration. Deletion of both Ntn1 and 
α3-integrin (Itga3) results in a large ectopic aggregation of interneurons in the VT, suggesting that Ntn1 signaling provides directional information to migrating interneurons (Stanco et al., 2009). In addition to Ntn1, Unc5 receptors also bind Flrt2 and Flrt3, which results in a repellent interaction, based on observations with Unc5d and Flrt2 during radial migration of cortical projection neurons (Karaulanov et al., 2009; Yamagishi et al., 2011). We detect both Flrt2 and Flrt3 in the LGE, a region through which MGE-derived interneurons migrate en route to the cortex. Moreover, Ntn1 is present in the VZ of the LGE and MGE, as well as in the striatal anlage. High levels of Unc5b in interneurons could repel them from these Ntn- and Flrt-rich areas. Cells overproducing Unc5b via focal electroporation preferentially migrate in a ventral direction, suggesting that they indeed avoid these Ntn1 and Flrt-rich areas. Further studies are necessary to define which ligand(s) is (are) primarily causing Zeb2-deficient cells to deviate from their normal path in the VT.  
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 In conclusion, our results identify Zeb2 as an essential transcription factor for cortical interneuron migration and maturation. Furthermore, we demonstrate that the regulation of precise Unc5b levels by Zeb2 represents a way of sorting the different MGE cell types generated during embryogenesis. In general, defining a global guidance code for each of the migrating cell types in the VT will be a challenge for the future.   
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6.6 Experimental Procedures 
Animals Mice were maintained in a CD1/Swiss background and were kept at KU Leuven in accordance to Belgian and EU regulations. Mice carrying a floxed (exon 7) Zeb2 allele (Zeb2fl/fl) (Higashi et al., 2002) were crossed with the following Cre mouse lines: Nkx2-1-Cre and Gsh2-Cre (Kessaris et al., 2006), Nestin-Cre (Tronche et al., 1999), Dlx5/6-Cre (Stenman et al., 2003), with RCEfl/fl reporter mice (Sousa et al., 2009) and conditional Zeb2 transgenic ROSA26-Zeb2tg/tg mice (kindly provided by G. Berx and J. Haigh).  
Immunohistochemistry and in situ hybridization For the postnatal study, mice were deeply anesthetized with pentobarbital before intracardiac perfusion with MEMFA fixative. Brains were removed and fixed overnight, followed by progressive dehydration and paraffin embedding. Coronal and sagittal sections from embryonic brains were prepared as described (Seuntjens et al., 2009). Brain sections were processed for immunohistochemistry or in situ hybridization using an automated platform (Ventana Discovery, Roche). Antibodies and mRNA probes are listed in Supplemental Experimental Procedures (in the online version of van den Berge et al., 2013). Sections were photographed using a Leica DMR microscope connected to a Spot camera (Visitron Systems). Three nonoverlapping pictures of 765 3 1,015 mm2 were taken in the cortex from the lateral part of the cortex to the midline. The number of marker+, GFP+, and double GFP+/marker+ cells was quantified. Three animals (age P20–P24) were used for each genotype. Cells were counted via ImageJ software and results are represented as mean ± SD. Statistical significance was determined using the Student’s t test.  
MGE Explant Cultures in Matrigel E14.5 WT;RCE|Nkx2-1 and Zeb2;RCE|Nkx2-1 brains were dissected in icecold HEPES-buffered Leibovitz’s L15 medium (Invitrogen) and embedded in 4% low-melting-point agarose. Organotypic slices of mouse telencephalon (coronal, 300 mm) were made using a vibratome (HM650V, Microm). MGE pieces were embedded in Matrigel on culture slides (both from BD Biosciences). Explants were cultured in Neurobasal/B27 medium for 1 or 2 DIV in a 5% CO2-humidified incubator. Neurons that migrated the furthest away from the explants determined a circumference around the explant for which 15 to 20 radii were measured determining the average maximum migratory distance away from the explant. Statistical significance was determined via Mann-Whitney U test.  
FACS of MGE-Derived Cells E14.5 WT;RCEj-, Zeb2;RCEj- and Zeb2;R26-Zeb2;RCE|Nkx2-1 telencephali were isolated in ice-cold HEPES-buffered Leibovitz’s L15 medium (Invitrogen), meninges and olfactory lobes were removed and the tissue was cut in small pieces. Cells were dissociated by incubation in Papain solution (150 ml per brain of 12 U/ml) (Sigma) supplemented with DNaseI (30 U/ml) (Roche) for 30 min at 37ºC followed by mechanical dispersion, washed with Dulbecco’s PBS (Lonza) and passed over a 70 mm cell strainer (BD Falcon). Highly fluorescent cells (population P2) were sorted using a FACSVantage SE (FACSDiva) (BD Biosciences). Sorted cells were immediately lysed in TRIzol LS (Invitrogen) and RNA was extracted using the RNeasy Micro kit (QIAGEN).  
RNA-Seq RNA-seq library was prepared for analysis according to the Illumina TruSeq protocol (http://www.illumina.com). Briefly, poly(A)-tailed mRNA was copied into cDNA fragments, end repaired, (A)-tailed, ligated with adaptors, and enriched by PCR. Six RNA-seq library stocks were pooled and sequenced for 36 bp using the HiSeq 2000.  
RNA-Seq Data Analysis  Three biological replicates of FACS-sorted WT;- and Zeb2;RCEjNkx2-1 samples were analyzed. The number of reads for the samples ranged from 13,737,422 to 17,967,187 (Table S4). Mapping was done 
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with TopHat to the mouse reference genome (mm9) using default parameters (Trapnell et al., 2009), resulting in 79.03%–79.84% of uniquely mapped reads (Table S5 in the online version of van den Berghe et al. 2013). Read counts were aggregated for each gene using HT-Seq (http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html) in the ‘‘union’’ mode (Ensembl r62 annotation). Gene expression levels were normalized using DE-Seq and filtered on a minimum of 150.0 normalized read count in at least one condition. Differential expression analysis was performed with DE-Seq (FDR < 0.05), resulting in 505 genes significantly upregulated and 366 genes significantly downregulated in Zeb2;RCEjNkx2-1, compared to control. GO enrichment was performed using GOrilla on a single ranked list (http://cbl-gorilla.cs.technion.ac.il).  
qPCR RNA was obtained from FACS-sorted E14.5 WT;RCEj-, Zeb2;RCEj-, and Zeb2;R26-Zeb2;RCE|Nkx2-1 telencephalic cells and cDNA was made via the SuperScript III First-Strand Synthesis System (Invitrogen). qPCR was carried out in duplicate on a LightCycler 480 Instrument (Roche) using SYBR Green PCR Master Mix (Roche). Relative quantitation was determined using qBasePLUS software.  
Plasmids Expression constructs used for focal electroporation were based on pCIG, a pCAGGS-IRES-eGFP plasmid obtained via P. Vanderhaeghen (Megason and McMahon, 2002). In the multiple cloning site of this vector, we cloned (1) the mouse Unc5b coding sequence which was isolated from a pcDNA3-mUnc5b construct (Yamagishi et al., 2011), (2) the rat Unc5b-coding sequence isolated from the pEGFP-N1/rUnc5b construct (Larrivee et al., 2007), and (3) the mouse Netrin1 coding sequence isolated from a Ntn1 expression plasmid (IRCKp5014G0516Q, ImaGenes). To trace electroporated cells in RCE|Nkx2-1 brain slices, the pCALNL plasmid (Addgene) was used. To delete Zeb2 in Zeb2fl/fl brain slices, a pCIG-Cre plasmid was used (a kind gift by P. Vanderhaeghen).  
Focal Electroporation Focal electroporation of MGEs from E13.5 WT, Zeb2fl/fl, or Zeb2;RCE|Nkx2-1 embryos was done as described previously (Passante et al., 2008) and carried out with the aforementioned plasmids at 1 mg/ml and 4% fast green (Sigma). For overexpression, pCIG-mUnc5b was mixed in a 1:1 ratio with pCIG (0.5 mg/ml) and 1 mg/ml was used for the pCIG-rUnc5b construct. To rescue the migration of Zeb2 KO interneurons, mouse Unc5b siRNAs (Smartpool, ON-TARGET plus, Thermo Scientific) or a NT pool of mouse siRNAs were used (200 mM) and mixed with pCALNL plasmid (1 mg/ml) to trace the electroporated cells. Electroporated slices were cultured for 3 DIV using an air-interface protocol (Polleux and Ghosh, 2002). Slices were fixed with 4% paraformaldehyde and analyzed via confocal microscopy (Nikon A1R Eclipse Ti). For each condition, we quantified (via ImageJ software) the total amount of GFP+ or RFP+ cells in the slice and calculated the percentage of GFP+ or RFP+ neurons that reached the cortex. 
Statistical significance was determined using the χ2 test.  
Immunohistochemistry in Electroporated Slices Slices were preincubated for 1 hr with PBS containing 0.3% triton (PBST) and 10% normal donkey serum. Primary antibodies (rabbit anti-cleaved caspase-3, 1:500, Cell Signaling Technologies; goat anti-GFP, 1:200, Abcam) were added overnight at 4ºC. After washes in PBST, secondary antibodies (donkey anti-rabbit CY3 and donkey anti-goat Dylight 488, both at 1:1,000, Jackson ImmunoResearch) were applied overnight at 4ºC. Slices were washed in PBST and mounted in Mowiol, and pictures were taken with a Nikon A1R Eclipse Ti confocal microscope.  
Accession numbers Data sets have been deposited in the GEO under the accession number GSE35616 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35616). 
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7.1 Increasing congruity of research disciplines over time   Molecular and cellular biomedical research has benefited from several seminal, often technological inventions and has become a truly multidisciplinary branch over the last 10 years. Overlapping fields and until recently separated fields need to connect to study complex system-based models and provide detailed molecular-mechanistic explanations. This has affected older disciplines such as developmental biology or embryology as typical examples and the focus of our Leuven based team for the last 25 years. Developmental biology is mainly concerned about the understanding of all developmental stages, from fertilization to early embryos and subsequently fetuses, and increasingly also early post-natal development, in particular for studies of the nervous systems. For many decades, nearly all studies were descriptive in nature and restricted to the resolution of the human eye. After the discovery and widespread use and further development of microscopy an enormous increase in resolution resulted in the expansion of the studies of model organisms. This benefited the developmental fields and resulted in a deeper understanding of embryos and (sub)cellular structures.    Many of these observations are still the foundations of modern biology and as such it is a prime example of how developmental biology is a field where researchers build on top of inherited notes and remarks and gradually collect more knowledge. To my opinion, a slightly different story presents itself in the area of genomics, where for a long time the single-most important technology to sequence DNA was, after chemical degradation (Maxam-Gilbert sequencing) the chain termination or Sanger method (Sanger et al., 1977). Despite being revolutionary this technique is eventually expensive, cumbersome and time-consuming and it was only after the break-through of next-generation sequencing, for a great part driven forward by the Human Genome Project (Lander et al., 2001), that sequencing both DNA (and RNA) became widespread and commonly used in almost all labs and projects. Although many genomes, epigenomes and transcriptomes have meanwhile been mapped, sequenced and very well functionally annotated we have only witnessed the start and early expansion of this field. This is reflected in the presentation of novel insights and interpretations concerning genomic structure and its dynamic regulation, including in a chromatin based architectural (and dynamic) setting, at an almost daily rate. Both such genomics and modern developmental biology, and by recent expansion also the field of stem cell research, are continuously meeting each other in the area of network biology. The latter focuses on the understanding of complex biological phenomena that can best be described by documenting the intricate coordination of its often large number of actors, interactions and co-occurring events. Network  inference is intertwined with systems biology which harbors a large and diverse number of applications, including visualization, description, prediction and modeling.    
7.2 How to network?  Networks are part of our daily life, consider as easy examples roads connecting cities, the network based and hierarchical structure of big organizations (universities, companies). Or how we are all loosely connected to each other’s’ life – now more then ever - via social networks. 
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Despite the omnipresence of networks, the arrangement of its elements or topology was to my knowledge described for the first time with Euler (1707–1783) studying the “Seven Bridges of Königsberg”. This presented in fact a historical mathematical problem where people sought to identify the optimal path to connect 2 islands and the mainland of the city Königsberg using some constraints on how often and in what direction one of these seven bridges could be used. Although Euler only managed to show that this problem had no solution it served truly as the starting point for network analysis.    Perhaps the practical use of networks outside mathematics started only with the realization that most ‘real’ networks display characteristics of scale-free and small-world networks instead of random networks. Only recently the network paradigm has been introduced for analyzing and constructing functional networks such as transcriptional regulatory networks (TRNs). Each TRN is a directed network that depicts in its simplest form the organization of TFs and their downstream target genes, allowing a conceptualization and analysis of a multi-component (gene transcription regulatory) system instead of one specialized component of it. The inference of these networks can greatly vary and should in theory always be driven by a pre-formulated biological question, which can start from studies on one component or a functional interaction or co-operation between limited numbers of them. In Chapter 2 of my PhD thesis research I devised a customized network inference strategy that combines several approaches, but still in a feasible, manageable manner, with the specific aim to get deeper insight in the transcriptional regulatory landscape that controls and is controlled by the well-studied and omnipresent TGF signaling system in our case.  
Selection is key To select and filter for relevant components/genes we first used a knowledge and literature based approach, which displays great overlap with assembled, literature-curated databases such as the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genome Elements (KEGG) sets. However a significant selection bias can be present when relying solely on this type of information. First, there is strong bias due to historic context of a gene. Researchers are more likely to continue working on or selecting for a gene for which previous data already exists. Although many of these genes do fulfill crucial roles, it also has led to the observation that a large fraction of the research community works on a relatively small fraction of known annotated genes.    Second, context can be a major source for bias by relying on information that was derived from different species, cell types or stages. In recent years it has become clear that certain frequently used systems, e.g. HeLa or Hek293T cells (true workhorses in labs) have their merits but also display their own very unique set of properties (including their transformed state) that cannot easily be translated to other cellular systems. To partially account for these known biases we supplemented our pre-determined list with differentially regulated genes that were identified using available other types of data, i.e. microarray datasets that made use of similar cellular differentiation systems.  
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Perturbations to derive regulatory logic To infer the edges/links/interactions between the nodes/vertices of a regulatory (here: transcriptional) network there are 2 common used approaches, i.e. co-expression and perturbation studies. The first one fails to derive any direct causality between identified interactions, but can nevertheless be extremely useful when complemented with additional, mostly functional data. Moreover attempts to infer valuable co-expression networks at the single-cell level have merely highlighted the need to solve concurring technical difficulties and to be cautious when interpreting GO based – or biased - on bulk cell data (see paragraph above) (Crow et al., 2016). Large-scale genetic screens have been pivotal for several biological discoveries. Random insertions or other types of mutagenesis have been applied to create for example random perturbations (in many animal species raging from fruit fly over worms to zebrafish and mice) that – if resulting in an observable phenotype – can ideally be traced back to the mutant allele (Amsterdam et al., 1999), meanwhile facilitated by various genomics technologies. Most of these approaches are collectively denoted as forward genetics and will still increase in project numbers because of the rapidly evolving, new efficient and fast gene-editing methods. In recent years more time and effort has been invested in sequence-specific genetic perturbations (or reverse genetics). RNA interference (RNAi) or the reverse overexpression of selected (trans)genes have been the most popular tools (Ding et al., 2009; Fazzio et al., 2008; Gingold et al., 2014; Kittler and Buchholz, 2005; Kittler et al., 2004). These are reasonably easy-to-use tools amenable for high-throughput screenings in a plethora of cell types and culture conditions, especially due to having a good trade-off between specificity and duration needed to detect an induced perturbation effect.    One major drawback of RNAi is the generation of off-target effects that can result in many false-positives that would require extensive validation. We sought to reduce this negative effect by making use of endoribonuclease prepared siRNAs, which are a mixture of enzymatic prepared mixture of siRNAs that all share the same target, but have different and thus diluted off-target effects (Kittler et al., 2004). Perhaps a more complex problem of RNAi is the fact that it works at the post-transcriptional level and it remains difficult to properly asses the efficacy of the knock-down, i.e. what is the maximum efficiency, duration and effect at protein level and, furthermore, how can we factor-in the kinetics of the targeted transcript itself? To overcome some of these limitations a new and very promising tool, CRISPR/Cas9 and its variants have already been used. This toolbox has the potential to be used to inhibit or induce specific expression, but can also perform subtler modifications of genomic regions and dissect the role of non-coding regulatory regions (Fulco et al., 2016; Sanjana et al., 2016).  
Spatio-temporal interpretation of perturbation effects To increase the possible impact and the underlying understanding of our perturbation screen we complemented the perturbation data with temporal and single-cell expression data (which became available during the course of my work), which allows us to make a more integrative analysis of mRNA expression level changes. However future research will benefit from more multivariate datasets that can simultaneously document changes in morphology, extracellular proteins (Bodenmiller et al., 2012) and/or activation status of signaling pathways using multiplex technology (O’Connell et al., 2016). From a more functional point-of-view the characteristic path between perturbation and read-out time-point is crucial to understand the 
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biology on the one hand, but also the limitations of your data on the other hand. While most screens have been performed on steady-state cell lines or compare two states, they intrinsically fail to capture the dynamic of longer-term differentiating cells. This dynamics is key in a field like developmental and stem cell biology and prompted us to perform transition perturbations between each identified cell stage, allowing us to document the role of each interaction in a more natural context. The group of Aviv Regev (Broad Institute, Boston, USA) followed similar logic in their quest to understand T-helper cell activation and differentiation (Amit et al., 2009; Yosef et al., 2013). Recently they have also integrated a spatial component by using zebrafish animal caps as a model system for which they had also obtained detailed in situ hybridization data for most of the crucial genes (Satija et al., 2015). A more combined approach is emerging and is generally referred to as spatial transcriptomics, which allows simultaneous visualization and quantitation of  thousands of transcipts with spatial resolution in individual tissue sections (Ståhl et al., 2016).    Although we do not have the same spatial information, and also considering that our team transited from a single-gene focus in embryology to a small scale systems-biology type of approach, we first invested time to create a robust, reproducible and homogeneous differentiation system. Moreover, despite the fact that we can demonstrate functional interactions by a combination of functional (including epistasis) analysis and biochemistry (protein-protein and protein-DNA interaction) characteristic to our team, we often lack the information to specify the relationships/interactions as direct or indirect. Using the Embryonic Stem Cells Atlas of Pluripotency Evidence (ESCAPE) (Xu et al., 2013) we verified if the downstream targets of our TF based interactions exhibited ChIP-seq identified binding sites within their promoter regions, but found only partial or little overlap (data not shown). We also could not detect specific chromosomal organization for the components of the TGF family system nor seemed there to be cis-enrichment for interactions (data not shown).    It is also worth situating transcriptional interactions in an evolutionary perspective to try to make sense of transcriptional networks. This has recently been done by Sorrells and AJohnson, who explain that there are basically 2 broad views on TRNs (Sorrells and Johnson, 2015). One is where TRNs are designed under evolutionary stress to match exactly its/their task and another one that takes evolution into account. Although the first view seems very intuitive, these authors eloquently discuss that if you take the chemo-physical properties of DNA and network changes into account it is in fact the latter view that provides a convincing explanation of the generation of master TFs and scale-free networks. Moreover, it also provides an explanation why many observed interactions, here defined as trans-acting TF binding on a cis-regulatory sequence (proximal or distal, including long linear distances), do not appear to be functional, although it remains difficult if not impossible to verify this in all possible contexts. Nevertheless, with the choices we made we do not have this problem as we define our interactions to be based on causality, i.e. a perturbation of gene X leads to an effect on gene Y, for which we hypothesize that at least a fraction of the TF-target gene interactions may be direct or via an intermediate TF that is not part of our small and selected list of genes.  
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7.3 Single-cell analysis, increasing knowledge with increasing complexity  The classification of cell types has been going on since Hooke first observed multicellular structures in plants and animals already in 1665. A common rough estimate for the number of human cell types is generally accepted to be 250, but these defined cell types are themselves both morphologically and functionally quite diverse. This diversity is also reflected at the transcriptional level, even in sometimes seemingly homogeneous, isolated cell populations. As such single-cell measurements might aid in the proper (sub-classification) of cell types and stages, for they can overcome the limitations of averaging single-cell signals from individual cells (see also Chapter 1.5.2).   One of the pitfalls in single-cell transcriptomic research is the low quality and hence processing and interpretation of data. This often results into very sparse data matrices that contain large number of zero’s, which might be due to missing values or no expression of certain transcripts. One of the most sensitive genome-wide single-cell transcriptome workflows is the combination of the C1 biomark platform (Fluidigm) and Smart-seq2 protocol. However recently Fluidigm itself has finished experiments (data not yet published) illustrating that single-cell qPCR has far better sensitivity and technical reproducibility compared to the genome-wide approach. In other words, if you are specifically interested in a limited group of genes whose expression might be low or experiencing drastic changes over time, then single-cell qPCR is still the best approach. Using the latter approach, we have shown that we can detect very subtle subpopulations, which might be preferentially termed primed populations depending on the definition of a subpopulation, that shows relevance from the biological perspective and can be maintained over different cell stages.    The next step would be to integrate multiple single-cell sources of information, ideally performed in the same cell, to avoid spurious correlation efforts. One technique has recently been published where previous protocols were extended and taken to separation of cytosolic RNA (for transcriptome profiling) and genomic DNA form the nucleus (to measure DNA-methylation) and obtain simultaneous read-outs for RNA level changes and DNA-methylation changes (Hu et al., 2016). In this particular study they were able to show that in neurons significant correlation of transcription variance and promoter or gene body methylation depends largely on the presence or absence of CpG islands. This technique would be a perfect complementation for studies performed in Chapter 3 and 4, where we noticed that both Zeb2 and Smad1/5 deficient mESC display changes at both the transcriptome and DNA-methylome level. Moreover in both systems we were able to demonstrate or deduce that single-cell heterogeneity played an important role in making cells more susceptible to signaling cues.       
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7.4 Communication and dynamics between transcription factors and epigenetic 
landscape  In Chapter 3 we provided evidence that BMP signaling, mediated via Smad1/5, was responsible for maintaining low(er) levels of DNA-methylation in both naïve ground state (Smad1/5 deficiency in 2i +LIF) and naïve metastable conditions (BMP responsive reporter in serum + LIF). This was further in agreement with the observation that BMP signaling was associated with higher Tet1/2 and lower Dnmt3a/b levels. These groups of genes, which are part of the core methylation machinery, were also affected in the Zeb2-deficient mESC (Chapter 4). Here we observed that Tet1 protein (and mRNA) levels remained high in differentiating embryos and although these cells initially acquire proper global DNA-methylation, they show the propensity to loose these differentiating marks upon introduction of neural differentiation stimuli. Interestingly this indicated that these cells could commit to an epiblast-like cell fate, but were also able to revert back to a more undifferentiated state after several days and passages in strong differentiation-stimulating conditions. It remains an open question as to how methylation, and by extension all DNA modifications, can be interpreted by the cellular transcriptional regulatory network. And although DNA-methylation is probably the most and best studies modification, it took the research a long time to realize that its function is multi-faceted and goes beyond simple site-specific repression of transcription.    One attractive hypothesis that gained increasing evidence very recently concerns about the number of factors that can bind to and hence recognize methylated DNA. Originally this was restricted to a limited set of proteins with a methyl-CpG binding domain (MBD), however it seems likely that a big group of TFs could with time be added to this list (Zhu et al., 2016). For example, genome-wide techniques and arrays to discover methylation-specific binding of TFs lead to the realization that TF specific putative binding sequences could vary depending on the methylation profile of aforementioned sequences. Some of these factors include genes that are in fact downstream or involved in TGF signaling, such as Smad4, Gata proteins, Klf proteins, but also many others were detected. It remains to be documented how Zeb2 and Smad1/5 are themselves, or their necessary co-factors, influenced by DNA-methylation, thereby switching roles and/or downstream target genes. For example, Morikawa’s paper also demonstrated that Smad1/5 was dispensable for maintaining naïve pluripotency and that they were able to show that this was mediated via differential usage of Klf factors (Morikawa et al., 2016). This included binding – and thereby inhibiting – Smad1/5. It would be an interesting exercise to examine the role of methylation influenced by BMP signaling itself on Klf function and genomic deposition alterations, providing a potential system to study the interplay of TFs and the methylation machinery to maintain a highly responsive balance between pluripotency and differentiation. Perhaps, and taking years of studies of BMP together, an intrinsic philosophy of BMP effects in addition to steering differentiation may very well be to cause “confusion” in cell populations/states by its intended creation of heterogeneity of response in a seemingly homogeneous cell population as part of the often referred to as “contextual effects” of these ligands.       DNA-methylation has also been shown to be an important mediator for the deposition of histone marks, including both repressive (e.g. H3K27me3) and active (e.g. H3K27ac) marks in 
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mESCs  at promoters and enhancer regions (King et al., 2016). In our Zeb2 KO mESC we also noted that enhancers were preferentially demethylated when cells reverted back to more pluripotent states (data not shown). Furthermore this connects to the 3D regulatory landscape, which is missing in our and many other studies, but appears to be crucial in future projects to define genomic neighbourhoods and the associated regulatory regions. Important roles to establish these neighbourhoods are attributed to Cohesin, CTCF and also the lesser known CTCFL (BORIS), whose genomic binding profiles can be influenced by methylation changes (Flavahan et al., 2016; Maurano et al., 2015). Hence it would be informative to dissect the hierarchy between Zeb2, Tet1, methylation and histone modifications when cells either revert back or differentiate.   
7.5 Where is this path taking us? This PhD thesis provides a primer to understand how the field of biological research is changing at record pace. It describes the importance of experimental design and reproducible research especially when applied to projects that benefit from a holistic approach. We show how genome-wide analysis provides crucial information to describe the genotype-phenotype association in both in vitro and more complex in vivo projects. In theory, a combinatory methodology of aforementioned projects would provide all the tools to dissect even the most complex biological mechanisms and processes in a relevant biological context. This would allow us to direct progenitor cells towards more mature and functioning cells or understand where errors can occur leading to for example tumor formation. However the methods and infrastructure to generate these kinds of datasets is not a bottleneck anymore. The number of genomic datasets increases exponentially and so does the number of inferential (e.g. CRISPR/Cas9) and observational techniques covering a broad spectrum of the regulatory layers of the epi-genome (structural variants, methylation, nucleosome and histone modifications, …) and transcriptome (alternative TSS, intron retention, alternative polyadenylation, …). The problem surfaces at the level of analyzing these integrating and high-dimensional datasets and communicating the results in an understandable and useful manner to a broader public and thereby maximizing its value.  While the human brain is an almost perfect machine in text, speech and image processing it is not intrinsically designed to understand a developing network or genome. Therefore we will need to accept our limitations and overlap this gap with quantitative super-human intelligence, which is better known as machine learning (ML). The field of ML is very broad and diverse and to achieve good performance it can not be used in an arbitrary manner, but will require – the training of - scientists that understand both theoretical and practical knowledge of the methods used and the biological research application area (Libbrecht and Noble, 2015).     
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